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Abstract 
The general mechanisms employed by the immune system have been widely 
understood; but we are still far from knowing how to support the immune system 
for all diseases and functional decline with age. Computational immunology is the 
promising field that uses high-throughput technologies to expand our holistic view. 
This study adopts bioinformatics methods to address questions of both technical 
and biological relevance using gene expression and flow cytometry.  
I used human and mouse co-expression maps to define evolutionary differences 
and similarities not only in the immune system, but also in other tissues, pathways 
and diseases. There is an overall conservation between the mouse and human 
immune system, however there are specific pathways that show signs of 
divergence, e.g. pathways related to the IFN alpha/beta, butyrophilins, defensins, 
prolactin and protein degradation for MHC class I antigen presentation. 
In addition, given the importance of flow cytometry to understanding the immune 
system, I developed the tool flowAI to perform quality control on flow cytometry 
data either automatically or interactively. flowAI detects and removes outliers and 
other anomalies from the aspects of flow cytometry: 1) flow rate, 2) signal 
acquisition, and 3) dynamic range. 
Finally, I analysed RNA-Seq data from 29 immune cell types to derive detailed 
insights on their transcriptional patterns, normalization and deconvolution. The 
cell subsets for which I found minimal gene expression specificity belong to 
memory cells. The transcriptomic composition was determined and expression 
values normalized for mRNA abundance were used to perform absolute 
deconvolution.  
In conclusion, the research areas that will mainly benefit from this thesis are related 
to translation from mouse models to human, standardization of flow cytometry 
analysis, and transcriptomic analysis of blood heterogeneous samples.  
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Preface 
Being admitted in a stimulating PhD programme is half the battle. I think I won 
that half, since it was a programme of 4 years, of which the first year was in 
Liverpool, the second and third year in Singapore, and the last one again in 
Liverpool. Singapore is one of the strongest economies in Asia and it has 
experienced impressive growth in recent decades. The Agency for Science, 
Technology and Research (A*STAR) of Singapore is a governmental body that 
strives to produce excellent research in a competitive global economy. A strategy 
for its mission is the establishment of collaborations with universities from all 
around the word. For the two-year placement in Singapore, I ended up in the 
Singapore Immunology Network (SIgN), an institute that focuses on 
immunological research located in Biopolis, one of the two main poles of 
A*STAR. SIgN is admirable for both the internal structure and its external 
relationships. Its flow cytometry facility is the largest in South-East Asia, allowing 
it to rapidly process blood samples from its own employees, as well as the 
neighbouring hospitals.  
When I started my PhD, I had a certain apprehension about the project I was 
embarking on. Upon finishing my masters’ project in bioinformatics analysis on 
lung cancer samples, I thought it would have been the right thing to continue with 
bioinformatics. Over the years, my fascination for how computational methods are 
useful to understand biomedical concepts has grown incessantly. In particular, I 
have been intrigued by the complexity of the immune system and how much 
bioinformatics can help interpret its mechanisms. 
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Chapter 1 Introduction 
The human body is equipped with an elaborate system, i.e. the immune system, to 
protect us from external invaders. Its complexity is the result of thousands of years 
of evolutionary processes. Several biological mechanisms involved in antigen 
recognition, signalling and killing, have been optimized to defeat viruses, bacteria, 
fungi and cancer cells. Despite the discovery of several effective drugs and 
therapies against pathological conditions, a well-functioning immune system 
remains crucial for a healthy life. 
Edward Jenner was a pioneer in the field of immunology whose observations led 
him to develop the first vaccination in 1796. A more recent achievement is the 
development of the hybridoma technology by Georges Kohler and Cesar Milsten 
in 1975 that allowed the mass production of monoclonal antibodies. These, and 
other findings, have contributed to the development of immunotherapy strategies 
that consist of inducing, enhancing or suppressing immune responses in the 
treatment of diseases.  
As technologies progress and high-throughput data volumes increase, the task of 
analysing and interpreting results becomes more overwhelming for biologists. For 
instance, microarray and next generation sequencing technologies require various 
pre-processing algorithms and statistical analyses to discern biological meaning 
from the raw data (de Magalhães et al., 2010; de Magalhães and Tacutu, 2016). 
Another example is the older flow cytometry technology that now requires 
bioinformatics expertise for conclusive data interpretation because of its recent 
advancement. At present, high expectations are placed on high-throughput data 
analysis to unravel immunological complexity. The need to develop and apply 
computational resources to study large scale data on the immune system has 
created the scientific field of computational immunology or immunoinformatics. 
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Thesis Outline 
This thesis consists of six chapters in total. The introduction in the first chapter is 
followed by three independent result chapters which are concluded by the 
discussion and conclusion chapters. The structure reflects the fact my time was 
divided between Singapore and Liverpool during my PhD programme. Due to the 
changes in environment and priorities, I embarked on different projects throughout 
the programme. The projects, however, all share concepts derived from 
immunology, gene expression and flow cytometry, which are elucidated broadly 
in the introduction in chapter 1. The three results chapters, 2-4, expand these 
concepts by giving new insights into immunology and data analysis techniques. 
Chapters 2 and 3 are based on two publications, and chapter 4 is currently under 
review. Since I employ distinctive methods to obtain the results depicted in 
chapters 2-4, I include the methodologies together with the corresponding results 
chapters rather than having a general materials and methods chapter in the outline. 
In chapter 5, I summarize the findings obtained throughout my PhD, putting them 
into context with current research, and present an outlook on potential works in 
computational immunology that could be derived from my thesis. Finally, chapter 
6 gives conclusive remarks on the major findings and the immediate impact that 
those will deliver.  
1.1 The Immune system 
The immune system is generally described as a complex dynamic network. This is 
because it is composed of organs, tissues, cells, molecules and soluble factors that 
interact with each other in constantly changing processes. After a brief 
introduction on the “three lines of defence” of the immune system, I describe the 
different cell types that compose the immune system since it is relevant for chapter 
4, where I report bioinformatics analyses on 29 immune cell types. Later, I detail 
further how they communicate through soluble factors and molecules, and I 
highlight some of the abnormalities that are clinically relevant for the diagnosis 
and therapy of immune system diseases. The understanding of immunological 
processes is necessary to interpret the functional enrichment analyses of related 
gene sets that I report in chapter 2 and 4. Concepts on antibodies and surface 
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receptors are relevant for chapter 3 and 4 where they are used to discriminate 
among different immune cells through flow cytometry. Finally, I introduce the role 
and impact of computational immunology in immunological research that sets the 
befitting context for the entire PhD thesis.  
Three lines of defence 
To protect our body against external invaders the immune system implements three 
lines of defence mechanisms: 
1. The physical barrier 
2. Innate immune system 
3. Adaptive immune system 
The first line of defence, the physical barrier, is essentially constituted of skin, 
mucosa and body secretions. The last-mentioned includes stomach acid, tears, 
earwax and mucus. All these physical barriers, in most cases, passively keep away 
microorganisms from our internal organs (Storey and Jordan, 2008).  
The second line of defence, the innate immune system, mounts non-specific 
immediate responses to the external invaders by recognizing peptides and other 
molecules that are broadly expressed by different microorganisms, or generated 
during disease (Tosi, 2005). 
The third line of defence, the adaptive immune system, adopts more complex 
mechanisms by generating specific responses for any kind of molecule that is not 
produced by the organism itself. Adaptive immune responses require more time 
than the innate response (Parkin and Cohen, 2016).  
1.1.1  The white blood cells 
The cells circulating in the cardiovascular system belong to one of two main 
groups, either red or white blood cells (Figure 1.1). Red blood cells are essentially 
represented by erythrocytes which are charged with the task of carrying oxygen 
throughout the body. White blood cells, also called leukocytes, are part of the 
immune system and are classified in three main categories: granulocytes, 
monocytes and lymphocytes. White blood cells are a mixture of phenotypically 
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and functionally diverse cell types. For example, granulocytes contain multilobed 
nuclei while lymphocytes have a well-rounded nucleus. However, this is an 
example of an extremely different phenotype noticeable even with a normal optical 
microscope. 
Monocytes and lymphocytes are referred to as peripheral blood mononuclear cells 
(PBMCs) because their nuclei are not segmented as for the granulocytes. 
Researchers often use PBMCs because there is a convenient method based on 
density gradient centrifugation to separate these cells from erythrocytes and 
granulocytes. It was developed in the 1964 and it consists of adding a density 
gradient medium (e.g. Ficoll) and a centrifugation step (Bøyum, 1964). 
 Granulocytes are part of the innate immune system and are subdivided into 
neutrophils, basophils and eosinophils. Neutrophils comprise 50-70% of the total 
leucocytes in the blood, which in turn only constitute 2-3% of the body’s 
neutrophils since the rest are found in the bone marrow and in tissues (Storey and 
Jordan, 2008). Neutrophils are summoned by infected tissues where, after 
activation, they proceed to kill microorganisms by engulfment, secretion of anti-
 
Figure 1.1 Schematic representation of haematopoiesis. All immune cells originate from the 
hematopoietic stem cells (HSCs) in the bone marrow. After different developmental stages the immune 
cells are released into the blood stream. Only a small number of developmental stages are reported in this 
representation. 
BONE MARROW
PERIPHERAL
BLOOD
THYMUS
PERIPHERAL
BLOOD
RED CELLSPLATELETS WHITE CELLS (LEUCOCYTES)
PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC)
T cellB cellNatural killer cell (NK)
Monocyte
NeutrophilsEosinophils Basophils
Hematopoietic stem cell (HSC)
Common myeloid progenitor (CMP) Common lymphoid progenitor (CMP)
Megakaryocyte
Erythroblast
Thrombocytes
Mast cell
Myeloblast
Erythrocyte
Plasma cell
Thymocyte
GRANULOCYTES
LYMPHOCYTES
 5 
microbials, and formation of neutrophils extracellular traps (NETs). Both 
basophils and eosinophils are associated with allergic reactions and their 
frequencies in blood is very low. Basophils constitute about 0-5-1% of white blood 
cells (Ducrest et al., 2005; Jiang et al., 2015), and similarly to mast cells, secrete 
heparin, histamine and leukotrienes after stimulation. Eosinophils account roughly 
for 1-4% of leucocytes and are thought to be associated with chronic allergies (e.g. 
asthma) and in the destruction of parasites that are too large to be phagocytosed; 
however, their role is still not clear (Rosenberg et al., 2013).  
Monocytes are also part of the innate immune system and eventually give rise to 
macrophages distributed throughout the body. Monocytes constitute 5-10% of the 
leukocytes (Gordon and Taylor, 2005), and can be subdivided into classical, 
intermediate and non-classical monocytes (Ziegler-Heitbrock et al., 2010). Each 
of the three classes display its respective functions of phagocytosis activity, 
production of pro-inflammatory cytokines and patrolling activity (Sprangers et al., 
2016). 
Dendritic cells (DCs) are another relevant immune cell type considered to be 
functionally related to monocyte and macrophages (Guilliams et al., 2014). 
Although DCs abundantly reside in tissues, the precursors can also be found in 
blood in low percentages in the blood. Together with macrophages and B cells they 
constitute the professional antigen presenting cells (APC) involved in the 
stimulation of the adaptive response. Dendritic cells have been grouped in two 
main subsets having different ontology and morphology, the myeloid DC (mDC) 
closely related to monocytes and plasmacytoid DC (pDC) morphologically similar 
to plasma cells (Hashimoto et al., 2011; Merad et al., 2013). 
Lymphocytes are subdivided in T cells, B cells and Natural Killer (NK) cells. T 
cell frequency is about 7-24% of leucocytes and they are further subdivided into 
cytotoxic T (Tc) cells, helper T (Th) cells, and regulatory T (Treg) cells. Briefly, 
Tc cells directly destroy tumour cells and virus-infected cells, Th cells promote the 
immune response of other cells such as Tc cells and B cells, and Treg cells 
modulate the immune responses to prevent autoimmune diseases. About 1-7% of 
leukocytes are B cells which, upon maturation into plasma cells, produce large 
quantities of antibodies (Broere et al., 2011). T cells and B cells are part of the 
 6 
adaptive immune system since each cell can only recognise specific epitopes 
thanks to their receptors, T cell receptor (TCR) and B cell receptor (BCR), 
respectively. Moreover, a subset of activated B cells and T cells generated during 
disease are kept in a memory compartment for a more efficient future immune 
response. NK cells are 1-6% of leukocytes and their role is analogous to the one 
of Tc cells. NK cells are considered to be part of the innate immune systems, even 
though it has recently been found that they show also memory properties that are 
typical for the adaptive immune response (O’Sullivan et al., 2015).  
There are more cell types that constitute the circulating immune cells in low 
frequency that are increasingly generating interest among immunologists. Mucosal 
associated invariant T cells (MAIT cells) and γδ T cells, for example, are two 
kinds of so-called “unconventional” T cells because they express an invariant 
TCR. Thus “unconventional” T cells reside at the border between the innate and 
adaptive immune system. Other examples are the innate lymphoid cells, recently 
described as the innate counterpart of helper T cells (Eberl et al., 2015), and 
myeloid-derived suppressor cells (MDSCs) which are considered to inhibit anti-
tumour immune response (Khaled et al., 2013).  
1.1.2 Soluble mediators 
Immune cells continuously patrol tissues or travel throughout the body in a resting 
state, but in the case of infection, certain cell types are activated and drawn via 
chemotaxis to the site of infection/disease. The messengers that regulate the 
immune processes are small soluble mediators that include cytokines, antibodies 
and complement proteins.  
Cytokines 
Cytokines are polypeptides, peptides and glycoproteins mainly secreted by helper 
T cells and macrophages, but also by B cells, mast cells, and other cells outside 
the immune system, such as endothelial cells and fibroblasts.  
The actual classification of cytokines can be rather misleading. This is due to the 
initial assignment of nomenclatures after the discovery of only a single or few 
properties of a cytokine. The name interferon (INF) refers to the resistance activity, 
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hence interference, against viruses (Isaacs and Lindenmann, 1957); the name 
colony-stimulating factors (CSF) denotes the ability of supporting proliferation 
and differentiation of white blood cells (Robinson et al., 1967); the name tumour 
necrosis factor (TNF) derives from the cytotoxic activity towards tumour cells 
(Carswell et al., 1975).  
In 1979, an international workshop was held in order to create a standard 
nomenclature system. The term “interleukin” was proposed for all the cytokines 
involved in the communication between leukocytes (Aarden et al., 1979). 
Subsequently, newly discovered interleukins were named as interleukins followed 
by a sequential number. At the time of writing, the latest member of the interleukin 
family is IL-40 (Catalan-Dibene et al., 2017). Although most cytokines are now 
named interleukins, many still preserve the original name assigned when firstly 
identified (e.g. IFN-α/β, TGF-β, GM-CSF). 
More recently, a new subfamily of cytokines has been identified and named as 
chemokines (Murphy et al., 2000). They are distinguished for their ability to attract 
cells to a specific locus using so-called directed chemotaxis. Chemokines are 
assigned to four groups according to their cysteine residues: C, CC, CXC, and 
CXXXC chemokines. 
The Complement system 
The complement system was first discovered in the 1890s and it is composed of 
about 30 proteins (Nesargikar et al., 2012). The complement proteins act together 
with the aim of destroying foreign pathogens through several mechanisms. The 
mechanisms of action mainly associated with the complement are: opsonisation of 
the pathogenic surface to facilitate phagocytosis, assembly of a membrane pore on 
the pathogenic surface to induce lysis, and promotion as well as modulation of 
immune responses (Holers, 2014). 
Complement proteins act through a sequential process. The activation of the first 
protein of the process is followed by a precise chain of steps known as complement 
cascade. Many of the proteins are zymogens, i.e. inactive precursors that become 
activated after cleavage. The activation of the complement system can be initiated 
through three different activation pathways: the classical, alternative, or lectin 
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(Ricklin et al., 2016). The classical pathway was discovered first and it is triggered 
by the binding of IgM or IgG antigen/antibody complexes to C1q, the first protein 
of the cascade. The alternative pathway is less specific which lead to the 
assumption that it might be a more ancient activation mechanism. It consists of 
casual binding of the C3b protein to amino or hydroxyl groups attached to the 
surfaces of invaders and consequential cascade activation. The lectin pathway has 
a main player called mannose-binding lectin. Mannose is a common carbohydrate 
expressed on the surface of many common pathogens including bacteria, viruses, 
parasites and yeasts (Dunkelberger and Song, 2009).  
Antibodies 
Even though the concept of an antibody (Ab) was introduced more than a century 
ago, the monoclonal antibody (mAb) has been used for applications in research 
and human health-care only after the development of the hybridoma technology in 
1975 (Alkan, 2004; Weiner, 2015). The basic structure of the antibody resembles 
the shape of a Y with two identical heavy chains linked together and two identical 
light chains connected to the heavy chains. The antibody region corresponding to 
the stem of the Y is the constant (Fc) region and its main function is to 
communicate with other component of the immune system. The antibody regions 
corresponding to the two tips of the Y are the variable (Fab) regions that can 
recognize and bind to a specific epitope. The light and heavy variable regions are 
made from the somatic recombination of two (V and J) or three (V, D, and J) gene 
segments. 
Antibodies are also known as immunoglobulins (Igs) and gamma globulins. In 
mammals there are five isotypes of antibodies: IgG, IgM, IgA, IgD, and IgE. They 
are distinguished by the differences in their heavy chain that allow them to 
intervene in different immune responses (Schroeder Jr. and Cavacini, 2016). IgG 
is the most abundant which constitutes 75% of all the antibodies present in the 
serum, and it provides most of the antibody-based immunity. IgA is the second 
most common antibody and it is the main effector of the mucosal immunity (Woof 
and Mestecky, 2005). IgM appears in a pentameric form and it is the main player 
in primary responses, the first encounter of a foreign antigen by the adaptive 
immune system. IgM also constitutes the majority of natural antibodies which are 
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those produced without exposure of foreign antigens (Ehrenstein and Notley, 
2010). IgD is found mostly on mature B cells and its role is still not clear. IgD is 
known to be conserved among species and to cross-link with basophils and mast 
cells to stimulate the innate immune response (Chen and Cerutti, 2011). IgE is the 
last immunoglobulin discovered and it is associated with parasites protection and 
allergic reactions (Wu and Zarrin, 2014). 
1.1.3 Cell surface receptors 
A cell surface receptor is any molecule facing the outside of a cell bound to the 
plasma membrane waiting for a signal to transmit inside the cell. They are 
fundamental in connecting the dynamic network of the immune system by exerting 
functions like antigen recognition, cell-cell communication, adhesion and 
signalling. Surface receptors are also generally referred to as surface markers as 
they are used for the recognition of a specific cell type and as therapeutic targets.  
Many surface markers have been characterized by the specific binding of a mAb. 
However, the reaction of a single clone of mAb to a molecule is not enough to 
distinguish a surface marker. Researchers are confident that a new surface marker 
has been identified only when a number of different mAbs, indicated as cluster of 
differentiation (CD), uniquely react with the same polypeptide (Bernard and 
Boumsell, 1984). The International Workshop on Human Leucocyte 
Differentiation Antigen has been involved in classifying the new surface markers 
identified with mAb over the past three decades (Clark et al., 2016). The naming 
convention consists of adding a sequential number to the prefix CD (e.g. CD1, 
CD2, etc.). Further letters are occasionally added to indicate provisional 
classifications or variants of the same molecule (Engel et al., 2015). According to 
a recent study, even though there are 1,015 genes that code for plasma membrane 
proteins in immune cells and tissues (Diaz-Ramos et al., 2011), only 408 have a 
CD nomenclature (Clark et al., 2016). This is due to the fact that only surface 
markers that are immunogenic in mouse or other animal models are able to 
stimulate the production of mAb (Zola and Swart, 2003).  
The largest group of surface markers belongs to the Ig superfamily (IgSF) and 70% 
of its members have also a CD nomenclature (Diaz-Ramos et al., 2011). Ig 
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domains have a central role for the adaptive immune response. They constitute 
important immune cell surface markers like T cell receptor (TCRs), B cell 
receptors (BCRs), the major histocompatibility complex (MHC), most Fc 
receptors, and some co-receptors, co-stimulatory or inhibitory molecules and 
cytokine receptors (Williams and Barclay, 1988). The second largest group of 
surface markers are chemokine receptors, which belongs to the G-protein coupled 
receptor superfamily with only 15% of its members having a CD nomenclature 
(Diaz-Ramos et al., 2011). Other relevant surface markers are complement 
receptors, some pattern recognition receptors (PPRs), and other cytokine receptors. 
TCRs are heterodimers and belong to two classes: TCR-αβ and TCR-γδ. They are 
distinguished by the type of subunit chain that constitutes the receptors. The TCR-
αβ is made of the α and β chains, as indicated by the name itself, and is expressed 
by the majority of T cells, i.e. about 90-99% of them (Laydon et al., 2015). The 
TCR-γδ is comprised of the γ and δ chains and it represents only 1-10% of the T 
cell repertoire. The function of TCRs is to recognize antigens through an Ig-like 
domain made from the V(D)J segments used to make antibodies. It has been 
claimed that after thymus selection, approximately 2x107 different TCRs are 
produced, and defining how the vast TCR repertoire interacts with antigen 
presentation is an interesting challenge for computational immunologists (Arstila 
et al., 1999; Rossjohn et al., 2015).  
Major histocompatibility complexes (MHC) are the molecules that present the 
antigens to the TCRs. They fall into two classes: MHC-I and MHC-II. The 
difference resides in the way the antigen is pre-processed and in the recognition of 
two different TCR-αβ co-receptors, i.e. CD8 and CD4. MHC-I is expressed by all 
the nucleated cells in the body where the antigen is firstly pre-processed by the 
proteasome in the cytosol and secondly presented though an MHC-I molecule to 
cytotoxic CD8 T cells (Neefjes et al., 2011). MHC-II is expressed in professional 
antigen presenting cells where the antigen is phagocytosed, digested by lysosomes 
and loaded onto MHC-II molecules for presentation to helper CD4 T cells (Roche 
and Furuta, 2015).  
The B-cell receptor (BCR) is the transmembrane protein of the IgSF expressed on 
B cells. Naive B cells express IgD and IgM isotypes that, after recognition of the 
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specific antigen, transmit activation signals into the B cells (Geisberger et al., 
2006). Upon activation, B cells go through a process called isotype-switching, 
where the immunoglobulin isotype changes to IgG, IgE or IgA, and they become 
a plasma cells, a highly productive antibody manufacturer (Tarlinton, 1997). 
Fc receptors are surface molecules that bind the constant regions of antibodies 
(Hogarth, 2015). There are Fc receptors for any class of immunoglobulins and they 
are involved in two main functions: phagocytosis of opsonised microbes and 
release of pro-inflammatory molecules (Woof and Burton, 2004).  
The pattern recognition receptors (PRRs) are the means used by the innate immune 
system to detect the presence of microbes. PPRs recognize pathogen-associated 
molecular patterns (PAMPs) that are recurrent molecules of microbes, and 
damage-associated molecular patterns (DAMPs) that are cell components derived 
from cell degradation (Cao, 2016). There are five main classes of PPRs but only 
two of them are comprised of receptors expressed on the cell surface: Toll-like 
receptors (TLRs) and C-type lectin receptors (CLRs) (Brubaker et al., 2015). 
Cytokine receptors have been classified according to their structures. The largest 
group belong to the class I cytokine receptors characterized by the presence of 
peculiar features, such as a tryptophan-serine-x-serine-tryptophan motif and 
conserved cysteine residues. Class II receptors differ from the class I by lacking 
the tryptophan-serine-x-serine-tryptophan motif. Other cytokine receptor families 
are TNF receptors, IL-1 receptor proteins, TGF-β receptors, and chemokine 
receptors. The chemokine receptors differ substantially from the other receptors as 
they are the only G protein-coupled receptors (Vilček, 2003). Most of the cytokine 
receptors are responsible for the activation of the pleiotropic JAK/STAT signalling 
pathway that leads to proliferation, differentiation, cell migration and apoptosis 
(Rawlings et al., 2004). 
1.1.4 Immune response mechanisms 
Most immune cells originate from the same place, the bone marrow, but they start 
migrating at different maturation stages and to different places. For example, 
neutrophils continuously circulate in the blood stream to fulfil their main role of 
patrolling. Monocytes commit to a more specialized function only after they 
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interact with the environment they are summoned to dwell in. T cells progenitors 
migrate to the thymus for a highly stringent “education” and selection before they 
are released in the blood stream.  
The different immune cell types have very particular functions and by 
communicating with each other they create a powerful network that is resilient to 
many adverse conditions. In case of invasion, for example, the dendritic cells travel 
from the tissues where they reside in, such as skin and mucosa, towards spleens 
and lymph nodes to recruit B cells and T cells with the antigen presentation 
mechanism. In the meantime, since eliciting the adaptive response requires a few 
days, large supply of high motile neutrophils quickly reach the area of infection 
guided by chemokine signalling.  
There are several mechanisms simultaneously implemented by different immune 
cells to generate the dynamic immune network. In this section I will elucidate: 1) 
how immune cells get rid of pathogens though phagocytosis and cell mediated 
cytotoxicity; 2) how the adaptive response is evoked though antigen presentation 
and remembers previous infections through immunological memory; 3) how the 
immune system regulates and controls itself by tolerance and homeostasis.  
Phagocytosis 
It is believed that the mechanism of phagocytosis appeared early in evolution as it 
is used by amoebas as a feeding system (Cosson and Soldati, 2008). Phagocytosis 
has then been adopted as a defence mechanism by some cell types of the innate 
immune system: neutrophils, monocytes, macrophages, dendritic cells, and mast 
cells (Gordon, 2016). They are generally referred to as “professional phagocytes” 
to distinguish them from cells that also uses phagocytosis, but it is not their main 
function, such as epithelial cells, endothelial cells, fibroblasts, and mesenchymal 
cells (Rabinovitch, 1995). Phagocytes can ingest a different variety of foreign 
microbes and particles, including bacteria, viruses, dead cells, protozoa, and dust 
particles (Naik and Harrison, 2013).  
Phagocytosis is carried out in multiple steps. Initially, the phagocyte adheres to the 
target particle with membrane proteins. Then, the particle is engulfed by enclosing 
it in a vacuole called phagosome, which does not have the ability to digest it. 
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Hence, other organelles, lysosomes, fuse with the phagosome membrane to create 
the phagolysosome. Here, the phagocytes kill the microbes or digest the particles 
with reactive-oxygen molecules and hydrolytic enzymes (Naik and Harrison, 
2013). 
To help phagocytes in the recognition or engulfment, foreign particles or microbes 
are sometimes opsonized with either antibodies or proteins of the complement 
system. Hence, the phagocyte can more easily recognize them through Fc receptors 
and complement receptors. Besides the mere role of microbes killing, professional 
phagocytes are also specialized in controlling the adaptive response. T cells and B 
cells are in fact activated by the phagocytes’ production of pro-inflammatory 
cytokines or exposition to foreign peptides through antigen presentation (Naik and 
Harrison, 2013). 
Cell mediated cytotoxicity 
Cytotoxic lymphocytes, that include Tc cells and natural killer (NK) cells, can 
mediate targeted cell death by triggering apoptosis. This can be done in two ways: 
1) exocytosis of cytotoxic granules and 2) engagement of Fas ligand (Feig and 
Peter, 2007). 
The first way of inducing programmed cell death starts with the release of 
cytotoxic granules containing granzymes and perforins within immunological 
synapses. Perforins mediate the delivery of granzymes into the target cell through 
the formation of pores on the membrane (Voskoboinik et al., 2015). Once inside 
the cytoplasm, granzyme molecules induce apoptosis through different 
mechanisms. Granzyme B is the most studied granzyme and it mediates apoptosis 
by activating the caspase cascade (Bots and Medema, 2006). The second way of 
inducing apoptosis is simply carried out by releasing the Fas ligand that then binds 
to the Fas receptor on the target cell. This will activate the extrinsic pathway for 
apoptosis characterized by the initial formation of the death-inducing signalling 
complex (DISC) and subsequent activation of the caspase cascade. 
The way Tc and NK cells trigger apoptosis in the target cell is the same but the 
mechanisms of recognition of the target cell differ substantially (Voskoboinik et 
al., 2015). NK cells, as a part of the innate immune system, have a much fast 
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reaction time compared to Tc cells. They can recognize bacterial cells from their 
conserved residues, such as lypopolysaccharides (LPS), or infected cells as they 
release stress molecules upon viral infection, such as IFN-α and IFN-β (Long et 
al., 2013). Tc cells, instead, can only be activated upon antigen presentation by the 
target cell (Andersen et al., 2006). 
Antigen presentation 
Antigen presentation is the strategy adopted by the immune system to activate its 
adaptive arm. Although antigen presentation is a hallmark feature of the adaptive 
immune system, any cell of the body can take part of it. Essentially antigen 
presentation consists in stimulating the T or B cell receptors by presenting an 
antigen though a MHC molecule (Blum et al., 2013). 
The MHC class I displays mutated or foreign peptides that are already inside the 
cell. All the nucleated cells are committed to expose any sign of irregular activity 
within themselves on their cell surface. The MHC class I binds simultaneously a 
TCR and a CD8 co-receptor expressed on cytotoxic T cells. The MHC class II, 
instead, is only processed and displayed by the so-called antigen presenting cells 
(APCs) that include macrophages, dendritic cells and B cells. They internalize the 
antigen either through phagocytosis (macrophages and dendritic cells) or 
endocytosis (B cells). Once within the cell, the antigen is processed, bound to an 
MHC class II molecule and brought to the cell surface. The MHC class II will only 
bind and activate T helper cells through recognition of a CD4 co-receptor together 
with a TCR. An additional property of APCs, and primarily of DCs, is that they 
can also assemble and present exogenous-derived peptides with MHC class I in a 
process called cross-presentation (Andersen et al., 2006).  
As soon as T cell receptors are triggered, a signalling cascade within the immune 
cell lead to three main responses: 1) cell cycle activation, 2) metabolic changes, 
and 3) increasing of the apoptotic threshold (Wensveen et al., 2012). T cells that 
never encountered its specific antigen are called naive cells and their full activation 
requires multiple steps to avoid erroneous responses. The sole stimulation with 
MHC molecules bring T cells to a hyporesponsive state, generally known as 
anergy (Pennock et al., 2013). Some T cells that have already been activated once, 
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become memory cells and are more easily activated upon infection with the same 
pathogen (see next section). 
Memory  
Immunological memory is another hallmark of adaptive immunity. Once a naive 
lymphocyte has been activated, it clonally expands to increase the effectiveness of 
the immune response against pathogens. As soon as the pathogen is cleared, part 
of the lymphocytes will remain available in case of a secondary infection and they 
will constitute the memory fraction. 
More specifically, some activated B cells differentiate into plasma cells for the 
production of antibodies. Since those cells have a short life, a part of the activated 
B cells differentiates into memory cells and thus persists for several years. The B 
cells are antigen presenting cells, hence they are activated upon binding of Th cells 
to the MHC class II. Th cells that have been successful in recognizing an antigen 
will also differentiate into memory cells to maintain long-term memory and will 
provide a much stronger stimulation to B cells than naive Th cells. Similarly, 
memory Tc cells will lead to faster and more intense secondary responses upon 
binding with MHC class I receptors (Kurtz, 2004).  
More than a decade ago, from studies on invertebrates, it was also speculated that 
memory is not only a feature of the adaptive immune system, but is often adopted 
by the innate arm too (Kurtz, 2005). Newer studies have supported this hypothesis 
auspicating a paradigm shift from the concept that memory is not a feature of cells 
with immediate response such as granulocytes, monocytes and NK cells (Netea et 
al., 2015). 
Tolerance 
The ability to discriminate self-antigens from foreign ones is referred to as 
tolerance (Chaplin, 2010). It consists of the elimination of all the lymphocytes, and 
especially T cells that are reactive to self-antigens. For T cells, this process occurs 
mainly in the thymus (central tolerance) but can also occur in peripheral blood 
(peripheral tolerance). In the thymus, the TCR is exposed to a comprehensive set 
of self-peptides through both the MHC of class I and II. The T cells that recognise 
and bind to an epitope are negatively selected and killed by apoptosis. It has been 
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discovered that antigen presenting cells in the thymus overexpress a transcription 
factor, AIRE, to present hundreds of tissue specific genes (Eldershaw et al., 2011). 
Generally, as soon as T cells leave the thymus, they are safe to circulate without 
causing self-reactions. However, some T cells that react to self-antigens might still 
escape the strict negative selection occurring in the thymus, which makes it 
necessary for other peripheral mechanisms to take over. The escaped T cells are 
killed by other cells of the body though apoptosis induction or their activity is 
suppressed by either T regulatory cells or lack of co-stimulation. When there is a 
lack of co-stimulation, T cells enter into a state of long-term hyporesponsiveness, 
i.e. anergy (Xing and Hogquist, 2012).  
There are also some mechanisms of tolerance for B cells, but usually they are less 
aggressive since B cells require a strong stimulus from T cells to be activated and 
start their differentiation to plasma cells. Central tolerance for B cells occurs in the 
bone marrow where some autoreactive immature B cells can undergo to a process 
called receptor editing instead of apoptosis (Pelanda and Torres, 2012). 
Homeostasis 
At the end of any infection, the body has to restore the balance of immune cell 
components to its ordinary state. To regain cellular homeostasis the body once 
again employs apoptosis to remove the surplus of activated T and B cells (Chaplin, 
2010; Feig and Peter, 2007). 
1.1.5 Immune related diseases and conditions 
The immune system network can be altered at different levels by either the 
deregulation of any of the mechanisms described in the previous section or by an 
overwhelming breach of pathogens. The responsible factors are generally either 
genetic or environmental, and sometimes a combination of both. There are several 
types of immunological disorders and the most relevant can be grouped into one 
of the following categories: infection, immunodeficiency, cancer, allergy, 
autoimmunity, and immunosenescence. 
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Infections 
Infectious diseases are still among the leading causes of death, especially in third 
world countries. They are caused by infectious agents that include bacteria, 
viruses, parasites and fungi and they can spread through different mechanisms 
such as direct contact, vehicles and vectors.  
Most of the common infections, such as influenza, can often be overcome by the 
ordinary immune response. However, there are cases of more overwhelming 
infections that can cause severe chronic conditions or death. Worldwide initiative 
have been taken in eradicating these kind of infections by distributing vaccinations 
and adopting containment measures (Dowdle, 1998). The smallpox is the only 
example of a human disease eradicated worldwide. The eradication of other 
diseases is underway and it is giving satisfactory results. Despite this, researchers 
are still struggling to find definitive treatments for certain infectious agents, such 
as dengue virus, HIV, and new ones are appearing every now and then. 
Immunodeficiency 
Immunodeficiency refers to the state in which the body is incapable or impaired in 
the generation of an immune response. It can be the result of a congenital defect 
(primary immunodeficiency), or the consequence of another condition such as an 
infection (secondary immunodeficiency) (Warrington et al., 2011).  
A total of 130 primary immune deficiencies have been described and they can 
involve both arms of the immune system. An example of the genetic deficiencies 
that affect T and B cells is the severe combined immunodeficiency (SCID) 
(McCusker and Warrington, 2011). Secondary immune deficiencies are far more 
common than primary ones. An evincive example of secondary immunodeficiency 
is the acquired immune deficiency syndrome (AIDS) caused by HIV (Chinen and 
Shearer, 2010). 
Cancers 
Three types of cancer can affect blood cells: leukemia, lymphoma and myeloma. 
There are many overlapping features between the three types of cancer, although 
distinctions can be found.  
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Leukemias can be either acute or chronic, according to the rate of developing, and 
they generally affect peripheral blood cells, both of lymphoid and myeloid lineage. 
Hence there are four main types of leukemia, acute and chronic lymphocytic 
leukemias (ALL and CLL) and acute and chronic myelocytic leukemias (AML and 
CML). A breakthrough discovery that is worth remembering as it pioneered cancer 
genetics is the Philadelphia (Ph) chromosome involved in CMLs and reported in 
1960 (Greaves, 2016). 
Lymphomas mainly arise in lymph nodes and are classified in two types: 
Hodgkin’s and non-Hodgkin lymphomas (HL and NHL). The main difference is 
visible under a normal light microscope as the cells of the Hodgkin lymphoma are 
up to five times larger than normal lymphocytes and are referred to as Reed-
Stenberg cells (Gobbi et al., 2017). NHLs are more common than HLs and they 
are usually associated with viruses and immune deficiencies (Hennessy et al., 
2017). 
Myeloma, also known as multiple myeloma, is a type of cancer that affects only 
plasma cells. Beside the uncontrolled proliferation of malignant cells, this cancer 
is also characterized by other side effects, such as anemia, lytic bone lesions, 
hypercalcemia, and renal disease (Naymagon and Abdul-Hay, 2016). 
Allergies 
Allergies are a set of conditions that are caused by hypersensitivity of the immune 
system towards molecules or substances that are typically not harmful. It affects 
only few parts of the body, such as skin and mucosal tissues, but under certain 
conditions the reaction can be systemic and therefore more dangerous (Tao and 
Raz, 2015). 
Characteristic features of allergies are the expansion of Th2 cells and the isotype 
switching of B cells towards plasma cells that generate IgE antibodies (Holgate 
and Polosa, 2008). It has been speculated that the increase of allergic diseases in 
developed countries is associated with the reduction of exposure to antigens. This 
phenomenon is referred to as “hygiene hypothesis” and it has been supported with 
epidemiological data (Okada et al., 2010).  
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Autoimmunity 
Autoimmune diseases are characterized by the loss of control of the immune 
system and the consequent responses against self-antigens. The causes are strictly 
linked with the malfunctioning of the tolerance mechanisms that I explained in the 
previous section. Autoimmune diseases can be systemic or tissue specific. Well-
known systemic ones include rheumatoid arthritis (RA) and systemic lupus 
erythematosus (SLE). Common tissue specific ones are celiac disease and 
thyroiditis (Perl, 2012). 
In the recent years, with the increasing availability of high throughput sequencing, 
numerous genetic mutations have been associated with autoimmune diseases. In 
some cases, they are caused by the mutation of a single gene, such as the 
transcription factor AIRE involved in the tolerance mechanism (Xing and 
Hogquist, 2012), but many are multigenic and more difficult to characterize 
(Invernizzi and Gershwin, 2009). 
Immunosenescence 
The decline of the immune system functionality because of physiological ageing 
is called immunosenescence. The main observed phenomena driving 
immunosenescence are a decrease in adaptive immunity functionality and 
"inflamma-aging". The latter is the manifestation of a low-grade chronic 
inflammatory state (Franceschi et al., 2000), that is a result of a higher basal 
production of pro-inflammatory cytokines (IL-1β, IL-6, IL 8, TNF and IL-15) 
supported by a decrease of anti-inflammatory cytokines, such as IL-10 (Franceschi 
et al., 2007). The major driving force is the accumulation of oxidative damage that 
elicits the cells of the innate system to the production of cytokines mainly from 
monocytes and macrophages (Cannizzo et al., 2011). 
In addition, thanks to large cohort studies on elderly people, the Immune Risk 
Phenotype (IRP), which is a collection of features associated with an increased risk 
of mortality, has been delineated. IRP includes a higher frequency of CD8+ cells, 
lower frequency of CD4+ cells, an inversion of CD4/CD8 ratio and increase of T 
cells at their last stage of differentiation, such as late effector and memory T cells 
(Ferguson, 1994; Wikby et al., 2002).  
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The strategies currently adopted to contend the immunological frailty are physical 
and mental activity, adequate nutrition, and vaccination. However, research on 
immunosenescence might give further clues on how to aid the immune system 
preserving its functionality also at the molecular level. 
1.1.6 Computational immunology 
The term immunoinformatics was coined during the early 2000s to establish the 
importance of computational analyses for the understanding of the immune system 
(Orosz, 2002; Brusic and Petrovsky, 2003). Immunoinformatics, or computational 
immunology, has since been recognized as an independent field of study although 
it remains strictly related to the parent field of bioinformatics or computational 
biology. 
The establishment of the immunoinformatics field was driven by the accumulation 
of bioinformatics resources for immunological data in the 90s. The International 
ImMunoGeneTics Information System (IMGT) is a database specialized in 
immunoglobulins (Ig), T cell receptors (TCR) and major histocompatibility 
complex (MHC) molecules created in 1989 and it has been identified as the first 
prominent computational immunology effort (Lefranc, 2014). Other notable 
databases storing sequences for MHC ligands and T-cell epitopes were 
subsequently developed, such as MHCPEP (Brusic et al., 1998) and SYFPEITHI 
(Rammensee et al., 1999). Apart from database curation, other popular 
immunoinformatics tasks were the prediction of immunogenicity of complex 
proteins, in silico vaccine design, evolutionary mechanisms and immune system 
modelling integrating large amounts of data (Tomar and De, 2010). In this regard, 
if we consider also the earliest approaches of mathematical modelling of immune 
processes, otherwise called theoretical immunology, as part of the 
immunoinformatics realm, we can even date it back to the 60s (Marchalonis et al., 
1968; Groves et al., 1969). 
Nowadays, computational immunology refers to any bioinformatics task using 
immunological high-throughput data. ImmuneSpace is a great example, as it is not 
only a repository but also a platform for the analysis of all sort of immune-related 
data, such as ELISA, flow cytometry, RNA-seq, Luminex, and CyTof data 
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(Sauteraud et al., 2016). A second noteworthy example is ImmPortGalaxy, whose 
concept is based on the popular Galaxy platform for genomics analysis. Other 
widely used bioinformatics platforms, such as GenePattern and Bioconductor, 
dedicated entire sections to the flow cytometry data analysis that is almost uniquely 
relevant for immunological data. A contribution that I made is reported in Chapter 
3, where I present the package flowAI that is now available from Bioconductor and 
ImmPortGalaxy.  
1.2 Gene expression 
The central dogma is a key concept in biology stating that DNA is transcribed into 
RNA, and RNA is translated into proteins. This process is not reversible, apart 
from some exceptions like retro transcription of DNA from RNA (Crick, 1958). 
To study the composition of DNA, RNA and proteins as a whole, new terms have 
been coined with the “omics” suffix (Lederberg and Mccray, 2001). The gene 
expression as a whole is referred to as transcriptomics and it has become possible 
to study it routinely with the advent of high-throughput technologies like 
microarray and RNA-sequencing.  
Chapter 2 and 4 report analyses based on gene expression profiling using both 
microarrays and RNA-sequencing. In this section, first I describe the technologies 
since understanding their principles is necessary to eliminate all the unwanted 
effects due to the technology itself from gene expression values. Next, I explain 
the principle of experimental design as they are essential to maximize the value of 
the data. Lastly, I describe the state of the art for the bioinformatics methods used 
in gene expression data that are relevant for my thesis.  
1.2.1 DNA microarrays 
Technological principles 
The DNA microarray has been a breakthrough technology to monitor genome-
wide expression levels of biological samples. A typical microarray consists of a 
solid surface holding different DNA molecules ordered at specific locations called 
spots. The DNA molecules are called DNA probes as their function is to hybridize 
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to specific DNA molecules and thus allow for the quantification of transcripts in 
the studied sample. The DNA probes can be either cDNA or oligonucleotides and 
they are fixed to supporting surfaces that are made of nylon membrane, glass, 
plastic, or silicon. Initially, the most common surface used was based on nylon 
membranes. However, they have been almost completely substituted by glass, 
plastic or silicon derived solid surfaces since they provide numerous advantages 
including less sensitivity to light, non-porosity and thermal stability. All these 
features allow easier washing steps, faster hybridization kinetics, better 
discrimination between probes and minimal background fluorescence (Heller, 
2002; Bumgarner, 2013; Dufva, 2009). 
Initially microarrays have been commonly distinguished and classified according 
to the arrayed material, cDNA or oligonucleotides. However, nowadays it is more 
convenient to classify microarrays based on their manufacturing technique since 
cDNA microarrays are rarely used anymore. Most of the techniques used to fix 
DNA probes on the supporting surfaces were developed during the 80s and 90s 
(Bumgarner, 2013) and they can be grouped in three main categories: 
• Spotting 
• In-situ synthesis 
• Self-assembling 
The first approach, spotting or printing, consists of fixing DNA fragments 
previously amplified or synthetized on the supporting surface. Robotic spotters 
have been designed to automatically collect DNA fragments stored in microtiter 
dishes and to release them on the supporting surface (DeRisi et al., 1996). Printed 
arrays are the only ones used for both cDNA or oligonucleotides, whereby the 
cDNA probe is obtained by PCR amplification and the oligonucleotide is 
chemically synthesized. The other two approaches, in situ synthesis and self-
assembling, only use oligonucleotides. 
The second approach, in situ synthesis, consists of the generation of 
oligonucleotides directly on the solid surface (Miller and Tang, 2009). This 
approach has been used by the companies Affymetrix, Roche NimbleGen and 
Agilent Technologies using different synthesis procedures.  
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The oligonucleotide probes of the Affymetrix GeneChips are synthesized by using 
nucleotides bound to photolabile protecting groups. When light is directed on the 
nucleotides, the protecting groups are decoupled and a new nucleotide can be 
added. A photolithographic mask is used by Affymetrix to avoid the addition of 
unwanted nucleotides to a growing oligonucleotide chain. The operation is 
iterative, and in the end each DNA probe will be a 25-mer oligonucleotide. The 
DNA probes are arranged in probe pairs and probe sets. Probe pairs of one perfect 
match and one mismatch are used to detect non-specific binding and reduce 
background noise. Probe sets of 11-20 probe pairs specific for each transcript are 
used to increase the specificity for transcripts. Affymetrix has been widely 
successful in generating standard genome-wide chip arrays for various animal 
species. However, the building of a series of photolithographic masks for the 
assembling of the pre-defined oligonucleotides on the solid support is a limiting 
factor for the generation of customized arrays.  
Roche NimbleGen invented a new method in which the photo-deprotection step is 
performed by micro-mirrors (Nuwaysir et al., 2002). This methodology still 
benefits from the usage of cheap reagents of photolithography and at the same time 
provides more flexibility for oligonucleotide synthesis.  
Agilent Technologies, instead, uses a completely different technology based on 
inkjet printing that consists of releasing a nucleotide in a defined spot combined 
with deprotection and coupling steps (Hughes et al., 2001). The synthesized 
oligonucleotides are 60 base pairs long. Here, probe pairs and probe sets are no 
longer required since the longer nucleotides provide a sensitivity and specificity 
almost comparable to cDNA arrays (Barrett and Kawasaki, 2003). 
The third approach, self-assembling, consists in the random disposal of beads 
conjugated with DNA probes to the supporting surface (Ferguson et al., 2000). 
This is the most recent technology and the manufacturing company is Illumina. 
The challenging part of this technology is the recognition of the DNA probe 
deposited in each spot (referred to as “decoding the array”). The most recent 
method consists of a series of hybridizations with known labelled DNA sequences 
that not only allows to map the beads in the array but also to test it before the actual 
experiment (Bumgarner, 2013).  
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 Library preparation 
To quantify the gene expression of the target sample, the mRNA must be pre-
processed prior to hybridization to the DNA probes and scanning with the 
detection system. After extraction, the mRNA is converted to either cDNA or 
cRNA and amplified. During amplification, the DNA fragments are labelled with 
a fluorochrome to allow their detection. The labelling techniques can be 
distinguished in two main types: the Cy3/Cy5 system for a two-colour experiment 
and the streptavidin/phycoerythrin system for one-colour experiments (Figure 
1.2). The two-colour experiments are less common and are performed only with 
certain models of Agilent Technologies microarrays and customized microarray. 
They consist on the simultaneous hybridization on the microarray of two different 
samples, usually reference and experimental samples, labelled with two different 
fluorescent molecules, Cy3 and Cy5. After hybridization, the detection system 
records the relative gene expression profile of the two samples. The one-colour 
 
Figure 1.2 Schematic representation of two methods to perform gene expression profiling. In 
the case on the left, two different samples are labelled with two fluorochromes, Cy3 and Cy5, 
and the gene expression values of the disease sample is in relation to the reference sample. In 
the case on the right, the sample is biotinylated and the gene expression values are absolute. 
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experiment is the technique of choice of popular microarray chips from Affymetrix 
and Illumina. The target cDNA or cRNA is first labelled with biotin and then 
stained with fluorescently labelled streptavidin. 
Data pre-processing 
Various pre-processing steps are necessary for the raw data before any statistical 
or mathematical algorithm can be applied. Each microarray technology needs its 
own set of pre-processing algorithms. Currently, new methods for microarray data 
analysis are rarely produced anymore since there are pre-processing pipelines that 
are sufficiently robust. The RNA sequencing technology, however, has recently 
gathered more popularity and is expected to completely substitute DNA 
microarrays in the near future.  
A generalized pre-processing pipeline for microarray data consists of three main 
steps: background correction, normalization, and transformation. Some of the 
algorithms can be used for different microarray types, but often customized 
algorithms and additional pre-processing steps are necessary to have optimized 
pipelines.  
The first step of microarray data pre-processing, background correction, consists 
of removing the background noise from the foreground signal. As a matter of fact, 
the signal recorded from each spot is a sum of the fluorescence due to probe-target 
hybridization and background noise. The simplest way to eliminate the 
background noise is to subtract the mean or median value of the pixels surrounding 
the spot from the foreground signal. This procedure, however, has been criticized 
to be overly simplistic, since it does not take spatial variations into account and 
produces negative values. More sophisticated methods have been developed to 
produce only positive intensities. The most frequently used method is the 
background correction step included in the robust multi- array average (RMA) 
method (Irizarry et al., 2003), developed originally for Affymetrix but then 
generalized for other chips and named normexp (Ritchie et al., 2007; Shi et al., 
2010).  
Data normalisation consists of the removal of whole scale changes within or 
between arrays that are due to technical procedures rather that biological factors. 
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Often, the variation is explained by different amounts of starting material used for 
the hybridization. Within-array normalisations are meant to adjust for spatial 
effects within the chip itself or to adjust the values of two-colour microarrays. 
Between-array normalisations are used to adjust intensities across a set of one-
colour microarrays. Early methods consisted of the alignment of the intensity 
values to either the mean, median or the 75th percentile of all microarrays. However, 
more complex methods have been developed to account for the non-linear 
relationship between arrays. Loess and quantile are two reliable normalization 
methods although ultimately the quantile normalization has become more popular 
for its simplicity and applicability to various technologies (Bolstad et al., 2003; 
Reimers, 2010). 
Data transformation is the procedure of converting a set of values into a 
corresponding set of transformed values with properties that are more useful for 
downstream analysis. The raw values of microarray data follow a heavily right 
skewed distribution and the variance is heteroscedastic. In other words, raw data 
have very few large values and the variance is not constant across ranges of values. 
It is common practice to transform the values to make the distribution symmetric 
and to stabilize the variance in order to apply parametric statistical methods and to 
more easily visualize patterns in the data through scatterplots or other graphs. The 
simplest transformation method is the logarithmic function. This method is still 
widely used; however, it has been pointed out that although it stabilizes the 
variance for large values, it also inflates the variance for small values and cannot 
handle the negative values produced by some background correction methods 
(Rocke and Durbin, 2001). Hence, new variance stabilization transformation 
methods have been developed that are able to produce linear values for low ranges 
and values similar to logs for high ranges (Durbin et al., 2002; Huber et al., 2002).  
1.2.2 RNA sequencing 
Technological principles 
Sequencing technologies are rapidly evolving, and nowadays it is possible to 
generate various kinds of information by deciphering nucleic acid compositions, 
including gene expression profiling with RNA sequencing (Figure 1.3). The next 
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generation sequencing (NGS) technologies, introduced in the early 21st century, 
have the outstanding feature of generating massive amount of data at reduced time 
and affordable costs. The various NGS technologies have been recently classified 
in two groups according to the way the DNA is sequenced: sequencing by 
synthesis (SBS) using DNA polymerase and sequencing by ligation (SBL) using 
DNA ligase (Goodwin et al., 2016). Another debated classification divides NGS 
technologies into second and third generation sequencing where the main 
distinction lies in the ability of the latter technologies to sequence single DNA 
molecules in real time. Real time sequencing is still not widely used although they 
bring several advantages, such as the elimination of possible bias due to DNA 
amplification, reduction of the cost of reagents, and reduction of running time. 
SBS technologies are the 454, the Illumina platform, Ion Torrent, Helicos, and 
Single Molecule Real Time (SMRT). SBL technologies are SOLiD and the 
 
Figure 1.3 Schematic representation of the steps involved in deep sequencing. After extraction 
from the sample, the nucleic acid material is fragmented and the sequences with desired length 
are selected. If required by the technology, the DNA templates are amplified. Common 
amplification methods are emulsion PCR and bridge amplification. Lastly, the DNA templates 
are sequenced and the incorporation of nucleotides is revealed by signals such as photons, 
fluorescence or hydrogen ions. 
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Complete Genomics platform. Recently the Oxford Nanopore Technology (ONT) 
has been released that does not enter in any of the two categories since it sequences 
upon the 3D conformation of a DNA segment. Of the ones cited only Helicos, 
SMRT and ONT are able to sequence single molecules. However, currently 
Illumina remains the predominant technology on the market. 
The approach used in several Illumina sequencing models to amplify a single DNA 
template in multiple copies is called bridge amplification. After having extracted 
the DNA/RNA from the sample, the single DNA molecule hybridizes on the 
surface of a flow cell and through repetitive PCR steps it forms clusters of DNA 
copies. A second amplification approach is called emulsion PCR and it has been 
adopted by 454, SOLiD and Ion Torrent. It consists of ligating a single DNA 
template to a bead floating in a droplet of a water-oil emulsion and generating 
copies ligated to the surface of the bead with PCR. 
The next step is the sequencing of the DNA templates. Illumina uses nucleotides 
modified as reversible terminators bound to a fluorescent molecule specific for 
each of the four different nucleotides. The decoding of the nucleic acid is cyclic. 
At each cycle, in each spot of the flow cell, a new nucleotide is incorporated, the 
fluorescence emitted is recoded, and the added base is decoded (Mardis, 2008). 
Most of the NGS technologies use fluorochomes to reveal which nucleotides have 
been added, however there are other methods that rely on the emission of photons, 
the 454 system, or hydrogen ions, the Ion Torrent. 
The applications relying on NGS technologies can be grouped in two categories 
depending on whether the final aim is to read or count nucleic acids. Applications 
that only require reading DNA/RNA are de novo assembly for the building of new 
genomes and resequencing for the search of genomic variants. Applications that 
are based on counting are RNA sequencing (RNA-Seq) for the gene expression 
profiling and ChIP-Seq/RIP-Seq for the discovery of interaction between 
DNA/RNA and proteins. In some cases, both reading and counting can be used at 
the same time; for example, when it is necessary to profile the gene expression of 
new mRNA or microRNA fragments. 
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RNA-Seq provides several advantages compared to microarrays. One advantage 
is that the quantification of the mRNA molecules provided by RNA-Seq is digital 
in nature and therefore it allows an exact quantification of gene expression. The 
microarray, instead, remains a semi-quantitative technology because of probe 
saturation. Another strength is that the RNA-Seq does not rely on transcript 
annotation data as the microarray does. As a matter of fact, RNA-Seq always gives 
an exhaustive gene expression profiling that includes transcripts not mapped 
before or new transcript isoforms (Malone and Oliver, 2011). 
Library preparation 
The RNA library preparation differs according to the sequencing platform used. 
However, most of them share similar strategies to isolate and amplify the starting 
material. Total RNA is extracted from the biological sample and the quality is 
verified with capillary gel electrophoresis. Next, the type of RNA required for the 
experiment is isolated. For example, in the case of mRNA, beads ligated to poly T 
oligomers are used to separate the mRNA from the remaining non-coding RNA. 
This is a crucial step, especially because it removes rRNA that constitutes more 
than 90% of total RNA and could severely undermine the quality of the data 
analysis. The mRNA is then fragmented according to the requirements of the 
technology. The Illumina HiSeq2000, for example, require fragments ~200–250 
nt long. The fragments are converted in cDNA, ligated to adapters and amplified 
with PCR (Chu and Corey, 2012; Griffith et al., 2015). The adapters ligated to the 
cDNA fragments are specific for each platform and are used both for amplification 
and sequencing.  
Different library preparation strategies have been developed to either improve 
efficiency or to overcome specific drawbacks of sequencing technologies. For 
example, Illumina can sequence both the 3’and 5’ ends of a cDNA molecule by 
ligating different adapters to the two ends. The application is called paired end 
(PE) sequencing and it helps in the accurate mapping of short reads and detection 
of structural variants (Mardis, 2013). Multiplexing is another strategy frequently 
adopted. It consists of ligating unique indexing sequences to the cDNA molecules 
of different biological samples. The samples can be then pooled together for 
sequencing and then sorted again right before data analysis (Smith et al., 2010).  
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Data pre-processing 
About 10 years have passed since the first RNA-Seq experiments were performed 
(Lister et al., 2008; Nagalakshmi et al., 2008; Mortazavi et al., 2008). Till now, 
several pre-processing methods have been developed and robust analysis pipelines 
have been defined. The general data pre-processing pipeline includes quality 
control, mapping to a reference genome, read counting and normalization. 
However, there is still room for improvements and several research groups are 
currently involved in it (Conesa et al., 2016).  
Quality assessment is a fundamental step not only at the beginning but also at 
different next stages of data pre-processing. A widely used tool is FastQC 
(Andrews, 2010). Several quality control metrics are implemented by the tool and 
it produces several charts to check: per base quality, GC content, duplicated 
sequences and other problematics that are encountered during sequencing. 
Trimming or filtering tools, like Cutadapt or trimmomatic (Bolger et al., 2014), 
can be used in case there are anomalies generated in the phase of library 
preparation or that are particular for some types of experiments. For example, in 
some cases it is necessary to trim the end of long reads, as the quality of base 
calling generally tends to decrease as sequencing progress. 
The next step consists of the identification of transcripts associated with the 
sequenced reads. This can be done by mapping the reads either to a reference 
genome or to a reference transcriptome, or by assembling the reads and hence 
building the transcriptome de novo. The Tuxedo suite is constituted by TopHat and 
Cufflinks, where the two tools perform both functionalities, mapping and 
assembling, respectively (Trapnell et al., 2012). In general, however, if a reference 
genome is available it is sufficient and often preferable to only map the reads to 
the genome. A more recent tool, STAR, has become quite popular because it can 
map reads more efficiently than TopHat (Dobin et al., 2013). Both TopHat and 
STAR have been defined as “Splice-Aware Alignment Tools” as they can 
recognize splice junctions within a read and map segments of that read to separated 
genomic locations (Williams et al., 2014). More recently, tools that use k-mer 
heuristic methods to map the reads to a reference transcriptome, such as kallisto 
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and salmon, have been appraised for their speed and accuracy (Soneson et al., 
2016). 
After the mapping step, it is preferable to visually asses the quality of the 
alignment. Integrative genomics viewer (IGV) and Savant (Robinson et al., 2011; 
Fiume et al., 2012) are two popular genome browser software used to visualize the 
files containing the mapping information, i.e. SAM or BAM files.  
The next pre-processing step is the translation of the mapped reads to abundance 
estimates. The easiest way is to count how many reads are aligned against each 
feature (e.g. a gene or transcript). The tools HTSeq and featureCounts are widely 
used for this step. They provide also a series of options for how to count multi-
mapping reads and the choice of the option can influence the results significantly 
(Robert and Watson, 2015).  
Transcript or gene counts need to be normalized for technical artefacts to be 
comparable between samples and sometimes also within the sample itself. Three 
simple normalization methods that correct for sequencing depth and feature length 
are: RPKM (Reads Per Kilobase Million), FPKM (Fragments Per Kilobase 
Million) and TPM (Transcripts Per Kilobase Million). RPKM was developed first 
for single-end RNA-Seq experiments. FPKM is based on RPKM and it is designed 
to normalize paired-end RNA-Seq data (Trapnell et al., 2010). TPM, instead, is a 
different method that recently is becoming more popular as it is more robust in the 
comparison of samples that undergo different library preparations (Li et al., 2009). 
Other technical artefacts that might introduce bias in the expression values are: GC 
content, RNA composition, and hexamer random priming. Genomic regions with 
high or low GC content are associated with lower expression abundance and the 
tools EDAseq and cqn are designed to correct for these artefacts (Risso et al., 2011; 
Hansen et al., 2012). The 10% of highly expressed genes can take up to 60% of 
the total read counts (Bullard et al., 2010) and some normalization methods have 
been designed appositely to overcome this caveat. Some examples are the upper 
quartile, the trimmed mean of the M value (TMM), and the method proposed by 
the author of DESeq (Li et al., 2015). There is no consensus on which is the 
preferred normalization method and the choice must be made according to how 
the data have been generated and what are the downstream analyses. For example, 
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within an experiment it might even be possible to compare the raw counts of the 
same transcript across difference samples as some artefacts can cancel each other 
out. 
1.2.3 Experimental designs in gene expression studies 
The key to successfully addressing biological questions is to carefully develop the 
experimental design before starting any kind of laboratory or computational work. 
A thoughtful balancing of the resources available is a crucial aspect of 
experimental design and three factors play a key role: sample size, costs and time. 
The investigator should optimize the three factors considering that the 
improvement of one factor has disadvantageous effects on the other factors. For 
example, it is always preferable to have a large sample size in order to gain 
precision and statistical power. However, when smaller sample sizes are able to 
yield enough precision and significance, it is convenient to avoid wasting time and 
funds for extra experimental units. 
Cornerstone concepts of experimental design were developed in the 30s by Ronald 
Fisher (Fisher, 1935). They are extensively used in any field of research and 
include randomisation, blocking, replication and factorial design (Jackson and 
Cox, 2013; Telford, 2007). They are also frequently used in microarray and RNA-
Seq data analysis with variation or novel approaches to accommodate the 
respective shortcomings of the different technologies.  
Two important concepts are randomisation and blocking which need to be applied 
at every stage of the study. The two concepts are related since they have been both 
devised to avoid unwanted sources of variability. Randomisation consists of the 
random allocation of experimental units to treatments or conditions. For example, 
when testing the effect of a treatment on samples coming from different facilities, 
the samples must be allocated randomly in the experimental groups. Blocking, 
instead, consists of creating heterogeneous blocks containing experimental units 
from all different treatments or conditions. For example, when processing the RNA 
samples on several microarray chips, the samples should be randomly distributed 
in blocks of equal proportions among the different chips to avoid that samples from 
the same condition or the same facility are processed in the same chip. The same 
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approach is used for sequencing flow cells with multiple lanes (Auer and Doerge, 
2010). When possible, randomisation and blocking allow to recognize and adjust 
the data for eventual technical batch effects.  
Another fundamental concept of experimental design is the replication. Replicates 
in biomedical research are distinguished as either biological or technical. 
Biological replicates are concerned in showing the variation due to biological 
diversity while technical replicates are used to discern from the data the variation 
due to different protocol and equipment. Technical replicates are usually reserved 
for the testing of the equipment and protocols to ensure that they are robust and 
reliable. Once this is established, they are no longer needed during data generation 
as they should not produce significant variation (Bell, 2016; Vaux, 2012). 
Biological replicates, instead, are always required and it is common practice to use 
a minimum number of three replicates. A caveat to consider is that humans cannot 
be kept in a controlled environment unlike animal models; therefore, larger sample 
sizes are usually necessary to account for the increased variability. Ideally, a power 
analysis should be performed to determine the sample size required to test a 
hypothesis with a certain degree of confidence. 
Typically, the main objective of an experiment is a comparison between control 
and treatment groups. However, there are cases where the researcher wishes to 
answer more than one question with the same experimental units. A factorial 
design is the combination of two or more designs that allows to address multiple 
questions in one single experiment. The different conditions or treatments to test 
are called factors and each factor is composed of two or more categories called 
levels. With factorial designs, it is not only possible to test the effect of each factor 
singularly, but also the interaction effect that the combination of two or more 
factors can have on the outcome of interest (Jackson and Cox, 2013). For example, 
the dependent variables of a linear model can be arranged through a factorial 
design and this is an important concept in gene expression analysis that will be 
elaborated further in the next section. 
There are experimental design concepts that are specific for gene expression 
analysis, and sometimes for either the microarray or the RNA-Seq technology. For 
example, the dye-swapping design has been developed after it has been shown that 
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dyes used for two colour microarrays have gene-specific bias. It consists of 
repeating microarray experiments by reversing the Cy3 and Cy5 labelling between 
samples of different experimental group (Churchill, 2002). Instead, sequencing 
depth is a concept specific for deep sequencing, hence RNA-Seq, and it refers to 
the number of time the same DNA fragment is sequenced. It is fundamental having 
multiple copies of the same fragment to be confident that the sequence generated 
is free from sequencing errors. The choice of the sequencing depth is based on 
various factors, such as the transcriptome complexity, the technology used, the 
cost of each running cycle, and the accuracy needed (Fang and Cui, 2011). Finally, 
pooling is a concept used for gene expression analysis independently of the 
technology at hand. Pooling is the process of combining several samples into one. 
It can be necessary when the amount of RNA from each sample is not enough or 
when the processing of individual samples is too expensive. However, the process 
of pooling itself can introduce unwanted variability, for example when mixing 
samples at different proportions (Kennedy and Cui, 2011).  
1.2.4 Differential expression 
The most common analysis when using gene expression data is undoubtedly the 
retrieval of a list of genes that are differentially expressed between two or more 
conditions. Often, this will result in long lists of differentially expressed genes 
(DEGs) whose biological relevance needs to be explored more. Because it is 
impractical to explain the role of each gene singularly, it is common practice to 
make a functional enrichment analysis (de Magalhães et al., 2010). This analysis 
reveals if there is an unexpected proportion of genes among the DEGs with related 
functionality. More details will be given on functional enrichment after an 
elucidation on the methods used for the retrieval of DEG.  
A rudimental way to find DEGs would be by ranking the genes according to the 
average log-ratio between two groups of samples, and select an arbitrary cut-off. 
However, biological samples generally show high variability, and just taking 
differences of the means to identify DEGs is not robust to large variance and 
outliers. The analysis of variance comes in handy, as it can determine if the 
difference between the averages of two or more groups is truly significant. The t-
test is used when only two groups of samples need to be compared. Assuming that 
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for each gene there are two vectors of gene expression values, one for control !" =	(&', … , &*+) and one for treatment !- = 	 (&', … , &*.) samples, the t-test can be 
computed with: 
 
/ = 	 &" −	&-1"23" +	1-23- (1.1) 
where the sample variance 12 divided by n observations is the standard error. This 
is the Welch’s t-test, a variant of the more popular Student’s t-test that assumes 
samples with unequal variance and unequal sample size, that is a common situation 
for gene expression experiments (Hatfield et al., 2003).  
For more complicated experimental designs, ANOVA, is used instead. The 
simplest form is the one-way ANOVA that can analyse only one factor, that is a 
categorical variable that indicates the groups of memberships of all samples. A 
one-way ANOVA testing a factor with two levels only, control and treatment for 
example, corresponds to a simple t-test. Experimental designs with two factors are 
tested with a two-way ANOVA that not only allows for the testing of the main 
effects but also the interaction effect. ANOVA allows to test any number of factors 
in a single analysis, however it is common practice to not exceed the three factors 
to avoid dealing with too many interaction effects at once. 
Both the t-test and ANOVA are two powerful techniques widely accepted for gene 
expression analysis. However, they present limitations when dealing with two 
common caveats. The first caveat is that the sample size n is usually small for 
biological experiments and therefore the variance is poorly estimated. A second 
caveat is that the experimental designs are often quite complex; mostly due to 
intricate designs for two colour microarrays or to the inclusion of different 
phenotypes and treatment conditions. Both caveats are generally addressed by 
using a Bayesian approach and linear modelling, respectively. 
The Bayesian approach makes the statistical estimation a more dynamic procedure 
compared to the frequentist approach. In fact, the Bayesian theorem states that 
parameters should be estimated from the new collected data by including prior 
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knowledge. The concept has been used to create a moderated t-statistic that 
substitutes the conventional standard error with a modified one that acquires 
information across the entire dataset (Hatfield et al., 2003). The procedure is called 
empirical Bayes because the prior distribution is empirically estimated from the 
data. From its introduction at the beginning of the 2000s, it has been implemented 
by several researchers for gene expression analysis (Efron et al., 2001; Baldi and 
Long, 2001; Lönnstedt and Speed, 2002).  
The use of a linear model, instead, is a statistical framework that allows to easily 
accommodate and handle complex experimental designs. It can be expressed in 
matrix algebra notation as: 
 5 = 67 + 	8 (1.2) 
where Y is the matrix with the gene expression dataset of dimension g genes by n 
RNA samples, X is the design matrix of dimension n x p, and 8 is a vector of 
residuals. The predictors p can be either factors or covariates, so that both ANOVA 
and regression can be performed with this linear model framework. The usefulness 
of linear models in gene expression analysis was firstly stated in 2001 by Kerr and 
Churchill. Through a contrast matrix, all the required combinations between 
treatments or phenotypes can be tested without changing the original model. A 
single contrast can be defined as 9:7, where c is a column vector with a number 
of rows equal to the number of coefficients in 7 and it contains a 0 in 
correspondence to the coefficients to exclude from the contrast. For example, in 
case it is necessary to compare the first two ; coefficients out of three, the contrast 
would look like 9: = 1,−1, 0 . 
The R package limma implements both the empirical Bayes method to moderate 
the variance and the linear model framework to facilitate the comparison of multi-
level factors. In addition, it can also pre-process raw data and assign weight to 
RNA samples to discriminate between low and high quality data. It was originally 
designed for microarray data analysis, but recently it has been adapted for RNA-
Seq analysis as well (Smyth, 2004; Ritchie et al., 2015). 
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The last step of differential gene expression analysis is to correct the p-values or 
the significance level to account for the occurrence of Type I error during multiple 
testing procedures. Current methods are either controlling the Type I error among 
the entire set of statistical tests, hence belonging to the familywise error rate 
(FWER) category, or among the significant tests only, hence belonging to the false 
discovery rate (FDR) category (Benjamini and Hochberg, 1995). Bonferroni is the 
oldest but also the most stringent FWER method and it assumes that all the 
conducted tests are independent. Because gene expression values are often not 
independent within each other, it is accepted and often suggested to use less 
stringent methods of the FDR category (Storey and Tibshirani, 2003).  
1.2.5 Functional enrichment analysis 
A typical differential expression analysis can identify hundreds to thousands of 
DEGs. A functional enrichment analysis consists of looking at the pathways or 
functions “enriched” by all the DEGs together instead of understanding their role 
singularly. The databases frequently used to retrieve gene sets with a determined 
function are Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes 
(KEGG), yet any database containing gene sets annotated with any biological 
phenomenon can be used for the analysis. Enrichment analysis tools can be 
classified in two main categories according to the approach used to perform the 
analysis: Over-Representation Analysis (ORA) and Functional Class Scoring 
(FCS) (Tarca et al., 2013). 
The ORA methods consist in the analysis of contingency table for the enrichment 
of gene sets. The preferred statistical tests for this approach are either 
hypergeometric test or the Fisher’s exact test (Rivals et al., 2006) and the methods 
are usually implemented as a stand-alone (e.g. GOstats) or web (e.g. DAVID and 
Enricr) application (Dennis et al., 2003; Falcon and Gentleman, 2006; Chen et al., 
2013). The main drawback of this approach is that it relies on a selection of genes 
based on an arbitrary p-value cut-off; hence it cannot incorporate the fold-change 
information in the analysis and it wrongly assumes that differential expression of 
the genes is always independent of each other.  
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The FCS methods consist of the analysis of fold changes or any kind of sample 
statistics associated with each gene from the gene expression analysis. The most 
popular one is Gene Set Enrichment Analysis (GSEA) based on a weighted 
Kolmogorov–Smirnov test on a gene list ranked according to the change in gene 
expression between two conditions (Subramanian et al., 2005). FCS methods 
attempt to solve the drawbacks listed for ORA methods, although they have not 
been free of criticism. For example, it has been pointed out that GSEA is only able 
to enrich gene sets from either up- or down-regulated genes, neglecting the fact 
that, in biological pathways, the up-regulation of one gene can be associated with 
the inhibition and therefore down-regulation of another gene (Saxena et al., 2006). 
A plethora of enrichment analysis tools have been produced and although the 
respective authors claim innovative features, the results obtained by the different 
methods are often consistent. A comparison of ORA methods suggested that a 
hypergeometric test together with a two-side test for the computation of the p-
value (Rivals et al., 2006) is the preferred technique. GOstats is based on the 
suggested method and distributed as R package, while DAVID and Enrichr, built 
upon the Fisher’s exact test, provide a friendly-user interface that do not require 
statistical or programming knowledge for the analysis.  
1.2.6 Other bioinformatics analyses  
Differential expression and functional enrichment analysis are routinely performed 
on transcriptomic data; however, there are several other bioinformatics analyses 
that can be applied to explore gene expression data. In this section, I discuss some 
additional bioinformatics analyses relevant for my thesis, i.e. clustering, co-
expression network, and deconvolution analysis (Figure 1.4). Other analyses that 
I do not explain but that are still worth mentioning include classification (Libbrecht 
and Noble, 2015), differential variability (Ho et al., 2008) and survival analysis 
(Pagnotta et al., 2013; Park, 2005). 
In the contest of machine learning, clustering is the unsupervised method to assign 
new classes to a set of unclassified samples, oppositely to classification that is the 
supervised method to assign unclassified samples to pre-defined classes. 
Clustering is more frequently performed and the two most common methods used 
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are hierarchical and K-means clustering, that are reported graphically through 
dendrograms and multi-dimensional scaling plots, respectively (D’haeseleer, 
2005). 
Co-expression network analyses consist of the generation of networks where each 
node is a gene and each edge indicates a pair of co-expressed genes. Similarity 
measures, like correlation or mutual information, are used to define the strength of 
co-expression among two genes, and clustering methods are used to define 
modules. Once the co-expression maps are built, several information can be 
retrieved from single genes or modules of genes (Leal et al., 2014). For instance, 
the function for genes not yet annotated can be deduced using the guilt by 
association principle and regulatory functions can be presumed by a relative large 
number of connections. Regarding the modules, several techniques can be applied 
to find the ones that are differentially co-expressed, changed in structure, or present 
in a subgroup of samples (van Dam et al., 2017). In chapter 2, I report an additional 
usage of co-expression maps, i.e. the comparison between species by adding 
homology information. 
 
Figure 1.4 Workflow of a typical gene expression analysis. 
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Deconvolution is a method that is used to extract the signal of single components 
from a mixed sample. I used this method in chapter 4 for the deconvolution of gene 
expression data from PBMC using the gene signatures of 29 immune cell types. 
Although this approach is still not widely used, it is promising for the analysis of 
cancer and blood samples. Gene expression deconvolution was performed the first 
time using a linear least squares approach to extract proportions of cells at different 
cell-cycle (Lu et al., 2003). However, the most influential work was done on 
immune cell types using an iterative linear least squares approach to avoid negative 
results (Abbas et al., 2009). A more recent method called CIBERSORT also 
brought large attention. It is based on support vector regression and the authors 
claim it is more robust to noise compared to previous methodologies (Newman et 
al., 2015). 
1.3 Flow cytometry 
Flow cytometry (FCM) is a technology based on the idea of analyzing immune 
cell types at a single cell resolution (Fulwyler, 1965; Robinson and Roederer, 
2015). Since its invention, it has never succumbed to newer technologies, on the 
contrary, the flow cytometry has been continuously improved and it has become 
more and more popular for both biological research and clinical diagnostics.  
I used flow cytometry data for the result chapters 3 and 4. In chapter 3, I developed 
a tool for the interactive and automatic quality control of FCM data while in 
chapter 4 I immunophenotyped samples and used the immune cell proportions for 
downstream bioinformatics analyses. Since I cover both technical and functional 
aspects of FCM throughout my thesis, a thorough explanation of both the 
technology and its applications are necessary.  
1.3.1 The technology 
In the last 50 years, the performance of flow cytometry has considerably increased. 
Numerous components of flow cytometry have been improved to ameliorate 
efficiency, sensitivity and costs. For example, the technology was originally able 
to detect only 1 or 2 parameters per cell while now it is possible to simultaneously 
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measure up to 30 parameters. However, the principles of the flow cytometry 
technology have never changed and they can be schematized in three main 
components (Recktenwald, 1993; Adan et al., 2016). They are: 
• the fluidic system 
• the optical system 
• the electronic system 
In addition to these three fundamental components, a device to separate single cells 
is added to the flow cytometry models used for sorting (Figure 1.5).  
 
Figure 1.5 Schematic representation of a flow cytometry instrument with ability of cell sorting. 
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The fluidic system 
The fluidic system directs the cells in a flow stream that pass through a laser beam 
for interrogation. The basic principle employed for the fluidic system is called 
hydrodynamic focusing. To achieve it, two fluids are necessary: one is the solution 
containing the sample, and the second one is called sheath fluid and is generally 
phosphate buffered saline (PBS).  
Both the sample solution and the sheath fluid are driven into a flow cell in a laminar 
flow by applying pressure. The sheath fluid is forced to enter the flow cell first and 
then the sample solution is injected into the center of the sheath fluid at a lower 
pressure. The hydrodynamic focusing is obtained because both fluids move in a 
laminar fashion with a different flow rate, hence they do not mix with each other. 
The strategy of creating a co-axial flow allows to change the flow rate and the 
diameter of the core stream, which contains the sample, in real time.  
When running an experiment, hydrodynamic focusing settings should be evaluated 
in conjunction to the kind of sample analyzed. Ideally, the flow rate of the sample 
should be at a speed where the cross-sectional area of sample stream allows only 
a single cell at a time to pass through the interrogation point. The increase in the 
diameter of the sample stream is proportional to the increase of the flow rate. A 
high flow rate has the advantage of reducing the time for each experiment. 
However, this also increases the cross-sectional area of the sample stream allowing 
doublets or more than two cells to pass at the same time through the interrogation 
point and to generate composite signals. Generally, it is possible to use a high flow 
rate for the analysis of surface markers, but for analyses that require a higher 
resolution, DNA for example, a slow flow rate is strongly suggested. 
The optical system 
The optical system can be further separated in two parts: the excitation optics and 
the collection optics. The excitation optics consists of one or multiple lasers and 
lenses that focus a beam of light to the interrogation point. The collection optics 
encapsulate a series of mirrors, light filters, and the optical detectors that route and 
collect the light coming from the cell or particle.  
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The collected light can be scattered light or fluorescence light. The scattered light 
gives morphological information of the cell. The light diffracted by the cell and 
collected on the same line of the laser beam direction is called forward scattered 
(FSC) and it is indicative of cell size. The light scattered in different directions by 
granules inside the cell and collected at 90° from the laser beam direction is called 
side scattered (SSC) and is indicative for granularity or internal complexity of the 
cell. The fluorescence light, instead, derives from fluorescence molecules. When 
a fluorescence molecule is hit by light at a certain wavelength, the light is adsorbed 
and the fluorophore emits light at a larger wavelength. This phenomenon is 
described as Stokes Shift. The amount of light emitted is proportional to the 
number of fluorophores that are bound to the cell or particle passing through the 
detection point. 
The number of lasers installed on a flow cytometry instrument vary across models. 
The first flow cytometry model was built with a single argon ion laser at 488 nm. 
The laser is used for the detection of both scatter light and fluorophores excited at 
488 nm such as fluorescein. The latest flow cytometry models integrate up to five 
lasers that can be either gas or solid state based. Moreover, the choice of the laser 
wavelengths is customizable among UV, violet, blue, green, yellow and red ranges 
of light.  
In combination to multiple lasers, light filters are needed in order to use a wide 
range of different fluorophores. Filters separate the light deriving from the 
excitation with a single laser beam in different sets of light wavelengths. There are 
long pass (LP), short pass (SP), and band pass (BP) filters. They can respectively 
transmit light above, below and within a range of a certain wavelength. For 
example, the filter LP520 transmits light with wavelengths above 520 nm, while 
the filter BP520/20 transmits light with wavelengths between 510 and 530 nm. 
Defining the right combination of fluorophores and filters is crucial for the setup 
of a flow cytometry experiment. Good setups allow to increase the number of 
fluorophores that can be used simultaneously. 
The last component of the optical system are the light detectors. A photodiode is 
used for the detection of FSC light. Photomultiplier tubes (PMTs) are used for any 
other channel, SSC light and fluorophores, as they are not as bright as FCS. A 
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photon, as soon as it enters the optical detector, is converted in electronic signal 
(see next section). 
The electronic system 
As soon as a photon hits the optical detector, a voltage pulse is generated. The 
optical detectors are not able to recognize specific wavelengths and hence a careful 
choice of the filters is necessary to discern the signal from the different 
fluorophores for each detector. The signal generated depends on two factors: the 
density and the brightness of the fluorophore. The amplitude of the electron pulse 
is proportional to the number of photons that hit the detector and it is possible to 
increase the sensitivity of photomultiplier tubes by increasing the applied voltage. 
Hence, when setting up a new experiment with a new set of fluorophores it is 
necessary to optimize the voltage applied to all the PMT. Ideally, the lowest 
voltage that gives the lowest coefficient of variation of dim fluorescence intensities 
should be chosen (Maecker and Trotter, 2006).  
When multiple lasers are installed in a flow cytometry instrument, the signal 
derived from each laser is recorded at different time points for the same cell. The 
electronic system is also charged of assigning the right signals to the corresponding 
cell by taking into account the flow rate. Any anomaly in the flow rate, laser 
alignment or electronic system can generate loss of signal or improper allocation 
of the signal.  
Once the voltage pulse is generated, an Analog-to-Digital Converter (ADC) is used 
to transform it to a digital number for the downstream data analysis. Early ADC 
had a resolution of 210 = 1,024 (10-bit) discrete analog levels and therefore they 
could assign a value between 0 and 1023 only. Because the expression of antigens 
on the surface of cells increases exponentially, log amplifiers were used to 
“transform” the voltage pulse before conversion. Nowadays, the new 16-bit ADCs 
assign up to 218 = 262,144 discrete levels, therefore log amplifiers have been 
substituted with linear amplifiers and the data can be logarithmically transformed 
in a downstream data analysis pre-processing step (Macey, 2007). 
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Cell sorting 
A great feature of flow cytometry is that cells remain alive meanwhile the pass 
through the flow cell for phenotypization and hence they can be collected for 
further analysis. The fluorescence-activated cell sorting (FACS) is an instrument 
that, additionally to the fluidics, optical and electronic systems, integrates an 
apparatus to sort the cell-types of interest.  
In FACS the cell pass through the interrogation point in a stream-in-air flow. As 
soon as the cells are interrogated, a piezoelectric crystal vibrates the stream 
breaking it into droplets. By using a specific vibration energy, each droplet will 
contain no more than one single cell. Right after the droplet formation, a positive 
or negative charge is applied to the droplets containing the cell of interest. Charged 
plates deflect the charged droplets to apposite containers while the remaining cells 
are directed to a waste tank. Stream-in-air instruments can sort 4-6 cell types at a 
rate of 30,000 cells per second. 
A more recent sorting approach relies on a catcher tube instead. As soon as the 
cells are interrogated, a catcher tube moves in and out to select the cell type of 
interest at a maximum rate of 500 cells per second. The performance of the catcher 
tube technology is still inferior to the stream-in-air one, however, it has the 
advantages that does not require a dedicated operator and is more suitable for 
hazardous samples (Davies, 2007). 
1.3.2 Panel design 
The process of choosing the antibodies, fluorophores and flow cytometry settings 
for answering a specific biological question is called panel design. The main 
challenge of panel design is the ability of simultaneously measuring a large number 
of surface markers without losing specificity. This is not trivial as designing and 
optimizing panels for novel experiments with no background information might 
require several months and abundant resources.  
Compared to the earliest experiments where it was possible to measure only 1-2 
surface markers, it is now relatively easy to target 15 markers (Bendall et al., 
2012a). Moreover, with the increase of the number of fluorophores available and 
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the number of lasers installed in a flow cytometer, it is now possible to create 
panels that can measure up to 30 characteristics of a single cell. However, this is 
still a burden that even highly experienced researchers try to avoid if it is not 
strictly necessary. The reason for this is that fluorophores usually emit light within 
a large range of wavelengths, hence it is often impractical to exactly discriminate 
between two or more signals. 
Fluorophores 
Although in the past it was possible to excite only at a few wavelengths, this is not 
a limiting factor anymore. As noted in the section describing the optical system, 
the latest flow cytometry models are built with up to 5 lasers emitting light in the 
UV, violet, blue, yellow-green and red range with the possibility of choice among 
multiple wavelengths. Instead, the most limiting factor that is still present 
nowadays is the availability of fluorophores with desirable properties. An ideal 
fluorophore should be stable to environmental conditions, have a narrow emission 
wavelengths range and a large brightness. A useful parameter for fluorophores 
used in flow cytometry is the stain index. It gives a value proportional to the ability 
of the fluorophores to separate the positive population from the background noise 
(Maecker et al., 2004). It is formulated as: 
 ?@ = 	A* − AB2	1*  (1.3) 
where A* and AB are the means of the negative and positive populations, and 1* is 
the standard deviation of the negative population.  
The temporal development of fluorophores for flow cytometry usage is depicted 
in Figure 1.6. They can be grouped in three broad classes: organic compounds, 
proteins, and quantum dots. The first fluorophore used in flow cytometry was the 
fluorescein isothiocyanate (FITC), an organic compound derived from fluorescein. 
It is approximately excited at 495 nm (blue color) and emits at 519 nm (green 
color). The first antibody labelled with FITC was generated in 1941 by Albert 
Coons and its group. However, the discovery of most of the fluorescent probes 
used nowadays is attributed to the company formerly called Molecular Probes 
founded in 1975, now owned by Thermo Fisher (Jameson, 2014). Widely used 
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organic compounds developed by Molecular Probes are Texas Red and the dyes 
of the Alexa Fluor family. Texas Red emits light in the far red, while Alexa Fluor 
dyes emits at wavelengths that span the entire light spectra. They are synthesized 
by the sulfonation of more traditional organic fluorophores with the purpose of 
making them more stable, brighter, and less pH-sensitive. Another family of 
organic fluorophores that have larger brightness compared to traditional 
compounds are the Brilliant violets dyes. They have been recently developed by 
Sirigen Ltd that is now owned by Becton Dickinson (BD).  
The fluorescent proteins commonly used in flow cytometry are either 
Phycobiliproteins or GFP-like proteins. Phycoerythrin (PE) and allophycocyanin 
(APC) are two phycobiliproteins in use for the last 25 years (Figure 1.6). They are 
still widely used because they are stable, can be stored for long periods of time and 
have high quantum yield (Murphy and Lagarias, 1997). Fluorescent proteins of the 
GFP-like family are instead isolated from various sea animals, such as the jellyfish 
Aequorea Victoria and have been used primarily in fluorescence microscopy 
(Telford, 2007). The last class of relevant fluorophores are the quantum dots 
 
Figure 1.6 Fluorophores used in flow cytometry from 1970 to 2010. Figure taken from (Bendall 
et al., 2012b). 
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(Qdots). They are nanocrystals made of semiconductor material and they have 
recently proved to have excellent fluorescent properties. They have almost all the 
desirable properties as they are bright, have narrow emission, and high 
photostability (Chattopadhyay et al., 2006). 
To increase the number of available options, a strategy often used is to covalently 
bind two fluorophores where one is the donor and the other one is the acceptor. 
The donor molecule is excited by the laser, and its emission light excite the 
acceptor molecule that is then recorded by the detector. They are referred to as 
tandem dyes, they have often the advantage of a larger Stroke Shifts compared to 
single dyes. However, they are generally less stable as they tend to degrade more 
quickly if exposed to light, to oxygen radicals or to temperature variations.  
Optimization 
The reason why designing a panel is not a trivial process is that the researcher has 
to keep in mind the properties of the fluorophores and the instrument in use. In 
some cases, also the affinity of specific antibody clones for the targeted antigen is 
a crucial matter and it requires thorough testing. Besides the knowledge of 
experiment components, other optimization steps for panel design are antibody 
titration and the implementation of different types of controls.  
There are few tips that need to be taken in consideration when choosing the 
fluorophores. For example, the antigen with higher density should be combined 
with a less bright fluorophore (Hulspas et al., 2009). Another suggestion is to avoid 
using two fluorophores with spectral overlap for antigens expressed on the same 
cell type. However, the same fluorophore can be used for antigens expressed in 
two different cell types if they can be distinguished by other lineage markers.  
After the antibody clones conjugated with fluorophores have been chosen for the 
targeting of specific antigens, they have to be titrated. This step is also fundamental 
as either low or large amounts of antibodies would cause loss of sensitivity. With 
too few antibodies not all the antigen will bind to an antibody. With too many 
antibodies, instead, the background signal would increase because of a higher 
chance of having non-specific binding. The antibody titration should be performed 
any time a new lot of antibodies is purchased and for any type of sample. It is 
 49 
important that time, temperature and cell concentration are kept constant during 
titration (McCarthy, 2007). 
Several types of controls have been developed in order to optimize various aspect 
of a flow cytometry panel. Three steps are generally fundamental for designing 
new panels: 1) setting the voltage of optical detectors, 2) compensation for spectral 
overlap, 3) setting threshold to each negative population (Maecker and Trotter, 
2006). The first step is done by using unstained cells or beads. If auto fluorescence 
values produce high signals, the voltage applied should be lowered while making 
sure that dim populations still produce a positive signal. The second step is done 
with a series of controls generally referred to as single stain controls. It consists of 
staining aliquots of a sample or beads with one fluorophore at a time and verify 
the spillover in all the channels. This will allow to subtract the spillover values 
from each channel with a procedure called compensation. The third step can be 
done with the fluorescence-minus-one (FMO) control, where aliquots of a sample 
are stained with a set of fluorophores comprising the full panel minus one 
fluorophore. This allows the verification of the values given by the negative 
population in the missing channel. The isotype control is also a common type of 
controlling methodology, and it consists of using antibodies that are affine to an 
irrelevant antigen. The antibody has to be an isotype of the one used to bind the 
antigen so that it is able to reveal any non-specific binding to the constant region 
of the antibody. However, this method has been criticized since numerous isotype 
controls widely used are not reliable (Maecker and Trotter, 2006). 
Compensation 
The data processing step aimed to remove the spillover of fluorophores from each 
channel is called compensation. The procedure is a matrix algebra operation where 
a compensation value specific for each fluorophore is subtracted to the signal 
recorded by the detector in order to obtain a better estimate. Tung et al. (2004) 
formulated the matrix operation of compensation for four fluorophores as: 
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?'?2?E?F 	 (1.4) 
where D stands for dye and it represent the value recorded for each fluorophore, 
M is a factor that accounts for the spillover, and S is the new estimated signal.  
The single stain controls are fundamental to calculate the spillover caused by each 
fluorophore on each channel. The compensation values (M values) to use in the 
equation (1.4) are calculated by inverting the spectral overlap values derived from 
the single stains. The current flow cytometry instruments automatically calculate 
the compensation values and apply them to the uncompensated data. Earliest 
procedures consisted of manually compensating the values by looking at 
logarithmically transformed data. However, this is highly error-prone as in 
multicolor experiments it is impractical and often impossible to simultaneously 
adjust for the spillover of all fluorophores (Herzenberg et al., 2006). 
1.3.3 Gating 
The procedure of characterization of cell populations from flow cytometry data is 
referred to as gating. It consists of delineating the cells that correspond to a specific 
cell type from biplots of two antigens. Gating is generally performed manually by 
using software that provide a graphic user interface, such as flowJo, FACSDiva or 
FCSExpress. However, the development of computational algorithms for 
automatic gating have been recently promoted so that the data analysis can become 
more efficient and reliable. 
To select a cell population of interest from a multicolor panel, it is often necessary 
to perform multiple sequential gating steps. A strong immunological knowledge is 
necessary for the characterization of particular cell types. Generally, cell types 
with low frequency require more gating steps for their identification as they are 
only revealed after the exclusion of more abundant cell types. However, there are 
few initial gating steps that are equal for any panel of surface markers.  
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The first common gating steps consists of plotting each fluorophore versus time 
(Figure 1.7). Ideally the pattern of values should remain constant over time. Any 
irregularity in the fluidic, optical or electronic system might be detected in this step 
and gated out. The second step consists of the removal of doublets. A way to 
achieve this is by plotting FSC-A versus FSC-H, with A and H being the measure 
of the area and the height of a cell, respectively. All events that have an area larger 
than the height are possibly derived from a clump of cells, generally called 
doublets, that passed through the interrogation point. The single cells are then 
filtered by gating only the events that have similar FSC-A and FSC-H. A third step 
consists on removing all the debris. By plotting FSC-A versus SSC-A, all the 
values below a threshold, that is usually around 50,000 for the present-day 
instruments, are considered not to be cells as they are too small. Moreover, from 
the same plot it is expected to detect three major immune cell populations with 
distinct morphological features of a whole-blood sample, i.e. lymphocytes, 
monocytes and granulocytes. Lymphocytes are the smallest cells with no 
granularity, monocytes are the largest cells with low granularity, while 
granulocytes have an intermediate size and high granularity (Figure 1.7). 
Additional gating steps for cleaning the data are the removal of dead and unwanted 
cells. Dead cell can be stained by using dyes that penetrate through damaged 
membranes and that bind to either DNA, such as DAPI and 7-AAD, or free amines 
in the cytoplasm, such as dyes of the LIVE/DEAD® family (Perfetto et al., 2010). 
To identify unwanted cells, instead, a single fluorophore can be dedicated to stain 
specific lineage markers. For example, for the identification of B cells and classical 
monocytes, the same fluorophore can be used to target CD19 and CD14. The 
channel used for gating out unwanted cells is generally called dump channel. 
 
Figure 1.7 Initial standard gating steps for cleaning the data from technical anomalies (first 
gate), clump of cells (second gate) and debris (third gate). The last gate shows how to select the 
three major cell types from forward and side scatter channel.  
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After the pre-processing gating steps the data should be clean of technical 
anomalies, doublets, debris, dead and unwanted cells. As stated before, using 
information on size and granularity obtained from forward and side scatter light 
makes it possible to discriminate only among the three major cell types 
lymphocytes, monocytes and granulocytes. Any other cell type can only be 
distinguished by fluorescent signal of labelled markers. There are a set of lineage 
markers that are routinely used to recognize major immune cell types. For 
example, the leucocyte common antigen, CD45, is expressed on all leucocytes, 
CD3 on T cells, CD19 on B cells, CD56 on NK cells and CD14 on classical 
monocytes. Other cell types can be recognized only through a specific combination 
of markers, since a surface marker is generally expressed on multiple cell types.  
Recognizing cell populations can be a complex task as there is not always a clear 
separation between two cell types. Instead, often there is an indefinite number or 
intermediary cells that give a continuum of surface marker signals. It is not always 
clear how to place a gate and, when multiple sequential gating steps are performed, 
it is difficult to keep track of previous gates. A solution offered by most of the 
current software is backgating. The gate used to define the final cell population 
can reveal all the events that have been gated out in the previous gates. This 
strategy helps verifying if there are precedent gates whose stringency should be 
adjusted.  
1.3.4 Research and clinical relevance  
At the beginning of this chapter I already stated the importance of flow cytometry 
in the characterization of immunological conditions. I also claimed that over the 
last decades it never succumbed to newer technologies, but rather has been 
increasingly adopted for new research and clinical applications. Flow cytometry, 
together with equipment like centrifuges and PCRs, is often considered an 
essential member of a laboratory asset.  
In research settings, besides the immunophenotyping of immune cells via the 
characterization of surface markers, flow cytometry can be used to scrutinise also 
molecules in the cytoplasmic and nuclear compartments (Adan et al., 2017). For 
example, it is possible to measure cell viability through fluorochromes that enter 
 53 
disrupted cells and stain organelles or other cell components. Apoptotic processes 
are also detectable through different approaches, such as the detection of active 
caspases, under-expression of Bcl2, or DNA fragmentation. Other essential 
intracellular detections are the measurement of the telomere length, intracellular 
cytokines and cell cycle stages (Lauzon et al., 2000; Pozarowski and 
Darzynkiewicz, 2004; Adan et al., 2017). 
In clinical settings, flow cytometry is invaluable for the diagnosis of certain 
pathologies. Here, both intracellular and extracellular measurements can be used 
as indicators of the pathologies. For example, the detection of an increase in DNA 
content can be associated with malignant cells. Moreover, together with 
immunophenotyping information, it is possible to identify the immune cell type 
that are tumorigenic (Betters, 2015). Often, a particular immune disease can more 
simply be associated with an imbalanced proportion of immune cell types. For 
instance, granulocytosis and neutropenia are respectively detected by an 
abnormally large number of granulocytes and an abnormally low number of 
neutrophils. An HIV infection is associated with substantial loss of CD4+ T cells 
and immune deficiencies in general need to be treated according to the leucocyte 
subsets that is absent within the immune system (Oliveira and Fleisher; Virgo and 
Gibbs, 2012). As reported in the section describing the immune system, an 
inversion of CD4/CD8 ratio is indicative of immunosencence. 
Beside the diagnosis of cancers and immune deficiencies, other clinical 
applications that benefit from flow cytometry are cell therapy and pre-transplant 
cross-matching (Jaye et al., 2012). 
1.3.5 Computational approaches 
Flow cytometry is a technology originally born to produce data for only few 
markers, hence immunologists used to analyze the data using 2D plotting and other 
basic visualization methods. The technology, however, has substantially improved 
since its inception and nowadays it is possible to analyze up to 30 markers at a 
time in a single experiment. Therefore, traditional methods of data analysis are 
becoming increasingly laborious, error-prone and poorly reproducible. 
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Recently, several computational tools have been developed in order to analyze 
Flow Cytometry Standard (FCS) data in an automatic or semi-automatic way and 
a wide range of tools have been distributed by Bioconductor. The essential package 
is flowCore as it enables to perform basic manipulations on FCS files such as 
importing, compensation and transformation (Hahne et al., 2009). Consequently, 
a series of complementary packages have been developed providing the possibility 
to perform further operations, such as visualization, quality assessment, statistical 
analysis and automated gating. Notably, the SPADE and flowSOM algorithms can 
create tree structures whose nodes are populations identified in an unsupervised 
manner (Qiu et al., 2011; Van Gassen et al., 2015). Also, the packages CYT and 
CytofKit provides a plethora of methods for performing dimensionality reduction, 
such as PCA and tSNE, and clustering on both flow and mass cytometry data 
(Amir et al., 2013; Chen et al., 2016).  
To improve and promote the computational methods for flow cytometry analysis, 
a competition, flowCAP, on the most recent software is periodically held 
(Aghaeepour et al., 2013). The flowCAP challenges demonstrated that the 
computational approaches now available are sufficiently mature to give accurate 
and reproducible automatic gatings. Moreover, computational approaches can 
delineate new immune cell types from multiparametric data and correlate them 
with clinical outcomes in an unbiased and efficient manner that is superior to 
manual analysis (Aghaeepour et al., 2016).  
1.4 Research questions 
My thesis focuses on developing and employing computational approaches, 
mainly for the understanding of the immune system but also for other aspects of 
biomedical research. The computational approaches treated here cover various 
aspects of immunoinformatics, ranging from methods that answer questions with 
a biological emphasis to questions that consider only technical aspects of data 
analysis. My goal was to intersect experimental immunology and computational 
approaches by equally balancing my interest for both subjects. Hence, with the use 
of two kinds of data commonly produced by biomedical research labs, flow 
cytometry and gene expression, I addressed topics for both biological and technical 
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areas of interest with an inclination towards the advancement of immunological 
knowledge. 
Chapter 2 focuses on the understanding of evolutionary differences between 
human and mouse using large scale data. This was driven by the fact that numerous 
studies are conducted in mice for convenience but only few can be translated to 
human due to unknown evolutionary differences. Using gene homology 
information and co-expression networks built from gene expression data of human 
and mouse samples I set up four conservation parameters applicable to gene sets. 
Essentially, the four parameters are four different ways to measure the 
evolutionary distance of a gene set. Hence, the main questions addressed are: 
which pathways, tissues and/or diseases are conserved in terms of co-expression, 
network connectivity and homology? In more detail, which processes of the 
immune system are the most similar and which are most dissimilar between mouse 
and human? 
Chapter 3 reports the development of a quality control tool to advance automation 
and standardization of flow cytometry data analysis. In recent years, flow 
cytometry slowly joined the family of high-throughput technologies but its data 
analysis continues to be prevalently manual and subjective. There is still a lack of 
bioinformatics algorithms capable of handling the increase in data output of flow 
cytometry. My contribution consists of the development of a bioinformatics tool 
capable of detecting and removing anomalies from flow cytometry data. It 
addresses the questions: is it possible to discern anomalies from flow cytometry 
data in an unbiased way? Is it possible to make this process automatic? 
Chapter 4 contains both technical and biological insights as I used RNA-Seq data 
from 29 immune cell types to address questions on gene expression heterogeneity, 
mRNA composition, and deconvolution. Immunological research is generally 
done on mixed immune samples, and there is still a poor understanding of the 
contribution of specific cell types to the generation of high-throughput 
transcriptomic data. The questions I address in this chapter are: how do 
transcriptomic profiles differ between different immune cell types? What is the 
best strategy to account for differences in mRNA yield when normalizing for gene 
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expression data? To what extent can we trust the deconvolution algorithms 
available and which are the immune cell types more suitable for this approach?  
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Chapter 2 Evolutionary differences between 
human and mouse tissues, pathways and 
diseases with a focus on the immune system 
using co-expression and genomic information 
The work presented in this chapter has been extended from the publication below 
in which I was the first author. 
Monaco G, van Dam S, Casal Novo Ribeiro JL, Larbi A, de Magalhães JP. A 
comparison of human and mouse gene co-expression networks reveals 
conservation and divergence at the tissue, pathway and disease levels. BMC 
Evol Biol. 2015 Nov 20;15:259. doi: 10.1186/s12862-015-0534-7  
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2.1 Introduction 
The divergence of mice and humans from a common ancestor occurred 
approximately 90 million years ago (Hedges et al., 2006). Because of close 
evolutionary affinities with the human species and because of numerous properties 
that facilitate its handling, the mouse has been used as an animal model in 
biomedical research to study mammalian development, diseases and to test drugs 
for over 50 years (Ueda et al., 2006; Van Dam and De Deyn, 2011; Cheon and 
Orsulic, 2011). Although there has been great progress in understanding the 
genetics, anatomy and physiology of the mouse, the attrition rate of compounds 
efficacious in mouse models that fail in the Phase II clinical trials is still high 
(Arrowsmith, 2011). This evidences the lack of a comprehensive knowledge of the 
molecular differences between mice and humans and limits the translation of 
mouse studies to humans (de Magalhães, 2014). 
Similarities and differences between mice and humans have been studied at 
different levels and more recently, research at a molecular level has benefitted 
from the application of high-throughput technologies. On the one hand, about 90% 
of the human and mouse genome regions have comparable synteny and 
orthologous genes have 78.5% of amino acid identity (Waterston et al., 2002). On 
the other hand, both lineages have undergone gene duplication in their evolution 
and, for example, genes related to olfaction, immunity and reproduction expanded, 
suggesting an extended functionality, in the rodent lineage (Waterston et al., 
2002).  
Liao and Zhang performed a large scale microarray analysis to evaluate the 
divergence in gene expression between mice and humans, reporting that only 16% 
of the human-mouse orthologous genes have expression profiles as divergent as 
random genes (Liao and Zhang, 2006). Zheng-Bradley et al. (2010) conducted a 
principal component analysis (PCA) on a merged dataset, containing gene 
expression data from mouse and human tissues, in order to capture the factors that 
mostly account for the variability of the dataset. Among the great heterogeneity of 
experimental conditions, the orthologous genes clustered in the top principal 
components according to tissue specificity, in particular liver, muscle and nervous 
 59 
cells, indicating a strong similarity of gene expression profiles between mice and 
human tissues (Zheng-Bradley et al., 2010). Nevertheless, whether the gene 
expression patterns cluster by tissues or by species was recently questioned and it 
seemed to be mostly related to the data available instead of the methodology used 
(Lin et al., 2014). This might be caused by the presence of both tissue and species 
specific genes, and the dominance of one of the two sets determines the clustering 
patterns (Breschi et al., 2016). 
Another powerful approach utilizing transcriptomic resources is the construction 
of co-expression maps (Wren, 2009). For a collection of samples, the gene 
expression profiles of pairs of genes are compared using a similarity metric. 
Consequently, a threshold on the similarity measure is selected in order to build a 
co-expression network where the nodes are the genes and the edges are the links 
between genes that are co-expressed (Leal et al., 2014).  
Numerous analysis approaches have been applied to co-expression maps to infer 
gene function information from single tissues, entire organisms or across species 
(Klomp and Furge, 2012; Hansen et al., 2014), but they are also employed to 
determine the differences and similarities between species (Stuart et al., 2003; 
Oldham et al., 2006). Tsaparas et al. compared the mouse and human co-
expression networks created from 28 shared tissues (Tsaparas et al., 2006). They 
firstly investigated the topology of the networks showing the conservation of the 
scale-free properties at a global level but high dissimilarity of the co-expression 
patterns of orthologous genes. Secondly, the functional similarity of co-expressed 
gene pairs were significant compared to randomized networks and specific genes 
of the immune systems and sexual reproduction were highly interconnected 
although this two classes are known to be more prone to positive selection 
(Tsaparas et al., 2006). 
Other research based on a comparison of co-expression maps of human and mouse 
brain tissue showed that gene interactions were highly conserved in the nervous 
system and revealed a cluster of genes specific to humans for Alzheimer’s disease 
(Miller et al., 2010). Analysis of co-expression maps can also reveal the preserved 
interactions in sets of genes known to be associated with a certain condition or 
function (Netotea et al., 2014), and using a method based on conserved co-
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expression has recently listed the most diverged and conserved GO categories 
(Yue et al., 2014).  
The current challenge is to explore and derive biological meaning from the vast 
amount of potentially informative data available. A small number of genome-wide 
scale analyses focused on the evolutionary aspects determining differences and 
similarities between mice and humans have been conducted, often relying on a 
limited number of orthologs and on small condition-specific datasets for the 
comparison. In addition, only few results were confirmed in multiple works, such 
as the gene expression conservation of the brain (Liao and Zhang, 2006; Chan et 
al., 2009; Miller et al., 2010), the highest divergence rate in testis (Chan et al., 
2009; Brawand et al., 2011; Necsulea and Kaessmann, 2014), and the high number 
of functional duplicated olfaction-related genes in mice (Gilad et al., 2003; Young 
et al., 2002).  
Regarding the immune system, no definitive conclusions have been made 
regarding its conservation. It has been shown that, the overall architecture of the 
immune system and the tissue morphology is well preserved (Haley, 2003). 
However, at the molecular level it has been reported that both the genomics and 
transcriptomics are overall diverged (Waterston et al., 2002; Yue et al., 2014). 
Similarities and differences have been studied (Mestas and Hughes, 2004; 
Mingueneau et al., 2013), but they are not exhaustive as they are done on candidate 
genes or relatively small datasets and some of the findings could not be 
reproduced. 
I believe that the use of co-expression maps built on an ample number of gene 
expression datasets would give a more comprehensive and reliable understanding 
of the degree of functional homology between mouse and human processes. The 
envisioned outputs include the following: 1) understand the relationship between 
different biological systems; 2) identify the best working models to dissect specific 
mechanisms; 3) reducing the attrition rate in Phase 2 studies; 4) provide hypothesis 
in growing health issues and research fields such as aging, dementia or metabolic 
diseases. 
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Therefore, I compared and contrasted human and mouse co-expression maps, 
obtained from GeneFriends (van Dam et al., 2012), an online tool entailing a co-
expression analysis of over 60,000 microarray samples using the latest homology 
annotation on approximately 16,000 genes. I explored the co-expression maps on 
a systems-level view primarily using a new parameter of conservation based on 
the number of commonly co-expressed genes (CCG) between humans and mice. 
Hence different biological aspects were considered, such as the association of the 
conservation of co-expression connectivity with selective pressure, patterns of 
duplications after speciation, functional enrichment in genes with conserved and 
diverged co-expression connectivity, and the evolutionary changes in 30 different 
tissues, 1,930 pathways and 208 diseases. This analysis led to the identification of 
gene interactions conserved through the two species independently of tissue, age, 
gender, health status and stimuli. 
2.2 Methods 
2.2.1 Data collection  
Co-expression networks of humans and mice were obtained from GeneFriends 
version 3.0 (van Dam et al., 2012). They were built using microarray data from 
3571 sets for the human map and 4164 sets for the mouse map 
(http://genefriends.org/about/), that in both cases they correspond to 
approximately 60,000 microarray chips and 20,000 experimental conditions. 
The human and mouse co-expression maps contain information on interactions 
among 19,727 and 22,766 genes respectively labelled with Entrez Gene identifiers 
(Genome assemblies: GRCh38 for human and GRCm38 for mouse). Biomart 
Ensembl was used to retrieve the homologous gene pairs and the nonsynonymous 
(dN) and synonymous (dS) substitution values. Among the list of homologous 
pairs, 14,846 had a one-to-one orthologous relationship, 1,211 had a one-to-many 
orthologous relationship and 1,016 had a many-to-many orthologous relationship, 
adding up to 17,074 pairs of genes with sequence homology. 
The gene sets used to decipher the evolutionary pattern of tissues, pathways and 
diseases were retrieved from four different online sources. Lists of RefSeq IDs 
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specific for 30 human tissues have been retrieved from the TIGER database (Liu 
et al., 2008), and Biomart Ensembl was used to convert Refseq IDs in Entrez IDs. 
The genes were specifically expressed in at least one of 30 different tissues 
catalogued by TIGER: Bladder, Blood, Bone, Bone Marrow, Brain, Cervix, Colon, 
Eye, Heart, Kidney, Larynx, Liver, Lung, Lymph node, Mammary gland, Muscle, 
Ovary, Pancreas, Peripheral nervous system, Placenta, Prostate, Skin, Small 
intestine, Soft tissue, Spleen, Stomach, Testis, Thymus, Tongue, Uterus (Liu et al., 
2008).  
A total collection of 1,930 pathway gene lists were retrieved from the Reactome 
database (Joshi-Tope et al., 2005). The Reactome pathways are grouped in 26 
broad categories and within each category the pathways are hierarchically 
organized. All the pathways containing less then 3 genes were removed from the 
analysis for a total of 1,720 gene sets. 
The disease gene sets derive from of an accurate selection (Zhang et al., 2010) of 
gene related diseases formerly made for the Genetic Association Database (GAD, 
Becker et al. 2004). GAD contains gene records collected from the survey of 
publications on candidate gene studies and genome wide association studies 
(GWAS), but Zhang et al. selected only the genes positively associated with a 
disease and that were annotated with a MeSH term were included in the collection. 
Because GWAS studies are known to be hardly reproducible, a more stringent 
filtering was applied compared to the Reactome database and I removed the 
diseases reporting less than 10 genes. Hence, from the 1,317 diseases contained in 
the downloaded file, I continued the analysis with only 207 disease gene sets. In 
addition, I included an aging gene set retrieved from the GenAge database (build 
17, human dataset with 298 genes), for a total of 208 diseases gene sets (Tacutu et 
al., 2013).  
2.2.2 Statistical analysis and data distributions 
The R software was used to perform statistical analyses and other operations on 
the data (Supplement 1). The kruskal-wallis rank sum test, Spearman correlation, 
Mann Whitney U test, F-test, Fisher’s exact test and multiple test corrections have 
been performed using pre-built packages. The set of data used were tested for 
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normality with the Shapiro test and for skewness using the R package moments. 
For all the distributions, I rejected the null hypothesis of normality and I depicted 
right-skewness (dN/dS values: Shapiro test W=0.82 with p-value < 2.2e-16, 
skewness = 1.78; number of commonly co-expressed genes: Shapiro test W=0.96 
with p-value < 2.2e-16, skewness = 0.57; network connectivity in human: Shapiro 
test W= 0.65 with p-value <2.2e-16, skewness = 3.57; network connectivity in 
mouse: Shapiro test W= 0.57 with p values < 2.2e-16, skewness = 3.93). 
2.2.3 Number of commonly co-expressed genes and functional 
annotation analysis 
For each gene of both the human and mouse co-expression maps, I arranged the 
co-expressed genes by decreasing co-expression value and the top 5% co-
expressed genes were selected. Hence, because the two co-expression maps are 
different in size, for each human gene we obtained 968 genes and for each mouse 
gene 1,138 genes. Next, for each homolog I counted how many homologs 
commonly appeared as co-expressed in both the human and the mouse lists and I 
referred at it as number of commonly co-expressed genes (NCCGs). DAVID was 
used to perform the enrichment analysis (Dennis et al., 2003) on the two gene lists 
derived from the human counterpart of the top 5% and bottom 5% of homologous 
pairs ranked by the NCCGs. The clustering tool of DAVID was used to report the 
results using as background the entire set of homologous genes. GSEA analysis 
was performed in the pre-ranked mode using the “classic” option for the 
calculation of the enrichment score. 
2.2.4 Co-expression maps and construction of directed networks 
Co-expression maps have been created using a vote counting approach. Precisely 
it was counted how many times the expression of two genes were simultaneously 
increased or decreased across the different conditions of each dataset and the 
obtained value was normalized with how often the two genes were not co-regulated 
(van Dam et al., 2012). Genes that are regularly associated in any condition have 
higher co-expression value compared to genes associated with different genes in 
various conditions.  
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Subsequently, I built two directed networks from both the human and mouse co-
expression maps. For each gene, I retrieved all the top co-expressed genes using a 
percentage threshold. I chose the threshold of 1% since it allows more significant 
and detailed results in comparison to a higher threshold and, at the same time, it 
does not strongly reduce the sensitivity compared to a more stringent threshold as 
also argued in previous works (Ala et al., 2008; Pellegrino et al., 2004). Moreover, 
a percentage threshold instead of one based on co-expression values is preferable 
since I aim to compare data coming from species-specific array where the 
expression levels are incomparable given the different hybridization properties 
(Liao and Zhang, 2006).  
A network is mathematically defined by G=(V,E) where V is the set of nodes and 
E is the set of edges. The basic structure of a network is the adjacency matrix A(G) 
with an mxm size and, referring to our networks, the variable m is the number of 
genes, where Aij=1 if gene i and gene j are connected and Aij=0 otherwise. To 
obtain directed edges, also called arcs, where Aij≠Aji, I assigned a directed edge 
from the node i to the node j only if i is present among the top 1% of co-expressed 
genes of j. The building and the topological analysis of the two networks were 
performed in R, with custom scripts and the igraph package (Csárdi and Nepusz, 
2006). 
2.2.5 Differential connected genes and functional annotation 
analysis 
The number of edges attached to a node in a complex network is defined by 
connectivity or degree (k). Therefore, the number of nodes that interact with the i-
th node is evaluated in terms of adjacency matrix as:  
 HI = 	 (JIK)LKM'  (2.1) 
Considering that I have two biological networks based on homologous genes 
between mouse and human where each node represents a gene, I defined k1(i) and 
k2(i’) the connectivity of the homologous genes in the human (1) and mouse (2) 
networks, respectively. The connectivity values were normalized in respect to the 
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size of the networks since they are built using a percentage threshold and the total 
number of genes is different in human and mouse.  
To calculate the differential connectivity values, I divided the connectivity 
numbers of each homolog by each other adding 10 in both the terms of the division 
in order to reduce the disproportionate fold change in connectivity among low 
values:  
 DNOOP N, NQ = (P' N + 10)/	(P2 NQ + 	10) (2.2) 
To better handle the differential connectivity values, I calculated the negative 
reciprocal for values comprised between 0 and 1, and later I subtracted 1 to positive 
values and added 1 on negative values. In this way, genes with a value greater than 
0 are more connected in human while genes with a value less than 0 are more 
connected in mice. To obtain differential connectivity values, we also tested the 
logarithm fold-change of the connectivity values and it gave similar results. 
As for the genes ranked by the number of commonly co-expressed genes, I 
performed an enrichment analysis with DAVID ranking our dataset according to 
the value of differential connectivity and using the top 5% and bottom 5% of 
human homologs for the DAVID cluster analysis. The top 5% of genes correspond 
to the homologs with higher connectivity in human, while the bottom 5% of genes 
correspond to the homologs with higher connectivity in mouse. 
2.2.6 Tissue, pathway and disease analysis 
The analysis on tissues, pathways and diseases gene sets was performed in the 
same way. For each gene set I reported four different parameters describing 
evolutionary aspects: (i) the conservation of co-expression in terms of the number 
of homologs commonly co-expressed, (ii) differential connectivity, (iii) ratio of 
duplication events and (iv) the ratio of non-homologous genes (Figure A.1). 
(i) The conservation of co-expression and (ii) the differential connectivity of a gene 
set was calculated using a Mann Whitney U test on the values of each gene set and 
the remaining genes. As a measure of variation, I used the median of the difference 
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between a sample of values of the gene set and a sample of values of the remaining 
genes.  
(iii) The ratio of duplication events and (iv) the ratio of non-homologous genes of 
each gene set were tested using the Fisher’s exact test. (iii) The proportion of 
duplicated genes of a gene set was compared with the proportion of duplicated 
genes in the remaining genes, and in a similar way (iv) I compared the proportion 
of non-homologous genes. 
The genes co-expressed with each gene set were retrieved in the following way. 
The re-occurring of a commonly co-expressed gene among the homologs of a gene 
set was calculate in terms of relative frequency. To assess the significance of 
association of a gene with the gene set, a permutation analysis with 1,000 iteration 
was performed on a number of homologs equal to the size of the gene set that were 
randomly selected from the entire dataset. The p-values were determined as a 
fraction of permutation values that are at least as extreme as the original value. 
Lastly, the multiple testing correction using Benjamini & Hochberg method was 
applied for each set of p-values. 
2.3 Results  
I obtained and analysed the human and mouse co-expression maps from 
GeneFriends v3.0 (van Dam et al., 2012). These maps have been constructed from 
the expression levels of 19,727 human genes in 4,164 datasets and 22,766 mouse 
genes in 3,571 datasets from the GEO database (Barrett et al., 2007). The co-
expression maps contain a co-expression value for each possible gene-pair, i.e. a 
measure of gene expression similarity given by the frequency a pair of genes is 
differentially up- or down-regulated together in all datasets (van Dam et al., 2012). 
2.3.1 Homologous relationships and molecular evolution rates 
To establish evolutionary differences and similarities between the human and 
mouse co-expression maps, I performed the analysis using the fraction of genes 
that have a homologue in both humans and mice, corresponding to 16,080 unique 
genes in humans and 16,463 unique genes in mice. Homologous genes can be one-
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to-one orthologs when they have an unequivocal relationship, but also one-to-
many or many-to-many orthologs, which occur when a duplication event, after 
speciation, leads to the formation of multiple genes (paralogs) with similar 
function or sequence in one or both species (Koonin, 2005). In the dataset, 14,846 
genes were one-to-one orthologs, while the remaining mouse and human homologs 
had a one-to-many or many-to-many relationship (see Methods).  
One aspect of species evolution is the magnitude of natural selection that acts on 
protein-coding sequences indicated by the dN/dS ratio (Yang and Bielawski, 
2000). The homologous gene lists and the dN and dS values were retrieved from 
Biomart Ensembl (Methods) and, to evaluate the impact of duplication events on 
the coding sequence divergence of humans and mice, I compared the dN/dS ratios 
of homologous genes with different types of homology (Figure 2.1). As expected, 
one-to-one orthologs have the lowest dN/dS ratio which progressively increases in 
one-to-many and many-to-many orthologs.  
 
Figure 2.1 Comparison of the distribution of dN/dS values among homologs with different 
orthologous relationships, accordingly one-to-one, one-to-many and many-to-many. The 
Kruskal-Wallis test was used to determine that the three distribution are significantly different 
(Kluskal-Wallis chi-squared = 1366, df =2, p-value = 1.66e-297), and a post hoc analysis (Mann-
Whitney test and Bonferroni correction) revealed that all the pairwise comparisons were 
significantly different. 
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Consequently, considering the higher likelihood for duplicated genes to have 
diverged, the subsequent analysis in this work have been performed using both the 
entire sets of genes and one-to-one orthologs only, and we reported relevant 
differences when necessary.  
2.3.2  Commonly co-expressed genes in humans and mice 
As a first step in comparing the mouse and human co-expression maps, the 
conservation of co-expression connectivity for each gene was determined. For this 
analysis, all the orthologous relationships were used. For each gene, I selected its 
top 5% of co-expressed genes from the human and mouse maps and determined 
the number of overlapping homologs, that I called number of commonly co-
expressed genes (NCCGs), see Supplement 2. The percentage threshold of 5% 
was determined to be the best choice among the tested values from 1 to 10%, even 
though the selection of other thresholds would not have considerably changed the 
results (Figure 2.2).  
I first tested the hypothesis that non-synonymous substitutions on protein coding 
genes influence the conservation of co-expression connectivity. To do so, I 
determined the Spearman’s correlation between the NCCGs in humans and mice 
with the dN/dS ratio values. As expected, a negative correlation was found, with a 
very similar correlation coefficient both when using the entire set of homologous 
pairs (rho= -0.19, p-value= 1.24e-134) and only one-to-one orthologs (rho= -0.14, 
p-value = 4.04e-65, Figure 2.3). A p-value was also re-calculated using a 
permutation test with 10,000 iteration and it confirmed the trend (p-value < 1e-04 
in both cases). Co-expression connectivity changes are more likely in genes 
undergoing faster molecular evolution changes. 
Homologs that have high or low NCCGs can reveal which pathways and molecular 
functions are more or less conserved between the two species. To investigate this, 
genes were then ranked according to the NCCGs and the top 5% and the bottom 
5% of the ranked list were selected for functional enrichment analysis using 
DAVID (Dennis et al., 2003). The results show that genes with the strongest  
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conserved co-expression connectivity are mainly operating in the extracellular 
matrix as they are involved in functions like signal transmission, cell adhesion, 
immune response and chemotaxis (Table 2.1). On the other hand, genes with the 
least conserved co-expression are associated mainly to sensory systems, in 
particular olfaction and gustatory system, and in the nucleus, as supported by the 
fact that the strongest enrichment is for several zinc finger domains, which are 
embedded in transcription factors and allow the establishments of contacts along 
the DNA (Table 2.1, Supplement 3: sheets 1-2). 
To uncover inconsistencies due to the inclusion of one-to-many and many-to-many 
orthologs, I performed the same DAVID analysis using only one-to-one orthologs. 
The main difference in this analysis is the emerging of transcription regulation 
terms as significantly enriched for the bottom 5% genes (Supplement 3: sheets 3- 
 
Figure 2.2 Comparison of thresholds used to retrieve the number of commonly co-expressed 
genes (NCCGs). Threshold percentages from 1 to 10 were used to retrieve the NCCGs from the 
human and mouse co-expression maps (Methods). The number of CGGs for each threshold was 
correlated (Spearman’s method) with the number of CGGs found with other thresholds. The mean 
and standard errors of the correlations of each threshold with the other ones is reported on the y-
axis. Following the line of the chart, it can be observed that the best threshold selection is 5% 
since it correlates the most with the other percentage thresholds. The mean correlation value was 
found to be no lower than 0.93, indicating that the choice of the threshold does not substantially 
influence the ranking of homologs in terms of NCCGs.  
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4). Because the choice of a percentage threshold of 5% was arbitrary, I also 
employed GSEA (Subramanian et al., 2005) and reported in Supplement 3 (sheets 
5-8), though results were similar. 
 
 
 
Figure 2.3 Comparison of the NCCGs among homologs divided in equally sized bins generated 
according to quartiles of dN/dS values. The black boxes represent the entire set of homologous 
pairs, while the grey boxes represent the subset of homologous pairs with a one-to-one 
relationship only. The range of dN/dS values in the x-axis are indicative of both sets of genes, 
and they were obtained by summing and then averaging corresponding quartiles. The choice of 
four bins was arbitrary but equal trends were obtained dividing the value in 10 bins or from a 
linear regression line fitted to the data (data not shown). 
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Table 2.1 DAVID analysis of the top and bottom 5% of homologous human genes ranked by 
the NCCGs. In the table are reported the key components selected from functional clusters 
that obtained an enrichment score greater than or equal to 4 (see Supplement 3 for the full 
results). 
Homologs with conserved connectivity 
Enrichment Score Functional annotation Benjamini 
33.66 
Signal peptide  1.22E-36 
glycoprotein 2.32E-35 
disulfide bond 3.56E-27 
27.85 Cell adhesion 5.67E-27 
19.52 Extracellular matrix 5.75E-18 
10.95 Response to wounding 1.84E-12 defense response 4.18E-08 
9.40 Basement membrane 7.21E-07 
8.78 glycosaminoglycan binding 2.06E-08 polysaccharide binding 2.68E-08 
8.27 plasma membrane part 6.18E-13 
8.03 topological domain: Extracellular 3.45E-12 
6.98 Immunoglobulin domain 1.47E-13 
6.75 Cell motion 1.29E-07 
6.29 Chemotaxis 7.33E-06 
6.27 EGF-like region, conserved site 1.46E-09 
4.26 Hydroxylysine 2.82E-09 Collagen triple helix repeat 6.18E-06 
4.09 Cytoskeletal protein binding 2.10E-04 
Homologs with diverged connectivity 
Enrichment Score Functional annotation Benjamini 
7.09 
Zinc finger, C2H2-like 2.30E-10 
DNA binding 2.00E-05 
Transcription 4.99E-05 
6.48 
sensory perception of chemical 
stimulus 
4.00E-13 
olfactory receptor activity 2.57E-11 
4.24 Mammalian taste receptor 2.16E-05 
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2.3.3 Exploring gene co-expression connectivity using directed 
networks 
To further explore and compare gene co-expression connectivity between mice 
and humans, I extracted directed networks from the co-expression maps. For the 
directed networks, each node corresponds to a gene and each arc indicates a pair 
of co-expressed genes. Directionality to each edge was given if one gene of the 
pair was co-expressed to the other one but not vice versa (see Methods).  
Network topology 
The global topology of biological networks has been shown to have a scale-free 
behaviour that follows a power law distribution, which is expressed 
mathematically as S H ~	HUV (Barabási and Oltvai, 2004; Stelzl et al., 2005; Zhu 
et al., 2007). In scale free networks, nodes are not randomly connected, but rather 
display a tendency to connect to nodes that have many links. Therefore, the 
topology of the network is dominated by a small number of nodes with high 
connectivity, called hubs, and a large number of poorly connected nodes (Barabási 
and Albert, 1999). As previously demonstrated (Tsaparas et al., 2006), the power 
law distribution fits the data, the topology of the networks was similar in mice and 
humans and no relevant differences could be observed (Figure 2.4).  
 
Figure 2.4 Log-log plots of the degree distributions of (a) human and (b) mouse networks. Both 
cases follow a power law distribution with no relevant topological differences. The parameters 
of the power law distribution are the exponent (y) and the minimum connectivity value k (kmin), 
which have been estimated for both networks (y=-3.552 and kmin=1091 for the human network; 
y=4.158 and kmin=1707 for the mouse network). 
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Relation of network connectivity with number of commonly co-
expressed genes and dN/dS values.  
The scale-free behaviour of the human and mouse networks indicates that the 
network connectivity among genes is characterized by an exponential trend line. 
Therefore, the diverse connectivity of genes in a network might have an effect on 
the number of interactions that result to be conserved among two species. For this 
reason, I performed a Spearman’s correlation between the NCCGs and the network 
connectivity of the genes in mice and humans, obtaining in both cases a positive 
association (human: rho= 0.34, p-value < 5e-324; mouse: rho= 0.32, p-value < 5e-
324). Nevertheless, there is a positive correlation between connectivity values and 
dN/dS values (human: rho= 0.06, p-value= 1.022e-15; mouse: rho= 0.08, p-value 
= 8.17e-29), that vanishes in humans and becomes weaker in mice if using only 
ono-to-one orthologs (mouse: rho= 0.048, p-value = 6.61e-07) but that increases 
if using one-to-many and many-to-many only (human: rho= 0.20, p-value= 1.45e-
21; mouse: rho= 0.13, p-value = 2.72e-09) showing that after duplication events 
the new genes may play pivotal roles in establishing new species-specific co-
expression connections. A permutation analysis confirmed the significance of the 
results for all cases (p-value < 1e-04). 
Loss or gain of co-expression connectivity in mice and humans 
From an evolutionary perspective, to evaluate the changes in network connectivity 
between mice and humans, I calculated a value of differential connectivity for each 
gene. The values were obtained by dividing the two network connectivity values 
of each orthologous pair (Methods and Supplement 2). The range of connectivity 
values is generally similar in human and mouse across the different orthologous 
categories apart from the non-homologous genes where we notice an increased 
connectivity in mice compared to humans (Figure 2.5).  
I ranked the homologs according to the differential connectivity values and, as for 
the previous analysis, I selected the top and bottom 5% from the entire list to 
perform the functional enrichment analysis. Genes with higher connectivity in 
humans are members of tumor-specific antigens (MAGE) and keratin family, and 
enrich functions involved in signal transmission and immune response mediated  
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by INF-α. Genes more connected in the mouse are largely related to olfactory 
activity, revealing that the divergence of this pathway is related to an increased 
functionality in mouse (Table 2.2, Supplement 4). The DAVID analysis was 
repeated using only one-to-one homologs and I noticed the absence of the 
annotations related to the interferon alpha and to the MAGE protein (Supplement 
4). 
 
 
 
 
 
 
Figure 2.5 Network connectivity in different categories of genes defined on the basis of 
homology relationship between mouse and human. In the figure, the central symbol indicates 
the median and the error bars extending from the symbols indicate the interquartile range. The 
network connectivity generally extends in a similar range for the gene categories, apart from the 
non-homologous genes which shows an overall increase in connectivity in the mouse species. 
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2.3.4 Conservation and divergence of immune system gene sets 
and others related to tissues, other pathways and diseases  
During mammalian evolution, the molecular components of different tissues, 
pathways and diseases go through different structural and functional changes. The 
tolerance of molecular changes largely varies among gene sets with different 
functions. For this section, I used four parameters to examine the conservation and 
divergence of curated gene sets that represent tissues, pathways and diseases. The 
four parameters are: (i) conservation of co-expression, which is based on the 
median NCCGs of a gene set; (ii) differential connectivity, which indicates the 
overall increase or decrease of connectivity for a gene set in the mouse or in 
humans; (iii) proportion of duplication events, which detects deviations in the ratio 
of one-to-many and many-to-many orthologs of a gene set compared to the entire 
set of genes; and (iv) the proportion of non-homologous genes, which detects 
Table 2.2 DAVID analysis of the top and bottom 5% homologous human genes ranked by 
differential connectivity (top genes are highly connected in human, bottom genes are highly 
connected in mouse). In the table are reported the key elements selected from functional clusters 
that obtained an enrichment score greater than or equal to 3 (see Supplement 4 for the full 
results). 
Higher connectivity in Human 
Enrichment Score Functional annotation Benjamini 
7.95 
Signal peptide  4.52E-09 
glycoprotein 8.34E-05 
Disulfide bond 2.61E-08 
3.93 
Interferon alpha 9.08E-06 
Autoimmune thyroid disease 1.94E-04 
Antigen processing and presentation 0.00665 
3.87 tumor antigen 0.008748 MAGE protein 0.024607 
3.19 region of interest:Coil 2 0.007066 keratin 0.001462 
Higher connectivity in Mouse 
Enrichment Score Functional annotation Benjamini 
4.21 
sensory perception of chemical 
stimulus 
1.80E-05 
olfactory receptor activity 3.67E-06 
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deviations in the ratio of non-homologs of a gene set compared to the entire set of 
genes (Figure A.1, Supplement 5 and Methods).  
Because of its superior quality, I used human gene sets for the analysis. I used gene 
sets specific for 30 tissues retrieved from the TIGER database (Liu et al., 2008), 
1,930 pathways retrieved from the Reactome Database v61 (Joshi-Tope et al., 
2005), and 208 including diseases from the Genetic Association Database (GAD, 
Zhang et al. 2010) and an aging gene set from the GenAge Database (Tacutu et al., 
2013).  
Lastly, for each gene set I also retrieved and reported novel candidate associated 
genes conserved both in humans and mice by counting how many times a gene 
was associated with the homologs of a gene set and calculating the significance 
using a permutation test (Supplement 6, Methods).  
Immune system: overall conserved with high proportion of duplicated 
genes 
The gene connectivity within the immune system is overall conserved, although it 
is characterized by a high proportion of duplicated genes (Figure 2.6). This 
suggests that there might be specific immune functions that are diverged. An 
advantage of using the Reactome database is that it provides an exhaustive list of 
biological processes in a hierarchical structure. Regarding the immune system, the 
pathways with immune functionalities are divided in three main branches: 
cytokine signalling, adaptive immunity and innate immunity. Here, I explore all 
the pathways related to the immune system up to the fourth hierarchical level.  
Among the pathways involved in the cytokine signalling, the ones involved with 
prolactin, growth hormone and interferon alpha/beta signalling appear to be 
divergent with an increased connectivity in humans only when including one-to-
many and many-to-many orthologs in the analysis. Pathways related to interleukin 
and interferon gamma signalling show instead significant conserved trends for the 
NCCGs and gene connectivity (Figure 2.6a,b,c). 
The few processes of the innate immune system that show signs of divergence are 
related to IRF7 activation by TRAF6 and to antimicrobial activity through  
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Figure 2.6 Evaluation of conservation of pathway-specific gene sets with immune functionality 
selected from the Reactome database. All the 99 pathways of the first four hierarchical levels are 
reported. In bold red, bold blue, bold black and regular black are the gene sets of the first, second, third 
and fourth level, respectively. For panel a and b I used the NCCGs and the differential connectivity 
values, respectively, and on the x-axis is reported the median of the difference between the values of a 
sample of a gene set and a of sample of the remaining genes. In panel c I reported the odds ratio of 
homologous genes that underwent duplication (one-to-many and many-to-many homologs), and in 
panel d I reported the odds ratio of non-homologous genes (Methods). The analysis has been 
performed both on the entire set of homologs (bars in black) and on one-to-one orthologs only (bars in 
grey) with asterisks indicating the significant results (FDR <0.05). For other details refer to Methods 
and Figure A.1. 
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defensins. IRF7 is a regulator of type I interferons (Ning et al., 2011) and its 
divergence is related to the one observed for IFN alpha/beta with an increased 
connectivity for duplicated genes. Defensins are antimicrobial peptides and its 
divergence between human and mouse has already been reported in previous 
works (Risso, 2000; Ouellette and Selsted, 1996).  
 Regarding the adaptive immune system, there are only two processes that 
significantly diverged in terms of commonly co-expressed genes. The immune 
modulation by butyrophilins is the more diverged one with also a higher proportion 
of duplicated genes. The second diverged process is the ubiquitination and 
proteasome degradation acting for the MHC class I antigen presentation (Figure 
2.6a,c). 
Tissues analysis: few cases of divergence  
There is an overall tendency of conservation in the 30 tissue-specific gene sets; all 
gene sets contain a low proportion of non-homologous genes, and 20 out of 30 
contain genes with conserved co-expression patterns (Figure 2.7). Differential 
connectivity values seem to be biased towards human versus mice (Figure 2.7), 
and a possible interpretation is that in human the post-transcriptional processes 
contribute to a greater variety of proteins and therefore interactions (Barbosa-
Morais et al., 2012). On the other hand, mouse has a greater amount of total 
annotated protein-coding genes (Church et al., 2009), and non-homologous genes 
are mainly responsible for the formation of new interactions (Figure 2.5).  
The conservation of brain and bone is striking, since they are the top two results 
among the tissues which have a higher conservation of co-expression connectivity 
(Figure 2.7) as well as having a relatively low ratio of duplications among their 
tissue specific genes (Figure 2.7c). When looking for novel associated homologs 
with tissue gene sets, I noticed that for the brain, the top 36 genes significantly 
establish a connection with 70-90% of the homologs of the gene set (Supplement 
6: sheets 1 and 4). Thus, this also suggests a high degree of interconnectivity for 
brain specific genes with other related genes that are not strictly tissue-specific.  
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On the other hand, testis, eye, skin, pancreas and lung are the tissues whose co-
expression connectivity was diverged the most (Figure 2.7a). I also noticed some 
inconsistencies when comparing the results obtained using the entire list of 
homologs and only one-to-one orthologs. For instance, the divergence of co-
expression and the increase of network connectivity in human of genes expressed 
in the skin dissipated when considering only homologs with a one-to-one 
relationship. In this case, this behaviour can be associated with a higher rate of 
one-to-many and many-to many homologs indicating that the duplicated genes 
specific for the skin tissue have a great impact in determining its divergence 
(Figure 2.7b, Supplement 5). 
Validation and novel insight on the remaining Reactome pathways  
After having analysed the immune system pathways in greater detail, I explored 
the remaining Reactome pathways belonging to 25 broad categories (Figure A.1, 
Figure A.2, Figure A.3, Figure A.4, Supplement 5).  
 
Figure 2.7 Evaluation of conservation of 30 tissue-specific gene sets. The tissues are ranked 
according to the level of conservation in terms of common co-expression (a) The way the results 
were retrieved for the four panels a-d are described in the Methods, Figure A.1 and Figure 2.6. 
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From a quick look at the full set of Reactome pathways, it is noticeable that most 
of the pathways show sign of conservation. The conserved pathways seem to be 
mostly involved in extracellular matrix organization, cell cycle, DNA replication, 
cell-cell communication, hemostasis, muscle contraction and signal transduction. 
The diverged pathways, instead, seem to be mostly related to chromatin 
organization, digestion and reproduction. However, there are exceptions within 
each category and some of them will be briefly reported here. 
Regarding the pathways related to activities with DNA, on the one hand, various 
stages and checkpoints of mitosis and chromosome maintenance are conserved, 
including DNA replication and DNA repair. On the other hand, genes involved in 
the pairing and recombination between homologous chromosomes during meiosis 
and in chromatin organization show a low NCCGs (Figure A.2, Figure A.3). 
Moreover, a better examination of telomere maintenance processes indicates that 
the co-expression connectivity is significantly conserved for the telomere 
extension mechanism but diverged for the packaging of telomere ends in 
conjunction with other divergence features, such us a higher proportion of 
duplicated and non-homologous genes (Supplement 5).  
The gene set related to gene expression is slightly diverged (Figure A.3) and more 
specifically the divergence is mainly due to genes involved in promoter opening 
(Supplement 5). From the analysis made to retrieve novel candidate genes 
associated with gene sets, I report that is strongly associated with pathways 
involved in transcription and RNA degradation (Supplement 6: sheets 3 and 4). 
Moreover, OIP5 was previously associated with centromeres in the G1 phase of 
cell cycle (Hayashi et al., 2004) and with different types of tumors, such as gastric, 
testis (Nakamura et al., 2007) and clear cell renal cell carcinoma (Gong et al., 
2013). 
Probably the least conserved pathway within the Reactome database is the one 
involved the olfactory signalling since it has significant features of divergence for 
three of the parameters considered with an increased connectivity in the mouse 
(Figure A.4, Supplement 5). This confirms my previous results obtained with the 
DAVID analysis, and since the divergence of this sense between mice and humans 
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is well-known (Niimura and Nei, 2005; Gilad et al., 2003), it underpins the 
reliability of the approaches used and confidence in the results obtained.  
Lastly, a diverged pathway that is worth mentioning because of its central role in 
apoptosis and cancer is the phosphoinositide 3-kinase (PI3K) signalling cascade 
(Yuan and Cantley, 2008; Carnero and Paramio, 2014). Despite its low proportion 
of duplicated genes and non-homologous genes, the genes of the PI3K cascade are 
divergent in terms of co-expression (Supplement 5). Given the importance of this 
pathway in research I reported a table in the Supplement 5 (sheet 4) that includes 
a list of the commonly co-expressed homologs for the genes involved in the PI3K 
cascade that are less conserved. Surprisingly, the list comprises also the crucial 
mTOR and AKT2 genes. 
Disease Analysis: an exhaustive conservation 
Since there is some controversy on the reliability of gene-disease association 
determined by genetic association studies, I used a curated repository of Genetic 
Association Database (GAD, Becker et al. 2004), validated by filtering and 
retaining only the genes that have a published evidence of being positively disease-
associated and MeSH annotated (Zhang et al., 2010).  
The analysis performed on 208 gene-sets revealed more modest p-values and 
statistics when compared to the results obtained on tissue and pathway gene sets 
(Supplement 5). Concerning the conservation of co-expression, the median value 
of commonly co-expressed genes of 80 disease related gene-sets is significantly 
higher compared to the remaining genes. Among the 80 gene-sets, the top most 
conserved gene sets are related to cardiovascular diseases, diabetes mellitus type 
2 and aging. Moreover, the MeSH classes used to catalogue the diseases 
(Lipscomb, 2000) that occur recurrently are Nervous System Diseases and 
Cardiovascular Diseases (respectively the 61% and 50% of all the disease gene 
sets). Aging, diabetes mellitus type 2 and hypertension are the top 3 significant 
gene-sets with low proportion of non-homologous genes, displaying also a high 
conservation of co-expression (Supplement 5). 
Among the diverged diseases, hypercholesterolemia, a nutritional and metabolic 
disease, is the only pathology that shows an increased connectivity in mouse. On 
 82 
the opposite side, 13 diseases show a significantly increased connectivity in 
human, with 8 of them being classified among the neoplasm MeSH category. 
However, they do not reach a significant threshold anymore performing the 
analysis on one-to-one orthologs only. 
2.4 Discussion and conclusions 
This study presents a comprehensive analysis of mouse and human transcriptional 
evolutionary changes exploiting co-expression maps and other genomic 
information. It is well known that the variability of gene expression does not only 
depend on conditions and tissues, but is also influenced by numerous other sources 
of biological and technical factors that are hardly controllable (Zakharkin et al., 
2005). The utilization of larger collections of microarrays can help eliminate the 
noise created by single factors and conditions, highlighting the canonical 
interactions that occur in an organism. The choice of using only mice and humans 
was driven by the fact that those are the two mammalian species with the most 
abundant data. Co-expression tools are usually employed to verify interactions in 
a single organism, but they can be used also to verify if interactions are preserved 
among different species. The human-mouse maps comparison conducted here 
aims to make researchers aware of the components that warrant further 
investigation based on their evolutionary changes, including in the context of 
biomedical research and drug testing.  
Even though I verified that the overall structures of both networks are scale-free 
in agreement with previous results (Tsaparas et al., 2006), issues have been 
reported when comparing co-expression networks (Lu et al., 2009). As a result of 
these problems, in a few occasions inconsistent results were drawn from different 
cross-species comparisons on transcriptomic data (Zheng-Bradley et al., 2010; 
Chan et al., 2009; Miller et al., 2010). To partially overcome such problems, my 
methodology utilizes a percentage based thresholds as cut-off for network 
interactions instead of coefficient values based on correlation. Additionally, even 
though the use of the same percentage threshold for the two networks might still 
not provide an absolute value of conservation when comparing lists of homologs, 
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it does not affect the way the gene sets are ranked in terms of conservation, 
assuring that they are comparable relatively to each other.  
I firstly focused the attention on the conservation of connectivity based on the 
number of commonly co-expressed genes (NCCGs) between humans and mice, 
and despite the principle has already been used in other works (Netotea et al., 2014; 
Yue et al., 2014), its construction is innovative. The role of NCCGs in the 
understanding of evolutionary changes was validated by determining their 
association with dN/dS values, which is a well-known parameter of molecular 
evolution rate. Moreover, I also integrated information on difference in network 
connectivity, recurrence of duplications and non-homology, highlighting the set of 
genes that were influenced by multiple criteria simultaneously.  
The findings reported here are frequently consistent with facts previously claimed 
in the literature. I found an overall high grade of conservation among human and 
mouse on molecular and cellular mechanisms associated with tissues, diseases and 
aging that is consistent with previous results (Tacutu et al., 2011; de Magalhães 
and Church, 2007; Liao and Zhang, 2006).  
The immune system, for which I dedicated an entire section, shows an overall 
conservation of gene-connectivity even though it has a high proportion of 
duplicated genes. The latter finding agrees with the first comprehensive study on 
the mouse genomics (Waterston et al., 2002). Accordingly, a study on the mouse 
transcriptomics also shows an overall conservation with signs of divergence (Shay 
et al., 2013) without explaining the pathways involved. In this study, I found that 
the duplicated genes contribute to the divergence in co-expression of the IFN 
alpha/beta and prolactin pathways. Other divergent co-expression that does not 
involve gene duplication regards the genes transcribing for butyrophilins and 
defensins and the genes involved in the ubiquitination and proteasome degradation 
for the MHC class I antigen presentation. 
Among the tissue gene sets, the brain shows the strongest conserved connectivity 
as well as a significantly low proportion of duplicated genes. The pattern of 
expression and interaction of the central nervous system was already reported to 
be highly preserved across species (Chan et al., 2009; Miller et al., 2010). Another 
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tissue also found to be strongly conserved, but not reported in previous studies, is 
bone.  
Reproductive organs have been reported as amongst the most divergent tissues, 
instead (Khaitovich et al., 2005; Voolstra et al., 2007), in agreement with my 
observation that they have the least well conserved co-expression pattern. 
Nevertheless, I failed to observe a significant difference in the rate of duplications 
among testis-related genes although this was reported in a previous work (Church 
et al., 2009). In another work, the eye was included among the tissues with 
relatively higher conservation of gene expression (Chan et al., 2009), but in my 
analysis, it proved to have a low number of commonly co-expressed genes, which 
warrants further analyses. The divergence of the skin tissue in terms of conserved 
connectivity depends partially from the inclusion of a group of genes of the keratin 
and MAGE family having one-to-many or many-to-many homologous 
relationship. I found that both families also showed a significant increase of 
connectivity in human as revealed by the functional enrichment analysis on 
differentially connected genes. MAGE genes are tumour-specific proteins mainly 
associated with melanoma, and it has already been suggested of being positive 
selected among species (Zhao et al., 2012).The keratin family is composed of 
genes that are expressed either in epithelial cells or in keratinized tissues such as 
hair and nails. The keratin genes enriched in my DAVID analysis belong to the 
epithelial group (Moll et al., 2008) and it may be a possible explanation for the 
increased thickness of human dermis and epidermis compared to the mouse skin 
(Schneider, 2012).  
The strong divergence of the olfactory system, encountered in all the conservation 
parameters considered with an increased connectivity in mouse, is in agreement 
with the fact that mice do not usually rely on sight to chase food (Young et al., 
2002; He et al., 2013). Regarding the extracellular matrix, a striking conservation 
was found for almost all the related sub-processes. The regulation of cell division, 
DNA replication and DNA repair are very well conserved functions, while some 
elements involved in the transcriptional regulation are diverged, and in particular, 
transcription factors of the C2H2 family and histone interactions in the promoter 
opening. Based on this observation I postulate that the transcriptional regulation 
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has a major role in determining evolutionary divergence among the two species. 
For example, it is well known that one of the causes of this divergence is the gain 
of complexity of the splicing system in human (Barbosa-Morais et al., 2012). 
However, this requires further investigation and high expectations are pinned on 
the RNA-Seq technology.  
Genes involved in cardiovascular diseases resulted to be overall conserved both in 
terms of co-expressed genes and proportion of homologous genes, but their 
network connectivity was increased in the mouse. This fits the findings showing 
that genes specific for the HDL-mediated lipid transport pathway and the blood 
tissue are highly connected in mouse. The lipoprotein metabolism pathway shows 
the same behaviour even though is no longer significant after multiple test 
correction (Supplement 5). Accordingly, it has already been shown that no inbred 
strains of mouse fed with a chew diet can develop atherosclerosis (Stylianou et al., 
2012; Mukhopadhyay, 2013). This warrant a deeper investigation of molecular 
interactions involved in lipid metabolism in the mouse.  
As suggested in a recent work, there is a lack of mouse models where the 
functionality of main effector genes of the PI3K cascade is altered by the 
manipulation of their regulators (Carnero and Paramio, 2014). This can be 
explained by the presence of essential genes of the PI3K pathway that are 
remarkably poorly conserved in terms of preservation of co-expression, and even 
more strikingly I found that the first top four diverged genes of this pathway are 
the crucial mTOR, PIK3R4, AKT2, FGF23. Therefore, knowing which are the few 
homologs that are commonly co-expressed with these genes, as reported in 
Supplement 5, pinpoint mouse targets for testing processes such as cancer 
progression and glucose metabolism defects caused by the de-regulation of the 
PI3K/Akt signalling.  
In conclusion, I believe that this study gives a comprehensive and detailed list of 
the conserved and diverged elements between mouse and humans. The reliability 
of my results is proved by the fact that numerous findings were in agreement with 
previous studies. Before commencing any experimentation on the mouse model, 
the results presented here should be consulted to avoid or validate possible mouse-
human inconsistencies. 
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2.5 Supporting data 
The full co-expression maps are available from the Zenodo Repository, 
https://doi.org/10.5281/zenodo.32579. 
Supplementary files 
Supplement 1 Custom computer scripts used to perform the analyses. 
Supplement 2 Gene co-expression and connectivity. List of humans and mice 
homologous genes annotated with HGNC symbols together with further 
information retrieved from Biomart Ensembl and from the analysis of co-
expression maps (Entrez IDs, Homology Type, dN/ dS, number of homologs from 
the top 5% co-expressed genes in humans and mice, number of commonly co-
expressed genes, connectivity values in humans and mice, differential 
connectivity) 
Supplement 3 Functional enrichment analysis of genes with high and low number 
of commonly co-expressed genes. Sheet 1: Functional annotation clustering 
conducted with DAVID of the top 5 % of homologs ranked by the number of 
commonly co-expressed genes. Sheet 2: Functional annotation clustering 
conducted with DAVID of the bottom 5 % of homologs ranked by the number of 
commonly co-expressed genes. Sheets 3 and 4: Same analysis as sheet 1 and 2 but 
using one-to-one homologous genes only. Sheets 5–8: Functional enrichment 
analysis using the GSEA method on the same gene lists as described for sheets 1–
4.  
Supplement 4 Functional analysis of genes differentially connected between mice 
and humans. Sheet 1: Functional annotation clustering conducted with DAVID of 
the top 5 % of homologs ranked by differential connectivity. Sheet 2: Functional 
annotation clustering conducted with DAVID of the bottom 5 % of homologs 
ranked by differential connectivity. Sheets 3 and 4: Same analysis as sheet 1 and 
2 but using one-to-one homologous genes only. Sheets 5–8: Functional enrichment 
analysis using the GSEA method on the same gene lists as described for sheet 1–
4.  
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Supplement 5 Evolutionary changes of gene sets described by the four parameters 
of conservation explained in the manuscript. Sheet 1: results using tissue gene sets. 
Sheet 2: results using pathway gene sets. Sheet 3: results using disease gene sets.  
Supplement 6 Novel candidate conserved homologs associated with genes sets. 
Sheet 1: results using tissue gene sets. Sheet 2: results using pathway gene sets. 
Sheet 3: results using disease gene sets. Sheets 4, 5 and 6: Same analysis as sheet 
1, 2 and 3 but using one-to-one homologous genes only. 
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Chapter 3 flowAI: an R package to 
automatically and interactively perform 
quality control on flow cytometry data  
The work presented in this chapter is included in a publication in which I am the 
first author. 
Monaco G, Chen H, Poidinger M, Chen J, de Magalhães JP, Larbi A. flowAI: 
automatic and interactive anomaly discerning tools for flow cytometry data. 
Bioinformatics. 2016 Aug 15;32(16):2473-80. doi: 
10.1093/bioinformatics/btw191. 
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3.1 Introduction  
Flow cytometry (FCM) is a laser-based methodology designed to capture the 
physical and biochemical characteristics of a cell or a particle in a stream of fluid. 
Fluorescence-conjugated antibodies are used to target antigens expressed inside or 
at the surface of the cells of interest. As cells pass through the laser (excitation), 
the fluorophore will change its state of energy and emit a light (emission) that is 
captured by a series of detectors. Flow cytometry applications have been 
developed mainly for both research and clinical settings in medicine but also for 
other non-biomedical domains such as marine and plant biology. The most 
common application is the immunephenotyping of blood samples and thus the 
quantification of the number and frequency of various immune cell populations. 
In haematology, FCM is the technology of choice, as, for example, it requires only 
few drops of blood to diagnose leukaemia through the detection of the perturbation 
of normal cell frequencies (Brown and Wittwer, 2000). Moreover, FCM helped 
increase our understanding of cellular functions of the immune system and is 
widely used in cell cycle analysis, pre-transplant cross-matching, cell sorting, 
apoptosis, vaccine development and other applications that scrutinize cellular 
properties (Mulley and Kanellis, 2011; Pozarowski and Darzynkiewicz, 2004; 
Vermes et al., 2000; Jaye et al., 2012).  
The data are stored in Flow Cytometry Standard (FCS) files, that include the 
fluorescence and scattered light levels for each cell that passed through the laser 
beams. Nowadays it is possible to analyse up to 30 markers at a time in a single 
staining panel by using an equal number of different fluorophores detected in 
separate channels. The common approach used to analyse the data produced by 
FCM is to visually select cells of interest through 1 or 2 markers known to be 
highly specific. However, to delineate the high heterogeneity of immune cell 
populations, it is necessary to look simultaneously at the whole staining panel. 
Principal component analysis has been used to study the complexity of CD8 T cell 
populations as they are characterized by intermediate phenotypes with a 
continuum of expression of different combinations of cytokines and surface 
markers (Newell et al., 2012). Another dimensionality reduction technique called 
t-Distributed Stochastic Neighbor Embedding (t-SNE) (Maaten and Hinton, 2008; 
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Shekhar et al., 2014; Becher et al., 2014) was successfully applied to identify 
ambiguous cell populations, including monocyte-macrophage intermediates and 
granulocyte variants in a mass cytometry experiment based on a 38-antibody panel 
(Becher et al., 2014).  
Several computational tools that aim to automatically characterize cell populations 
without losing multi-dimensional information are constantly developed and 
periodically benchmarked by the FlowCAP consortium (Aghaeepour et al., 2013). 
Undoubtedly, the widest range of tools has been distributed by the Bioconductor 
platform based on the R programming language. The root package for flow 
cytometry data is flowCore, since it defines the container class and it enables to 
perform essential manipulations such as compensation and transformation (Hahne 
et al., 2009). In addition, a series of complementary packages has been developed 
for further operations, such as visualization, quality assessment, statistical analysis 
and automated gating (Sarkar et al., 2008; Hahne et al.; Finak et al., 2012).  
To accompany and support the large development of automatic methods to define 
populations, it is important to use high quality flow cytometry data as input. This 
becomes essential for experiments looking deeper into the complexity of cell 
distribution. For instance, target cell sub-populations may represent as low as 
0.05% of the total cell population suggesting that minute variation in the quality 
of the data may lead to false positive results or loss of signal. Standardization, 
calibration and quality control guidelines using beads have been defined to ensure 
that the signal acquired is the most accurate and with the least variation (Oldaker, 
2007; Perfetto et al., 2006). Nonetheless, these procedures are not always carefully 
monitored and even having the FCM instrument at optimal conditions before 
sample processing does not exclude electronic drifts or fluidic instability issues at 
the time of data recording. An R package, flowQ (Gentleman et al., 2006; 
Bashashati and Brinkman, 2009), creates concise reports of quality checks on 
single and multi-panel experiments to highlight issues that can be encountered in 
data acquisition. The reports indicate the number of cells, percentage of boundary 
events and anomalies on the fluidics and signal acquisition over time. Another 
package, flowClean (Fletez-Brant et al., 2016), determines and marks low quality 
cells using compositional data analysis. In brief, it splits the time in equally sized  
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 bins and flags the events that are within time frames containing unusual ratios of 
cell populations. However, flowQ does not actively detect and remove the 
anomalies and flowClean is poorly intuitive and thus it does not allow to infer the 
source of the anomalies.  
Here, I present a package called flowAI that provides two solutions, one automatic 
and one interactive, to discard cells from flow cytometry data that do not reach 
appropriate quality standards. The workflow adapts and expands previous ideas 
with methods never implemented before to provide a more objective, efficient and 
intuitive solution for the quality control of flow cytometry data.  
3.2 Implementation and methods 
3.2.1 The software 
Both the automatic and interactive methods have been implemented in the R 
package flowAI and distributed by the Bioconductor platform 
(http://bioconductor.org/packages/flowAI/). More recently the automatic 
algorithm has also been implement in ImmPortGalaxy (Thomas et al., 2016) and 
flowJo (Tree Star, Ashland, Oregon). My tools incorporate functionalities from 
several other R packages. For example, the automatic method integrates functions 
from the mFilter (Balcilar, 2007) and changepoint (Killick and Eckley, 2014) 
packages in the algorithms aiming to automatically detect the anomalies. The 
interactive method, instead, leverages on the R shiny framework (Chang et al., 
2015) to build the web graphical interface.  
3.2.2 Workflow 
The entire quality control analysis of flowAI consists of three main steps to detect 
and remove anomalies from FCM data complementary for both the automatic and 
the manual methods (Figure 3.1).  
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3.2.3 Flow Rate check 
The first step evaluates the steadiness of the flow rate of the analysis. The flow 
rate is reconstructed by reporting the number of cells acquired per unit of time. 
This is only possible for FCS files of version equal or greater than 3.0 which 
implement the keyword $TIMESTEP to allow for kinetic analysis (Seamer et al., 
1997). The keyword stores a value corresponding to the resolution of the “Time” 
channel in terms of seconds or fractions of a second. Ideally, the detection of 
 
Figure 3.1 Workflow of the quality control of flow cytometry data using the flowAI package. Data 
can be processed manually with a Shiny application or automatically with the call of an R function. 
The steps are complementary for both cases. On the one hand, the manual method allows the user 
to interactively choose appropriate thresholds on plots portraying flow rate and signal acquisition 
through visual inspection. On the other hand, the automatic method performs this selection through 
anomaly detection algorithms. Both the interactive and automatic methods eliminate negative 
outliers and events recorded at the upper limit of the dynamic range. 
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anomalies in the flow rate check could be performed at the maximum time 
resolution allowed by the flow cytometry instrument. However, the setting of a 
larger time step for the analysis greatly decreases the running time and memory 
usage. 
A stable flow rate of FCM instruments can be pictured by a line with non-periodic 
fluctuations but with a constant variation. The anomalies in the flow rate that 
mostly affect the quality of signal acquisition are abrupt surges and significant 
changes in the speed of the fluid generally caused by factors such as debris and air 
intrusion in the fluidic system. To discard anomalies through the interactive 
method, users can adjust two horizontal sliding bars to eliminate flow rate surges 
and two vertical sliding bars to discard regions at the beginning and the end of the 
flow rate where the instabilities mostly occur. Instead, for the automatic version I 
designed an anomaly detection algorithm built upon the generalized extreme 
studentized deviate (ESD) test (Rosner, 1983) and optimized to work on time 
series data.  
As stated in a review of outlier detection methods, the anomalies are contextual to 
the nature of the data (Chandola et al., 2009) and hence it is preferable to develop 
techniques customized for the domain of interest. The patterns depicted by the flow 
rate of FCM data are generally similar to the ones treated by economists, engineers 
and social scientists in time series analyses, whose basic idea is to extract 
additional information from time series data by splitting it in its components.  
As a first step for my automatic method, I implemented the Christiano-Fitzgerald 
band pass filter (Christiano and Fitzgerald, 2003; Balcilar, 2007) to split the value 
(yt), corresponding to the number of events recorded at the time point t, into the 
trend (τt) and cyclical (ct) components:  
 &- = W- +	X- (3.1) 
The trend component will be a smooth line that indicates long-term increase or 
decrease in the flow rate, while the cyclical component will contain the non-
periodic fluctuations and abrupt surges from the trend line.  
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Secondly, the flow rate values are penalized by adding or subtracting the 
corresponding absolute values of the cyclical component according to their 
direction from their median: 
 &. YZ3- = 	 &- + |X-|, &- ≥ ]Z^N_3(&)&- − |X-|, &- < ]Z^N_3(&) (3.2) 
Lastly, the generalized ESD test is applied on the penalized flow rate to detect the 
anomalies. This method, with an iterative process, searches for a number of 
outliers not exceeding a predefined threshold k for a dataset of sample size n, 
performing a k number of r tests a':c = 	a', a2, … , ac . At each iteration, an 
observation &. YZ3- is tested as a potential outlier and it is removed from the data 
before the next iteration. An exemplary iteration has the following steps: 
1. Extraction of the observation that largely deviates from the central 
tendency indicator (mean or median) scaled by the measure of dispersion 
(standard deviation or median absolute deviation): 
 aI = 	max	{ &. YZ3- − ]Z^N_3 & : /	h	3}	GJD(&)  (3.3) 
2. Computation of the critical value lambda λi from the t distribution using a 
defined level of significance α. The observation &. YZ3- is flagged as an 
outlier if the computed r statistic value is higher than lambda: ri > λi. 
3. The observation ri is removed from the data, and the sample size is then 
reduced to n – 1.  
The procedure uses the median and the median absolute deviation (MAD) because, 
particularly in presence of outliers, they are a more robust alternative to the mean 
and standard deviation (Leys et al., 2013). 
3.2.4 Signal acquisition check  
The second step verifies the stability of the signal acquired over time. A common 
practice to verify the quality of signal acquisition is to use Levy-Jennings-type 
graphs, where fluorescence is plotted against time (Barnett and Reilly, 2007). A 
stable signal acquisition should produce intensity values whose distribution is 
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consistent throughout the course of the entire experiment. This is the expected 
behaviour if we assume that cells from a heterogeneous sample are randomly 
aspirated by the FCM tube over time. Therefore, changes in the signal intensities 
are not due to biological variation but rather to technical issues such as defective 
laser-detection system, voltage instability or poor quality of sample preparation, 
for example, inadequate vortexing.  
For each channel, flowAI creates Levy-Jennings-type graphs by splitting the 
intensity values of a marker in equally sized bins and plotting their median against 
time. This method is already implemented by the flowQ package, where the user 
can infer the quality of an FCS file from the visualization of time line plots. 
However, in addition to that, flowAI allows the removal of the regions with an 
unstable signal. As for the flow rate, this operation can be performed manually 
through visual inspection or automatically. The latter method implements a step 
detection algorithm to identify shifts in the mean and variance of the intensity 
values. The algorithm used, binary segmentation, is implemented in the 
changepoint package (Killick and Eckley, 2014). Its basic concept has been firstly 
described by the genetists Edwards and Cavalli-Sforza as a new clustering method 
based on the analysis of variance (Edwards and Cavalli-Sforza, 1965). This 
method is computationally fast and most frequently used among the changepoint 
detection methods. 
This approach iteratively splits the data in two groups at a time simply applying 
the method of least squares. In my case, given an ordered set of n fluorescence 
values m1:n = (m1, m2, …, mi, …, mn) corresponding to the medians of all bins, the 
total sum of squares (SST) from their mean is calculated as a measure of 
dispersion:  
 ??j = (]' −])2*IM'  (3.4) 
A changepoint mi that splits the data in two segments, s1 = (m1, …, mi) and s2 = 
(mi+1, …, mn), is detected when the cost function, represented by the within-groups 
sum of squares (SSW), is minimized: 
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 arg	minI 	 (]o' −	]o')2 	+ (]o2 −	]o2)2*o2MIp'Iq'M'  (3.5) 
The minimization of the cost function (3.5) is equivalent to the maximization of 
the between-group sum of squares (SSB), and the sum between SSW and SSB 
results in the SST.  
In flowAI I used a variant of this method provided by the changepoint package 
that not only searches for shifts in the mean but also in the variance. The same 
procedure is then repeated on each new segment created. The search of new 
changepoints terminates either if the minimized cost function is higher than a 
defined threshold or if a pre-established maximum number of changepoints has 
been detected.  
The binary segmentation algorithm is performed independently on each 
fluorescence channel and lastly the longest region that does not contain 
changepoints in any of the channels is chosen as the high quality one. 
3.2.5 Dynamic range check 
A third quality step is performed on the lower and upper limit of the dynamic 
range. Signals recorded by flow cytometry instruments can only fall within a 
determined dynamic range. The last generation of flow cytometry has reached a 
dynamic range of 224 channels (Novo and Wood, 2008), but most of the 
instruments nowadays used in laboratories and clinics have a range of 218. Due to 
this limitation, all measurements with a real value higher than the upper limit will 
be recorded at the last channel of the dynamic range causing an accumulation of 
signals that is not directly comparable with the rest of the data. These values are 
commonly called margin events. My package allows the removal of events where 
at least one of the parameters has an intensity value at the upper limit of the 
dynamic range. 
The values of the lower limit are treated in a different way. For the signal of the 
light scatter channels (reflecting the morphology of the cells) any value less than 
zero is removed. Instead, for the immunofluorescence channel, small fluctuations 
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in the range of negative values are usually acceptable since they are the by-product 
of standard operations such as correction of background noise, auto fluorescence 
and spectral overlap. Nonetheless, technical issues, such as flow rate surges or 
voltage instability, can exacerbate the magnitude of a negative value to an 
unacceptable range, that would also interfere with the downstream signal 
processing, such as logicle transformation or automatic gating.  
The flowAI package uses an outlier detection method to remove the outliers among 
the negative values. Every value that is inferior to a certain threshold is labelled as 
outlier and consequently removed. For each channel, a threshold referred to as Z-
score is computed with a method recommended by Iglewicz and Hoaglin (1993). 
The formula is given in (3.6), where the threshold is obtained for a set of n negative 
values x1:n = (x1, …, xn):  
 r = 	−	3.5	GJD(A':*)0.6745 + ]Z^N_3(A':*) (3.6) 
Alternatively to the removal of negative outliers, the lower limit of the dynamic 
range can be truncated at the cut-off suggested by the FCS file. This method was 
previously adopted as pre-processing step for the cleaning of flow cytometry data 
from erroneous measurement (Qian et al., 2012; Van Gassen et al., 2016). 
3.2.6 Results evaluation 
At the completion of the analysis with the automatic method, a report is generated 
indicating the percentage of cells that did not pass the quality checks and a series 
of graphs showing where the anomalies in terms of time and parameters were 
detected. My suggestion is to firstly run the automatic method with default settings 
on a small sample of flow cytometry data, secondly customize the settings if 
necessary, thirdly perform the quality control automatically on the entire dataset, 
and lastly intervene manually only for those files whose automatic control is not 
able to meet the accuracy required.  
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3.3 Results and discussion 
Here, I provide analysis results obtained using the automatic method in flowAI on 
several FCM data. I studied the nature of the abnormalities detected in each quality 
control step and then I evaluated the overall improvement of computational 
analysis with the cleaned data.  
3.3.1 Overview of the datasets 
A total of 4,469 flow cytometry files from 11 different datasets, precisely 2 in-
house and 9 from the online database FlowRepository (Spidlen et al., 2012), were 
used for my evaluation. The two in-house datasets contain 84 samples each, and 
are part of a larger project called the Singapore Longitudinal Aging Study (SLAS). 
Ethical approval was obtained from the National University of Singapore 
Institutional Review Board for SLAS blood collection and experiments. A 
different panel was used for the two datasets. Panel 1 consisted of 16 antibodies 
targeting markers for the overall white blood cell populations: CD16, CD4, CD38, 
CD62L, CD19, CD66b, CD45, CD27, CD56, CD3, CD8, CD14, CD123, HLA-
DR. Panel 2 consisted of 14 antibodies targeting the B lymphocyte populations: 
CD19, CD20, CD21, CD23, CD24, CD27, CD38, IgG, IgM, IgD, HLA-DR. 
Regarding the 9 datasets retrieved online, I selected the ones used for the flowCAP 
contests. Data and details are available on flowrepository.org under the IDs with 
the prefix FR-FCM- and followed by: ZZYA, ZZZU, ZZY2, ZZY3, ZZYY, ZZY6, 
ZZYZ, ZZZV, ZZ99.  
3.3.2 Examination of anomalies in FCM data from different 
perspectives 
In this section, the anomalies detected in each quality control step is analysed 
separately. The main consideration is that even though my workflow schematizes 
the quality control in three different steps, they are usually strictly related. For 
example, a surge in the flow rate often corresponds to an unstable signal 
acquisition that in turn would potentially result in a value in the upper margin or 
in the negative outlier space of the dynamic range. Nonetheless, given the high 
variability of anomalies that can occur in a flow cytometry experiment, the division 
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of the quality control in the three steps defined in my work is necessary to assure 
the detection of those anomalies that are not visible from a single perspective.  
Here, I focus on the file 220662.fcs from the ZZZV dataset to show how a 
complete quality control with flowAI works on an FCS file. In addition, numerous 
other examples are reported in the appendix. 
Surges and trend shifts in the flow rate 
The flow rate was recreated dividing the time channel of an FCS file in equal 
intervals with a time step of 1/10 of a second. Fluidics’ stability in the sample is a 
good indicator for the absence of anomalies such as clogging and air bubbles in 
the flow cell and other disturbances in the flow stream. My algorithm has been 
designed to acknowledge cyclical patterns to detect local anomalies, i.e. surges, as 
well as to remove global anomalies, i.e. large deviations of the trend from the 
median flow rate (Figure 3.2). From all the FCS files analysed, I verified that the 
beginning and the end of the flow rate are the regions where irregularities occur 
the most. Flow cytometry experts recognize these patterns as being frequent and 
mainly due to air bubbles, debris or clogged cells (Figure A.5). In Figure 3.2a the 
flow rate takes about 10 seconds to stabilize but usually strong fluctuations vanish 
more quickly (Figure A.5a and Figure A.6a). Nevertheless, there are cases of 
flow rate surges interspersed over the entire course of the experiment (Figure A.7a 
and Figure A.8a) possibly caused by clusters of debris suddenly aspirated by the 
flow cytometry tube (Figure A.8a-c). However, even though it was not always 
possible to associate flow rate surges with debris or clogged cells, surges removal 
is still necessary because of their association with signal intensity variation.  
Lastly, in an FCS file I observed a steady change of the flow rate, and hence the 
signal, in the last part of the analysis. The resulting low quality cells have a 
distribution uniformly shifted compared to the one of the high-quality cells. This 
is probably due to the manipulation of the speed settings by the instrument operator 
during the running of the experiment (Figure A.9). 
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Figure 3.2 Quality control results of the file 220662.fcs from the ZZZV dataset. The plots (a) 
and (b) were extracted from the report generated by the automatic method of the flowAI package 
using default settings. (a) Strong fluctuations are detected in the flow rate at the beginning of 
the experiment. The anomalies detected are indicated with green circles. (b) Changepoint 
detection in signal intensity over time represented as median of equally sized bins. The region 
discarded is complementary to the one detected as instable in the flow rate check. The yellow 
region is selected as being steady and therefore categorized as high quality. (c) ECDF curves of 
raw intensity values of the low (in red) and high (shades of blue) quality events of the PE Tx 
RD-A channel. The sample size of the three high quality samplings equals the number of low 
quality events detected. (d) Density plots of the logicle transformed data of the PE Tx RD-A 
channel using the logicle parameters estimated from raw data (green line), from data with 
negative values truncated at -111 (blue line), and from data without negative outliers (red line). 
The density curves vary among the three sets of data indicating the repercussions on the 
estimation of the logicle parameters according to the dynamic range used for the data. 
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Mean and variance deviation from stable acquisition regions 
For each channel, the signal acquisition over time is reconstructed firstly dividing 
the total number of cells in equally sized bins and secondly calculating the median 
value of each bin. The output is graphically shown with line plots (Figure 3.2b). 
Mean and variance shifts in the signal acquisition are detected using the binary 
segmentation method from the changepoint package (see Implementation and 
methods).  
In most of the analysed cases, signal instability is strongly related to flow rate 
fluctuations (Figure 3.2, Figure A.5, Figure A.6, Figure A.8, Figure A.9). 
However, anomalies caused by laser-detection systems can eventually occur 
independently of the speed variations of the flow rate. In Figure A.7, for example, 
the numerous flow rate surges are hardly detectable in the signal plots and the 
channels storing the signal elicited by the green laser (G780-A, G710-A, G660-A 
and G610-A) show a delay in the reaching of stability that warrants a careful 
monitoring of the functionality of that specific laser-detection system.  
In Figure A.8, even though the flow rate surges are associated clearly with the 
signal plots, the signal acquisition gradually weakens at different rates in different 
channels after a first region of steadiness (FSC-A, FSC-H and APC-A), while in 
other channels it remains constant for a longer period. In this rare case, other 
technical issues should be investigated. Some of the factors that might cause less 
common anomalies, but should be kept in mind, are laser power instability, 
detection system irregularities, poor quality of the sheath fluid and accumulation 
of dirt in the flow cell.  
Refining the dynamic range: removal of negative outliers and margin 
events 
Because of the quantum nature of light, both the scatter and fluorescence channel 
values cannot theoretically fall in the negative range of values. However, because 
of the background and noise correction of the optical detection system of flow 
cytometry instruments, negative values are recorded for both light scatter and 
immunofluorescence channels. This problem is also exacerbated by instable signal 
acquisition, for instance during flow rate surges (Figure A.6a-c and Figure A.7a-
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c), or by compensation, where a value proportionate to the spectra overlap of other 
channels is subtracted from each channel. Negative estimates are considered part 
of a negative population of cells with a low mean and a large coefficient of 
variation. Therefore, with the logarithmic transformation not being able to handle 
negative values, new transformation methods have been developed. Probably the 
most popular one is the logicle transformation, also called “bi-exponential” (Parks 
et al., 2006). With this method, values with an absolute small magnitude are scaled 
linearly, while large values are scaled in a log-like fashion. The transition from the 
linear to the logarithmic scaling is defined by the ω parameter of the formula. It 
determines the width of the linearized data and its value is estimated from the fifth 
percentile of the values below zero. I noticed that this estimation method lacks 
accuracy when the outliers in the negative range are more than 5% of negative 
values and precision when the negative values acquired are low and with sparse 
values. To overcome the arbitrary estimation of the ω parameter, a cut-off at the 
value -111 has been suggested (Qian et al., 2012). Nevertheless, this procedure 
does not have any theoretical explanation either and, as the authors of the logicle 
transformation method also implied, the truncation of the values would deform the 
distribution of the negative population and result in an improper estimation of its 
statistics (Parks et al., 2006). The idea I adopted, instead, is to use an outlier 
detection method to remove only the negative values that stray from the ones that 
compactly aggregate around zero. Generally speaking, with this approach, I expect 
a better estimation of the parameters for negative cell populations, since the data 
are neither affected by outliers nor by a truncation to an arbitrary threshold. 
Overall, although this procedure might not give any substantial advantage for 
downstream manual analysis, it should improve the quality of the results for any 
kind of automatic analysis, from simple statistics calculations to gating. In Figure 
3.2d, I depicted the differences among the distributions of the logicle transformed 
data for a channel of the 220662.fcs file where the ω parameter was estimated: 1) 
on the raw data, 2) after truncating the data at -111 and 3) after removing the 
negative outliers.  
A last issue to consider when analysing FCM data is the signal which value 
exceeds the limitations of the machine, thus generating the so-called margin 
events. In fact, the signal can only be recorded up to the upper value of a dynamic 
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range pre-set by the manufacturer of a FCM instrument. Therefore, it is impractical 
to discern subpopulations of cells whose values are all stored at the upper value of 
the dynamic range. This is already a common practice especially among 
computational biologists that require clean data to improve the quality of the 
analysis which is why I implemented it in my pipeline. 
3.3.3 Overall improvement using computational methods 
In the previous sections, I described each step of my pipeline separately in order 
to examine the anomalies from different perspectives. Instead, in this section I look 
at the final results using approaches that analyse the multi-dimensional data in its 
entire complexity.  
Disappearance of undefined populations in high quality data 
I used SPADE to identify and visualize populations from high dimensional flow 
cytometry data (Qiu et al., 2011). In brief, SPADE firstly prunes high density 
regions, secondly identifies clusters and thirdly links them together with a 
minimum spanning tree. 
The SPADE results before and after quality control of the file 220662.fcs are 
reported in Figure 3.3a. The FCS file was part of an experiment designed to 
identify the functionality of CD4 and CD8 T cells in response to an HIV 
vaccination through intracellular cytokines staining. Looking at the SPADE results 
through the markers CD3, CD4 and CD8 it is possible to identify CD4 T cells at 
the bottom-right branch and CD8 T cells at the top-right branch (Figure 3.3a).  
The analysis was made with default settings and from the 200 populations 
identified by SPADE in the original file 43 disappeared in the high-quality data 
(Figure 3.3). From the examination of the data reporting the coefficient of 
variation, a high variability was found for the markers CD3 and CD8 in the 
discarded populations. One may also suspect that those are new undefined 
populations that solicit further investigation. However, plotting the CD3 channel 
against FSC-A with the flowJo software, it was possible to identify the faulty 
populations only in the files with high instability in the flow rate (Figure 3.3b). 
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Erratic populations revealed using dimensionality reduction  
Another approach consisted in applying a dimensionality reduction method, t-SNE 
(Maaten and Hinton, 2008), to capture non-linear relationships in the high 
dimensional space with the intensity values of high and low quality events. For the 
analysis, I used the R package cytofkit (Chen et al., 2016) that includes an 
algorithm based on support vector machine to identify the clusters from the new 
components defined by t-SNE (Figure 3.4a-b). 
 
Figure 3.3 Quality control and SPADE analysis on the file 220662.fcs file from the ZZZV dataset. (a) 
SPADE analysis before and after quality control with flowAI. The raw intensity median values and 
the coefficient of variation of the CD3, CD4 and CD8 channels are used as color-code for the 
populations identified by SPADE. The nodes removed by the quality control (in grey) correspond to 
the ones with high coefficient of variation. (b) Comparison of quality control using manual gating, 
flowAI and flowClean. The CD3 channel is plotted against the FSC-A channel and the negative 
population disappears after quality control using manual gating and the automatic method of flowAI. 
With flowClean the negative population becomes less dense but it is not completely removed. The 
negative population is not present in other files of the ZZZV dataset without anomalies. 
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Figure 3.4 t-SNE analysis on low and high quality data extracted from two FCS files of the SLAS 
dataset (Panel 2), one file for (a-c) and one for (d). The FCS file used for (a-c) is the same used for 
Figure A.5 (a) Density based clustering obtained with the cytofkit R package on the two 
dimensions produced by the t-SNE dimensionality reduction method. The clustering method, built 
upon a support vector machine algorithm, detected nine clusters. (b) Low and high quality events 
are indicated in red and blue, respectively. Low quality events partially form irregularly shaped 
sub-populations and partially superimpose with high quality events. The superimposed low quality 
events show anomalies in only one or few channels, therefore, the multi-dimensional based 
approach still maps them together with the high-quality events. The events in the clusters M1 and 
M2 can be visually classified as part of the same clusters in the t-SNE 2D plot, but do not cluster 
together in the analysis with cytofkit. (c-d) tSNE analysis obtained after the removal of debris, 
margin events in the scatter parameters, doublets and dead cells. In (c) a faulty population of cells 
recorded as margin events in the CD19 channel was detected as low quality. (d) In this case, the 
low-quality events form complementary clusters that do not overlap with the high-quality events 
because of a consistent shift in the intensity signal. 
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Using 2D plots of the first two components, I noticed that in most of the files a 
fraction of low quality cells was still superimposing to the populations of high 
quality cells while a remaining fraction formed separate sub-populations of events. 
In an FCS file from the SLAS dataset (Panel 1), I ascertained that the new 
populations in the low-quality data mainly derived from dead cells and margin 
events; the borders are jagged and the shape is irregular reflecting the erratic nature 
of the acquired signal (Figure 3.4b). In contrast, the populations of high quality 
cells have smooth borders and a regular round shape. 
T-SNE was then computed on B cell populations pre-processed with flowJo, where 
debris, doublets and dead cells were removed (Figure 3.4c-d). In Figure 3.4c an 
irregular CD19 population was revealed that was not found in the analysis of the 
raw data (Figure 3.4b). Further analysis revealed that the expression values of the 
CD19 channel were recorded at the upper margin of the dynamic range. This 
demonstrates that anomalies in only one channel can be easily camouflaged as 
valid cell populations in a multi-dimensional analysis if a careful quality control 
has not been applied beforehand. Lastly, in Figure 3.4d, a significant shift in the 
average acquisition signal was visible in the t-SNE analysis by the formation of 
adjacent complementary population.  
In summary, I advocate the importance of making a comprehensive cleaning on 
the data from different perspectives. Once faulty signals are included in 
downstream analysis, it becomes hard to detect them and they would eventually 
lead to false discoveries. 
3.3.4 Benchmarking and performance 
The automatic method in flowAI was compared with a manual quality control 
using flowJo and the R package flowClean. The flowQ package was excluded from 
the comparison because it does not actively detect anomalies.  
Agreement assessment using flowJo, flowAI and flowClean 
The time channel is a fundamental element of an FCS file to perform quality 
control after acquisition. The datasets ZZYA, ZZY2, ZZY3, ZZYY, ZZY6 and 
ZZYZ seemed to be already pre-processed and did not have a proper time channel. 
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Although flowAI is still able to check the signal and dynamic range of a FCS file 
without the time channel, it is impossible for flowClean and impractical for flowJo 
to do the quality control. Therefore, only the remaining datasets with a proper time 
channel were used for the benchmarking.  
The flowJo analysis was executed by removing the margin events from the FSC-
A and SSC-A scatterplot and unstable acquisition regions from the channel with 
more visible anomalies plotted against time. Regarding flowClean, and the 
automatic method in flowAI, they were both run with default settings. The kappa 
statistic was used as a metric for the agreement of two quality control methods on 
each FCS file. For each dataset, the median of the significant kappa coefficients 
has been reported in Table 3.1. For the Cohen’s kappa test, a minimum value of 
anomalies was required to reach the significance level.  
Overall, flowAI showed a stronger agreement with the manual quality control and 
it was the most stringent with respect to the detection of anomalies, while 
flowClean was the most tolerant (Table 3.1 and Figure 3.3a), Nonetheless, both 
flowAI and flowClean still require a fine tuning of the settings for certain datasets 
to perform optimally. For example, better agreements would have been reached 
for the SLAS panel I dataset if less stringent settings were used for flowAI. In this 
respect, a decisive advantage of flowAI is its intuitiveness. In fact, based on the 
flow rate and signal plots, it is relatively easy to establish if the settings have to be 
more or less stringent. On the contrary, I found the diagnostic plot produced by 
flowClean harder to interpret. 
Table 3.1 Pairwise agreement scores among the quality control made manually with flowJo, and 
automatically with flowAI and flowClean. 
Dataset (n)* Median kappa coefficients (n)**  
 flowJo - flowAI flowJo - flowClean flowAI - flowClean 
ZZZV (240) 0.9 (177) 0.25 (88) 0.26 (86) 
ZZZU (308) 0.33 (255) 0.33 (3) 0.26 (64) 
ZZ99 (766)  0.81 (390) 0.7 (327) 0.82 (328) 
SLAS panel I (84) 0.07 (73) 0.23 (4) 0.018 (3) 
SLAS panel II (84) 0.57 (82) 0.1 (43) 0.07 (39) 
* total number of files per dataset 
** total number of Cohen’s kappa tests with p-value < 0.05 selected for the calculation of the median kappa coefficient  
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Running time 
The running time of the automatic method in flowAI was measured on a laptop 
with a 2.7 GHz CPU and 16 GB of RAM. I used four batches of datasets to evaluate 
the time performance. Each batch consists of five datasets of increasing size (100, 
500, 1,000, 1,500 and 2,000 MB) formed using an increasing number of FCS files 
with same size, number of events and parameters (Figure 3.5a).  
The speed of flowAI is mostly influenced by the size of the FCS file rather than 
the number of parameters or events and the creation of the graphics for the full 
report takes the largest fraction of time. The possibility of creating a mini report 
containing only the percentages of anomalies is provided but it is discouraged for 
now, unless the user is sure of the nature of all the anomalies in the entire dataset. 
On the contrary, the running time for flowClean increases considerably with the 
number of parameters because of its way of defining cell populations through 
combinations of positive signals from the different parameters (Figure 3.5b). 
Overall, flowAI performance was faster for all the datasets used and, in particular, 
at least 3 times faster when using FCS files with 22 parameters (Figure 3.5). 
 
Figure 3.5 Running time of a quality control analysis with the automatic method of (a) flowAI 
and (b) flowClean. (a) The graphics’ creation for the full report, which is fundamental for an 
accurate examination, takes a considerable amount of time. Alternatively, a mini-report 
containing only the percentages of anomalies is produced without significant running time 
increase. (b) In comparison with flowAI, the analysis with flowClean takes longer, especially 
with an increasing number of parameters.  
Report
full
mini
0
10
20
30
40
10 50 10
0
15
0
20
0 3 15 30 45 60
Number of files
(respectively corresponding to a total size of 100, 500, 
1000, 1500 and 2000 MB in each group of bar charts) 
R
un
ni
ng
 ti
m
e 
(m
in
)
10 MB
11 parameters
~250,000 events
10 MB
22 parameters
~125,000 events
33.3 MB
11 parameters
~800,000 events
33.3 MB
22 parameters
~400,000 events
FCS files characteristics
10 50 10
0
15
0
20
0 3 15 30 45 60
0
50
100
150
10 MB
11 parameters
~250,000 events
10 MB
22 parameters
~125,000 events
33.3 MB
11 parameters
~800,000 events
33.3 MB
22 parameters
~400,000 events
FCS files characteristics
10 50 10
0
15
0
20
0 3 15 30 45 603 15 30 45 6010 50 10
0
15
0
20
0
R
un
ni
ng
 ti
m
e 
(m
in
)
a Performance flowAI b Performance flowClean
 109 
3.4 Conclusions 
Over the last few years we have seen increasing efforts in automating pipelines for 
biomedical data analysis through computational algorithms. However, flow 
cytometry is still largely dependent on manual analysis since usually the data 
produced has high variability that requires human interpretation. Often, the 
analysis demands high expertise and the results are still conditioned by a subjective 
evaluation. My idea was born from the intention of removing the technical 
variability of flow cytometry data in an objective way, thus reducing subjectivism 
in interpretations and improving the performance of downstream computational 
analyses. This is especially the case when a high number of files is analysed and 
when anomalies are generated by multiple sources. 
I defined an approach and created an R package, flowAI, to automatically or 
interactively detect anomalies in flow cytometry data. The interactive method is 
built using the R shiny framework while the automatic method implements 
different algorithms within an R function, that include outlier and changepoint 
detection. Both the automatic and interactive methods perform three 
complimentary steps of quality control on three aspects: 1) flow rate, 2) signal 
acquisition and 3) dynamic range. The first step consists in the removal the 
anomalous patterns and peaks from the flow rate. The second step consists in 
checking the stability of the signal over time for each channel and removal of shifts 
in mean and variance. Lastly, the third step consists in the removal of the margin 
events and negative outliers from the upper and lower sides of dynamic range.  
From the use of the flowAI package, I expect a general improvement in the quality 
of research that employs flow cytometry instruments. Removing events with 
erratic intensity values will facilitate different aspects of flow cytometry analysis 
such as: 1) more effective compensation since the overlapping signal is subtracted 
only from real values; 2) more accurate detection of rare cells due to the removal 
of background noise; 3) easier characterization of the nature of an ambiguous cell 
population (either as undefined cell type or as technical issue).  
When doing the quality control for a new FCS dataset, I suggest using the 
automatic method first on a small set of FCS files to infer the optimal setting for 
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the dataset in use. In fact, the reports produced by flowAI are intuitive and 
therefore they allow to easily understand the source of recurrent anomalies in the 
flow cytometry experiment. Next, after having customized the settings, the 
automatic method of flowAI should be run on the entire dataset. Lastly, because 
the automatic quality control might still not meet the expectations for certain FCS 
files, the checking of the full reports reveals where it is necessary to intervene 
manually or with the interactive method of flowAI.  
The previous paragraph states a limitation of flowAI that could be potentially 
overcome by the dynamic adjustment of the settings of the automatic method. 
However, for now it remains an open question that warrants further investigation. 
An additional consideration is that flowAI is designed to detect anomalies within 
a single FCS file, hence, other tools are necessary to check for anomalies between 
batches of FCS files.  
In conclusion, my quality control approach produces a comprehensive check of 
the flow cytometry data implementing algorithms never employed before. I 
recommend the usage of flowAI as a first pre-processing step of the data right after 
they are obtained from the flow cytometry instrument so that all the downstream 
analyses, from compensation to detection or rare cells, will benefit from it.  
3.5 Supporting data 
The flowAI package is available from Bioconductor: 
https://doi.org/doi:10.18129/B9.bioc.flowAI. The automatic algorithm of 
flowAI is also available from ImmPortGalaxy (https://immportgalaxy.org) and 
as a flowJo plug-in (Tree Star, Ashland, Oregon). 
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Chapter 4 Transcriptomic signatures of 
human immune cells with clues on mRNA 
composition and absolute deconvolution  
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4.1 Introduction 
The cellular heterogeneity of the immune system is essential for generating diverse 
and targeted immune responses. All immune cells derive from hematopoietic stem 
cells (HSCs), most HSCs reside in the bone marrow, but a small percentage also 
circulates in the blood and placenta (Krause et al., 1996; Lee et al., 2010). Through 
self-renewal, HSCs generate common lymphoid progenitors (CLPs) and common 
myeloid progenitors (CMPs) (Selvarajoo, 2013). T cells, B cells, natural killer 
(NK) cells and plasmacytoid dendritic cells (pDCs) derive from the CLPs; while 
monocytes, granulocytes and myeloid dendritic cells (mDCs) derive from the 
CMPs. These major classes of immune cells can be further subdivided in more 
specific cell types according to their function or maturation stage. 
Investigations into the immune system are often conducted on peripheral 
mononuclear cells (PBMCs) as these are relatively easy to isolate. PBMCs 
comprise lymphocytes, monocytes, NK and dendritic cells (DCs) and often they 
also contain a small fraction of low-density (LD) granulocytes that have been 
generally associated with diseases (Deng et al., 2016; Wright et al., 2016). 
However, studying the PBMCs in their entirety can sometimes lead to inconclusive 
results, as generally it is not yet possible to accurately ascertain which is the 
specific immune cell type responsible for a given signal.  
An effective solution to discern specific immune cell type signals from a 
heterogeneous sample is to use a deconvolution approach. The various 
deconvolution methods developed so far can extract cell proportions, gene specific 
signals or both from mixed samples (Shen-orr and Gaujoux, 2013). The methods 
have been developed and tested on few transcriptomic datasets at the microarray 
level only (Abbas et al., 2005; Novershtern et al., 2011); however, no 
comprehensive analyses at the RNA-Seq level have been produced yet. 
Here, using RNA sequencing, I studied the heterogeneity of 29 immune cell types 
that constitute the PBMC. My results unveil both biological and technical aspects 
of their data analysis that include: 1) gene expression patterns and signatures, 2) 
RNA complexity and its normalization, 3) absolute deconvolution. 
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4.2 Materials and methods 
Donors 
Blood from four Singaporean healthy individuals (S1 cohort) aged 20-35 years (2 
males and 2 females) was collected for transcriptomic profiling of 29 immune cell 
types. Blood from the S1 cohort and from a further nine Singaporean healthy 
individuals (S1Plus cohort) aged 20-35 years (9 males and 4 females) were used 
to isolate PBMCs and to optimize absolute deconvolution from RNA-Seq and 
microarray data. Samples were collected under pseudo-anonymized conditions. 
The identity of each subject was coded and all subjects signed an informed consent 
(IRB number NUS-IRB 10-250). To keep sources of variability at minimum, each 
donor sample was collected and processed at the same time of day (between 9 and 
11 am) under fasting conditions.  
Blood processing 
BD Vacutainer® Mononuclear Cell Preparation Tubes (CPTTM; Becton Dickinson, 
USA) were used for the blood collection (8 ml/CPTTM). The tubes were centrifuged 
for 20 minutes at 1650 relative centrifugal force (RCF) with no brake. The plasma 
was removed and the PBMC layers were transferred to a falcon tube. The cells 
were washed by adding about 10mL of buffer solution made of 95% phophate-
buffered saline (PBS; Thermo Fisher Scientific, USA) and 5% fetal bovine serum 
(FBS; Thermo Fisher Scientific, USA) for each CPTTM. The solution was 
centrifuged for 5 minutes at 340 RCF and after re-suspension, the cells were 
counted using a haemocytometer and split according to the downstream 
experiment. At this stage, aliquots of ~5x106 PBMCs were separated and lysed in 
1mL of TRIzol® (Thermo Fisher Scientific, USA) and then stored at -80°C.  
Antibody panel design and staining 
Four antibody staining panels were designed to immunophenotype and sort the 29 
immune cell types from the following broader categories: 1) CD4 T cells (panel 
1); 2) CD8 T cells, mucosal associated invariant T (MAIT) cells and γδ T cells 
(panel 2); 3) B cells and progenitor cells (panel 3); and 4) monocytes, NK cells, 
DCs and LD granulocytes (panel 4). The 29 cell types were chosen to cover the 
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majority of cells that constitute a PBMC sample. For a complete list of the subtypes 
see Table A.1. The antibody panels were designed and optimized over a first set 
of blood withdrawal. The antibody clones were purchased either from BioLegend, 
BD, or Miltenyi Biotec (Table A.1). For the staining of CCR7, I used the clone 
G043H7 with a pre-incubation step at 37°C at 10 min. Clone G043H7 proved to 
give a better staining index compared to the previously suggested clone 150503 
(Maecker, 2012). General staining was performed at 4°C for 25 minutes; cells were 
then washed and re-suspended in a buffer solution of 5% FBS, 2 mM of ethylene-
diamine-tetra-acetic acid (EDTA; First Base Laboratories, Malaysia) and rest of 
PBS.  
Immunophenotyping 
After isolation, aliquots of 1x106 PBMCs were stained with each antibody panel. 
The solutions were vortexed thoroughly and the samples of the S1Plus (panel 1-4) 
cohort were immunophenotyped with the flow cytometers BD Symphony. The 
quality of the flow cytometry data was verified with flowAI (Monaco et al., 
2016).The flow cytometry data were automatically compensated with the 
FACSDiva software (Becton Dickinson, USA) and gated using the FlowJo 
software (USA).  
FACS Sorting  
From the S1 cohort, ~2-3x108 PBMCs were separated into CD3+ and CD3- 
populations using magnetic beads. The CD3+ fraction was then split into two 
equally sized aliquots for the staining of T cells (panels 1 and 2). The CD3- fraction 
was also split into two aliquots, one aliquot of 60% for the staining of B cells and 
progenitors (panel 3), and one aliquot of 40% for the staining of monocytes, 
dendritic cells, NK cells and low-density granulocytes (panel 4). After staining, 
the immune cells were sorted using the following FACS machines: a BD Influx 
for panel 1 and 3, a FACS Aria 5 for panel 2, and a FACS Aria 4 for panel 4. All 
cells were stained and sorted within 7 hours after blood withdrawal and kept on 
ice between processing steps. After sorting, cells were lysed in TRIzol and stored 
at -80°C. 
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RNA extraction and quantification 
The total RNA of all samples (PBMCs from S1Plus and 29 immune cell types from 
the S1 cohort) was extracted for gene expression analysis. A double extraction 
protocol was used: 1) RNA isolation by TRIzol® extraction and 2) Qiagen RNeasy 
Micro clean-up procedure (Qiagen, USA). The quality of all RNA samples was 
assessed with the Agilent 2100 Bioanalyzer. The RNA Integrity Number (RIN) for 
two samples of CD4 TEMRA was not available as the total RNA obtained was too low; 
hence they were also excluded from further analysis. The RIN of the remaining 
samples ranged between 6.2 and 9.6 and it was considered sufficiently high. The 
RNA concentration was determined using a Quant-iTTM RiboGreen ® RNA Assay 
Kit (Thermo Fisher Scientific, USA).  
Microarray and RNA-Seq data acquisition 
The RNA from 13 PBMC samples of the S1Plus cohort were used for the 
microarray analysis with the Illumina HT12-v4. The cDNA was amplified with 
the TargetAmp™ 2Round aRNA Amplification Kit 2.0 (Epicentre, USA) and the 
data was exported with GenomeStudio. 
The RNA samples of the S1 and S1Plus cohorts were used for RNA-Seq analysis 
with the Illumina HiSeq 2000. The cDNA libraries were prepared from 2 ng of 
total RNA and 1 μl of a 1:50,000 dilution of external RNA control consortium 
(ERCC) RNA Spike in controls (Thermo Fisher Scientific, USA) using 
SMARTSeq v2 protocol (Picelli et al., 2014) with the following modifications: 1) 
use of 20µM template-switching oligos (TSO), 2) use of 250 pg of cDNA with 1:5 
reaction of the Illumina Nextera XT kit. The length distribution of the cDNA 
libraries was monitored using a DNA High Sensitivity Reagent Kit (Perkin Elmer). 
All samples were subjected to an indexed PE sequencing run of 2x51 cycles (16 
samples/lane). In total, 114 samples (two samples of CD4 TEMRA and four samples 
for each of the remaining 28 immune cell types) of the S1 cohort and all 13 samples 
of the S1Plus cohort were taken forward for further analysis. 
Microarray and RNA-Seq data pre-processing 
The microarray data were quantile normalized and corrected for batch effects with 
ComBat (Johnson et al., 2007). For the cross-platform normalization I selected 
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genes with a Pearson’s correlation > 0.7 from the corresponding microarray and 
RNA-Seq PBMC samples of the S1Plus cohort. The upper quartile of the 
microarray values was then divided by the upper quartile of the RNA-Seq 
expression values. The resulting scaling factor was then used to normalize the full 
set of microarray genes. The maximum value of the resulting microarray dataset 
was 2500.  
The genome assembly and annotation for the RNA-Seq data analysis was 
downloaded from GENCODE (version 26). The quality of the RNA-Seq data was 
assessed with FastQC. The software kallisto was used to pseudo-align the reads to 
the transcriptome and get the transcript expression values. The R package tximport 
was used to summarize the transcript expression values into gene expression 
values. The MultiQC software was used to assess and summarize the performance 
of all the pre-processing steps. The counts were normalized for sequencing depth 
and gene length using the Transcript per Million (TPM) method (Li et al., 2009). 
The effect of GC content was explored with the EDAseq package (Risso et al., 
2011). The normalization of the TPM values for mRNA abundance was performed 
using scaling factors derived as following: 1) dividing Quanti-iTTM Assay values by 
FACS enumeration, 2) inverting the trimmed mean of M-values (TMM) (Robinson 
and Oshlack, 2010), and 3) using my method based on LLSR deconvolution and 
optimization (see Deconvolution section). These 3 normalizations are abbreviated 
as TPMTMM, TPMFACS, and TPM{{|}, respectively. The tilde on top of the subscript 
abbreviation of the mRNA normalization procedure indicates that the scaling 
factor is a central tendency estimation (e.g. median) for a cell type instead of a 
single sample. 
Transcriptomic analyses 
To explore the transcriptomic landscape of the 29 immune cell types I used log2 
TPM values and I kept only the genes with a row count ≥ 4 in at least three samples 
(unless otherwise indicated). All analyses were performed in the R environment 
(custom scripts in Supplement 7). 
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The Rtsne package and the prcomp function from the stats package were used to 
perform the t-SNE and PCA analysis, respectively. The hierarchical clustering was 
built using the hclust function with Euclidean distances.  
The transcriptomic hematopoietic tree was generated using the Spearman’s 
correlation coefficient (1-ρ) as pairwise distances and the neighbor-joining 
approach for the clustering. Bootstrap values were calculated for each node to 
show the consistency of the branching patterns. These values were calculated by 
building 100 trees from randomly sampled genes with replacement and retrieving 
the number of times each branch conserved the topology of the consensus tree. 
The tree and bootstrap values were generated with the R package ape.  
For circos plot visualization, I summarized the TPM expression values of the genes 
belonging to contiguous genomic regions of 15 Mbp. The R package circlize was 
then used to generate the circos plots. 
The analyses described were not only applied to the 29 immune cell type 
classification, but also to broader categories (Supplement 8). The differentially 
expressed genes (DEGs) were found with the limma package on both the TPM and 
TPMTMM values. For the design matrix, each cell type or category was contrasted 
against the remaining samples. The PBMC samples were only included for linear 
model fitting but they were excluded from any contrast. The R package WGCNA 
was used to find the modules of DEG and co-expressed genes on TPM values, and 
to perform the Gene Ontology (GO) enrichment of the modules (Supplement 9). 
The heatmaps have been produced with the R package ComplexHeatmap (Gu et 
al., 2016). The enrichment analysis of the DEGs for each cell type and cell 
category on TPMTMM was performed with the fisher.test function in R using the 
Reactome databases V61 (Fabregat et al., 2016) (Supplement 10).  
Deconvolution analyses 
Deconvolution was used to first estimate scaling factors to normalize for mRNA 
abundance and then to estimate cell-types proportions. The signature matrices 
were built using the median TPM expression values of each cell type or category 
that were eventually normalized for mRNA abundance. Uninformative genes were 
removed using the results obtained from the differential expression analysis on the 
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TPM values. I ranked the genes by their q value and I kept the ones with a fold 
change > 2 and a q-value < 0.05 (false discovery rate). A set of filtering procedures 
was performed to remove noisy genes with: 1) very low expression (sum of all 
sample < 50), 2) very high expression (at least one cell type > 5000), 3) poor 
specificity (log2 difference < 0.1 between the first and second cell types with 
highest expression), and 4) a further set of 31 genes having at least one of the 
criteria just described but that were not excluded by the arbitrary thresholds 
applied. Whenever possible, cell types that on their own gave poor deconvolution 
results were included in broader categories.  
To retrieve the scaling factors to normalize the TPM values for mRNA yield, I 
adopted a basic deconvolution method based on linear multiple regression. The 
model is described as: 
 ~	 = b'Ä + b2Å + ⋯+ b*É + e (4.1) 
where y is the gene expression of a mixed sample (in my case PBMCs), x1,x2,…,xn, 
are the gene expression of each immune cell type, and b1, b2,…, bn, are the 
coefficients describing the change of y with respect to x. Italic bold characters 
indicate vectors of numbers, while italic characters are single numbers. In this 
model, there is no intercept term because the regression is forced to pass through 
the origin. In other words, when all the predictor variables (the expression of all 
the immune cells) are 0, also the response variable (the expression of the mixed 
sample) must be 0.  
When the gene expression values are correctly normalized and correspond to the 
real absolute gene expression, the b coefficient correspond to the immune cell 
proportion only. When the gene expression values are not normalized by mRNA 
yield (i.e. TPM values), the b coefficients account for both immune cell proportion 
and mRNA yield. In this case, the model can be re-written as: 
 ~	 = b'1'Ä + b212Å + ⋯+ b*1*É + e,    b	 > 01 > 0  (4.2) 
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where the b coefficients account for the cell proportions, the s values account for 
mRNA yield values, and both the b and s values are positive numbers. We cannot 
estimate both the b coefficients and s values with the gene expression values only. 
However, we can estimate the s values by knowing the real flow cytometry 
proportion. The strategy I adopted consisted of using an optimization algorithm to 
find the s values that minimize the root mean square error (RMSE) between the b 
coefficients and the real proportions calculated by flow cytometry. Therefore, for 
each cell type: 
 mino∈(Ü,á) (7 − àâ)2äãM'  (4.3) 
where the vectors b and pr are respectively the estimated and real proportions of 
one immune cell type for a set of k individuals; and ll and ul are optional lower and 
upper limits for the s value. For the optimization procedure, I used the optimize 
function from the R stats package, which uses a combination of golden section 
search and successive parabolic interpolation (R Core Team, 2017; Brent, 1973). 
The analysis was repeated on the set of signature matrices of increasing size and 
the mean estimates were calculated over the entire set of results. 
To estimate cell type proportions, first, I compared the performance of five 
deconvolution methods with or without noisy genes and with increasing 
collinearity in the signature matrix. The methods compared are: linear least squares 
regression (LLSR), non-negative linear least square regression (NLLSR) (Abbas 
et al., 2009), robust linear regression (RLR), quadratic programming (QP) (Gong 
et al., 2011) and CIBERSORT (Newman et al., 2015). Filtered signature matrices 
with low condition numbers, calculated with the function kappa in R, for both 
RNA-Seq and microarray deconvolution are reported in Supplement 11 together 
with the full signature matrices. Second, I used LLSR and the filtered signature 
matrices with low condition numbers to obtain optimal deconvolution results of 
16 and 18 cell types or categories for microarray and RNA-Seq, respectively. 
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4.3 Results 
4.3.1 Study design 
Blood samples from four Singaporean individuals (S1 cohort) were sorted from 
for transcriptomic analysis by RNA-Seq of 29 immune cell types. Additionally, 
PBMC samples of 13 Singaporean individuals (S1Plus cohort) were collected for 
transcriptomic analysis with both RNA-Seq and microarray technologies, and for 
flow cytometry-based immunophenotyping of the 29 immune cell types 
(Materials and Methods). Figure 4.1 shows a schematic representation of the 
workflow.  
The 29 immune cell types for this study were chosen based on functional relevance 
and discriminatory ability. I made sure that each cell could only be assigned to one 
cell type and that by merging all the cell types would reconstitute a complete 
PBMC sample.  
 
Figure 4.1 Representation of the isolation of the 29 cell types from blood. The blood is collected 
in a CPTTM to isolate the PBMCs first. Then, aliquots of the obtained PBMCs are used for 
transcriptomic profiling and staining with 4 antibody panels for cell sorting and 
immunophenotyping. Before cell sorting, the PBMCs are split in CD3+ cells CD3- with 
magnetic beads to maximize the number of cells obtained during sorting. After sorting, the 29 
immune cell types obtained are used for RNA-Seq profiling. 
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The gene expression profiles of the 29 immune cell types (S1 cohort) were first 
used to get an overview of the similarities and differences between cell types 
through clustering, differential expression, and co-expression network analysis. 
Two aspects of transcriptome composition were then explored: gene expression 
proportions and mRNA abundance (S1 cohort). Lastly, gene expression of PBMCs 
and flow cytometry proportions were used to investigate normalization and 
deconvolution algorithms.  
4.3.2 Transcriptomic relationships and ontogeny 
I explored the relationships between the 29 immune cell types using 
dimensionality reduction and clustering methods on the TPM expression values 
(Figure 4.2 and Figure A.11). Although with TPM values it is not possible to 
compare the gene expression in absolute terms, as they are not adjusted for mRNA 
abundance, it is nonetheless possible to correctly compare the gene expression 
proportions.  
My analysis confirms that generally the immune cell types that are more closely 
related have also more similar gene expression patterns, however I still found few 
 
Figure 4.2 Immune cell types relationship. (a) t-SNE analysis of the genes that are expressed in 
at least one cell type. Each plot highlights the PBMCs and the cell types processed in each of the 
four staining panels. (b) Transcriptomic hematopoietic tree of the 29 immune cell types fixing 
the progenitor cells as the root of the tree. 
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exceptions. The t-SNE analysis (Figure 4.2a) shows that, for some cell types 
(progenitors, plasmablasts, low-density (LD) neutrophils, LD basophils, and 
pDCs), the samples of different individuals clustered so closely that only one dot 
is visible in the plots. The naive compartments of the CD4 T cells and CD8 T cells 
showed high similarity as they clustered more closely together than with their 
corresponding memory subsets. The T-cell memory subsets formed two separate 
clusters: the CD4 T effector memory RA (EMRA) aggregated with the CD8 T 
effector memory (EM) and CD8 TEMRA, and the CD8 T central memory (CM) 
aggregated with the remaining CD4 memory subsets. A closer look into the 
expression of genes related to degranulation activity, namely granzyme B (GZMB) 
and perforin (PRF1), revealed increased expression levels in the CD4 TEMRA 
compared to the remaining CD4 T memory, in accordance with previous results 
(Marshall and Swain, 2011). 
Some cell types, such as the mature T cells subtypes, mature B cells subtypes and 
intermediate (I) and non-classical (NC) monocytes, did not form distinct clusters. 
The hierarchical cluster (Figure A.11) reveals that the gene signatures of these 
subtypes were more strongly influenced by the inter-individual variability than by 
the cell type differences.  
The transcriptomic hematopoietic tree illustrated in Figure 4.2b is another way to 
visualize the relationship between cell types. Here, I observed that the pDCs did 
not cluster with any broader group and they were the most closely related cell type 
to progenitor cells. The naive T and B cells, although being at an early maturation 
stage, already exhibited a well-defined phenotype as they clustered far from the 
progenitor cells. 
4.3.3 Differentially expressed and co-expressed gene modules 
The landscape of the dataset was explored with both TPM and TPMTMM expression 
values. TPM values highlight the difference in gene expression proportions, while 
TPMTMM values highlight the differences from a core of similarly expressed genes. 
The importance of distinguishing between TPM and TPMTMM will be later explained 
in more detail. The cell types were also grouped in broader categories and the 
analysis was repeated on those. 
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I performed a differential expression analysis first with the R package limma, 
contrasting each cell type or category with the remaining samples (Supplement 
8). The heatmap in Figure 4.3 reports the log2 TPM values of modules of DEG 
with corresponding GO enrichment. Figure A.12 shows extra information on the 
modules selection and inter-correlation. Figure 4.4 and Figure A.13 reports the 
heatmap and information on co-expression modules selection, instead. 
The two heatmaps highlight two important aspects of the transcriptional landscape 
of the 29 cell types: 1) genes that are specific for a defined cell type (Figure 4.3), 
and 2) genes similar patterns independently of cell type specificity (Figure 4.4). 
The heatmap on DEG reveals the high-quality of the transcriptomic data, as each 
cell type or category enriches for known relevant GO terms. A comparison of the 
 
Figure 4.3 Heatmap of DEGs between each cell type or category and remaining samples. Modules 
of genes were found by hierarchical clustering on Euclidean distance (Figure A.12). The most 
relevant GO terms associated with each module are reported on the left. The top DEGs are reported 
on the right (Full list in Supplement 7). 
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genes specific (fold change > 2 and a q-value < 0.05) for four major cell types (T 
cells, B cells, NK and DC) was performed with two publicly available collections 
of specific markers retrieved with microarray data (Abbas et al., 2005; Bindea et 
al., 2013). Between the four cell types, B cells showed the greatest overlap 
indicating that they might be less prone to inter-individual variability Figure A.14. 
Another expected and validating finding is that the modules in the co-expression 
map that are highly expressed in all or almost all the samples enrich for basal 
metabolic functions. Figure A.13c shows the distribution of the connectivity  
 
Figure 4.4 Heatmap of modules of co-expressed genes. The adjacency matrix has been built on 
pairwise bicorrelations. The matrix has been then converted in a topological overlap matrix (TOM) 
with WGCNA. The modules of genes were retrieved using hierarchical clustering on the TOM and 
then merging similar modules (Figure A.13). The most relevant GO terms associated with each 
module are reported on the left. For each module, the genes with higher intra-modular connectivity 
are reported on the right (Full list in Supplement 7). 
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values of each co-expression module. Modules 8, 3, 11 and 7 (ordered by 
decreasing q-value) were enriched for the transcription factors and co-factors 
retrieved from the public resource AnimalTFDB (Zhang et al., 2015), and the four  
modules are all related to transcriptional activity. Most of the transcription factors 
and co-factors however, were either not expressed in any immune cell (38% of 
them) or were too central to belong to a specific module (36% of them). 
The heatmap on co-expressed genes shows some overlap with the DEG one, 
although most of the modules are expressed by undefined cell categories or show 
variation across individuals instead of cell types. The Supplement 9 contains the 
list of genes belonging to each module and it is a source of potential candidate 
markers. 
The DEG of each cell type and category retrieved from the TPMTMM normalization 
(q value < 0.05) were used to perform an enrichment analysis on the gene sets of 
the Reactome database (Supplement 10). Selected pathways are reported as violin 
plots in Figure A.15 and Figure A.16. Two notable results were the enrichment 
of the mitotic cell cycle for plasmablasts, and the down-regulation of non-coding 
RNA activities for LD neutrophils. Moreover, there are additional results that 
might be relevant only in specific contexts and hence are not elucidated here.  
The RNA-Seq data is also a good resource to explore immune cell housekeeping 
(HK) genes. As a starting point, I retrieved two publicly available list of HK genes 
(Eisenberg and Levanon, 2013; Hsiao et al., 2001). The median TPM value of 
these HK genes was used as a scaling factor to normalize the TPM values for 
mRNA abundance. The HK scaling factors generated a Pearson’s correlation of 
0.86 with the inverted TMM scaling factors, demonstrating that the two methods 
have a similar normalization effect. For each gene, the mean and standard 
deviation of the TPMTMM values was calculated (Supplement 10). As expected, the 
standard deviation of the known HK gene lists has a lower standard deviation than 
the remaining genes (data not shown). However, there are numerous discordant 
cases. To provide a new list of reference genes, I highlighted the genes with 
variance < 0.5 and mean expression > 4 (Supplement 10). Notably, 58% of the 
list overlapped with the genes reported by Eisenberg and Levanon (2013).  
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Moreover, the commonly used HK genes GAPDH and ACTB, although expressed 
in all cells, were under-expressed in lymphoid cells and over-expressed in myeloid 
cells. 
4.3.4 mRNA composition part 1: proportions 
The TPM normalization scales all the expression values so that their sum is always 
106 in e 
ach sample which creates the possibility to compare proportions between samples. 
However, in the case of samples where the total mRNA is dominated by the 
expression of only few genes, the remaining fraction of genes will show very small 
expression values. Moreover, in comparison to microarray, the effect of having 
few genes responsible for most of the mRNA is generally more evident with the 
RNA-Seq technology as it does not have an upper limit in the dynamic range 
(Bullard et al., 2010).  
Comparing cumulative TPM expression between different immune cell types 
makes possible to identify profound differences in the mRNA composition in 
terms of proportions. Figure 4.5 shows that in plasmablasts and neutrophils, 
relatively few genes are responsible for the largest fraction of total mRNA. An 
 
Figure 4.5 Composition of the gene expression in terms of proportions. (a) The cumulative sum of 
the median TPM values of nine relevant cell types or categories. The cumulative sum was 
calculated from values sorted in a decreasing order. (b) The number of genes for all 29 cell types 
that contribute for 80% of the cumulative sum of TPM values (106). This number corresponds to 
the dashed red line in (a). 
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opposite profile is given by progenitor cells with a lower number of dominant 
genes. This finding is in line with the fact that these cells are not committed to a 
specialized function yet (Kingsley et al., 2013). Moreover, this also explains why 
in the heatmaps of Figure 4.3 and Figure 4.4 plasmablast and neutrophil samples 
have a substantial different scaling from the other samples. I generated circos plots 
to visualize the genomic regions and the genes that contribute the most to the total 
mRNA in the different immune cell types (Figure A.17, Figure A.18, and Figure 
A.19). As expected, the hotspots of expression in plasmablasts are located in the 
chromosomes 2, 14, and 22 for the production of immunoglobulins.  
Because the same amount of RNA starting material for each cell type, was used 
for the RNA-Seq profiling of the 29 immune cell types, the effect of masking the 
expression of low-expressed genes by few dominant genes is noticeable when 
using raw counts. When exploring the effect of GC content with the EDASeq tool, 
I found that the expression tends to increase at medium values of GC content in 
accordance with findings by the EDASeq developers (Risso et al., 2011) (Figure 
A.20). Nonetheless, neutrophils, plasmablasts show a lower and progenitors show 
a higher GC content effect in comparison to other cell types. From my 
interpretation, this is not actually due to a different GC content effect, but rather to 
differences in mRNA abundance that will be elucidated in the next section. 
4.3.5 mRNA composition part 2: abundance 
The fact alone that plasmablasts and LD neutrophils have a similar composition in 
terms of proportions, is not enough to assume that they have similar complexity. 
A second factor that must be considered is total mRNA yield, which can vary 
greatly among cell types likely due to two main factors: 1) cell size and 2) 
metabolic activity. 
Estimations of the mRNA yield per cell type are generally not made when using 
standard methods of library preparation for gene expression analysis. Moreover, 
commonly used devices to count cells within a sample, such as haemocytometers, 
are poorly accurate. In my case, however, the FACS sorting gave me the exact 
enumeration of each cell type. Hence, by dividing the total RNA yield obtained 
from the RNA quantification assay (see Materials and Methods) by the 
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corresponding number of cells obtained from the FACS analysis, we obtained an 
estimation of the RNA yield produced by a single cell for each immune cell type 
sample (Figure 4.6a). The results indicated high mRNA yield for plasmablasts, 
DCs and monocytes and low mRNA yield for LD granulocytes, progenitor cells 
and CD4 TEMRA.  
Then, I reported the inverted TMM values (Robinson and Oshlack, 2010) (Figure 
4.6b) which were used for the TPMTMM normalization and should be proportionate 
to mRNA abundance. By comparing the patterns formed by the two approaches 
(Figure 4.6a,b), we can notice a substantial discordance for few cell types. In 
particular, it is relevant discussing the effect of TMM normalization on the LD 
neutrophils. The TMM method revealed that, similarly to plasmablasts, LD 
neutrophils have few highly-expressed genes that cover the largest part of the total 
mRNA. Hence, the TMM method estimates a high mRNA scaling factor in an 
attempt to normalize the expression of the core gene set (the majority of genes) of 
LD neutrophils with the core gene sets of the remaining cell types. However, the 
 
Figure 4.6 RNA and mRNA abundance estimation and normalization. (a) RNA yield in 
picograms per cell estimated by dividing total RNA yield from FACS enumeration (donors are 
color-coded). (b) mRNA yield scaling factor per cell type obtained by inversing TMM values 
(donors are color-coded). (c) mRNA yield scaling factors obtained with the LLSR deconvolution 
procedure (see Materials and Methods). (d) Total RMSE obtained by comparing the real PBMC 
gene expression with the reconstructed PBMC gene expression using 5 different normalization 
strategies (see Materials and Methods). 
●
●
●
●
●
●
●
●
●
● ● ●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●●
●
●
●
●
●
●
●● ● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●0
1
2
Ba
so
ph
ils
 L
D
Ne
ut
ro
ph
ils
 L
D
M
on
oc
yte
s C
M
on
oc
yte
s I
M
on
oc
yte
s N
C
m
DC
s
pD
Cs Tf
h
Tr
eg
s
Th
1
Th
1/
Th
17
Th
17 Th
2
T 
CD
4 
Na
ive NK
Th
 T
EM
RA
T 
gd
 V
d2
T 
gd
 n
on
 V
d2
M
AI
T
T 
CD
8 
Na
ive
Tc
 C
M
Tc
 E
M
Tc
 T
EM
RA
Pr
og
en
ito
rs
B 
Na
ive
B 
NS
M
B 
SM B 
Ex
Pl
as
m
ab
las
ts
Cell type
Q
ua
nt
−i
T 
/ F
A
C
S
 (p
g 
pe
r c
el
l)
● ●
●
●
●
●
●
●
● ●
●
●
● ●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●●●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
● ●
● ●
●
● ●
● ●
● ●
●
● ●
●
●
●
●●
●
● ●
●
●
●
●
●
● ●
●
●
●
●
● ●
●
● ●
●
● ●
●
●
●
●
●
●
●
●
1
2
3
Ba
so
ph
ils
 L
D
Ne
ut
ro
ph
ils
 L
D
M
on
oc
yte
s C
M
on
oc
yte
s I
M
on
oc
yte
s N
C
m
DC
s
pD
Cs Tf
h
Tr
eg
s
Th
1
Th
1/
Th
17
Th
17 Th
2
T 
CD
4 
Na
ive NK
Th
 T
EM
RA
T 
gd
 V
d2
T 
gd
 n
on
 V
d2
M
AI
T
T 
CD
8 
Na
ive
Tc
 C
M
Tc
 E
M
Tc
 T
EM
RA
Pr
og
en
ito
rs
B 
Na
ive
B 
NS
M
B 
SM B 
Ex
Pl
as
m
ab
las
ts
Cell type
1/
TM
M
 sc
ali
ng
 fa
cto
r
a b
●●
●●
●●●●●●● ●
● ●●●●●● ●● ● ●●● ●●●●● ●
●● ●●
●
●
● ●●●● ●
●●●●● ●●● ●●● ●●●●● ●●●●
● ●●●●●●
●●●●● ●●●● ●●● ●●
●● ●●●● ●
●● ●●● ●●
●●●
●●
●●●●
●●●●● ●
● ●● ●●●● ●●
●● ●●●● ●
● ●
●
●
●
●
●
●●● ●
● ●●
●
●● ●●
●
●
● ●●●●●● ●
●●●●● ●●
●
●●
●
●
●●●
●
●
●
●● ●
●
●●●
0.0
2.5
5.0
7.5
10.0
Ba
so
ph
ils
 L
D
Ne
ut
ro
ph
ils
 L
D
M
on
oc
yte
s C
M
on
oc
yte
s N
C+
I
m
DC
s
pD
Cs
T 
CD
4 
M
em
or
y
T 
CD
4 
Na
ive NK
T 
gd
 V
d2
T 
gd
 n
on
 V
d2
M
AI
T
T 
CD
8 
Na
ive
T 
CD
8 
M
em
or
y
B 
Na
ive
B 
M
em
or
y
Pl
as
m
ab
las
ts
Cell type
De
co
nv
olu
tio
n 
sc
ali
ng
 fa
cto
r
tpmTMM
tpmRNAymed
tpm
tpmRNAycell
tpmRNAyOPT
0
10
0
20
0
30
0
RMSE (real PBMCs vs assembled PBMCs)
No
rm
ali
za
tio
n 
m
et
ho
ds
c d
TPMTM
TPM
TPMFACS
No
rm
ali
za
tio
n 
m
et
ho
ds
TPMFACS~
TPMLLS~
Q
ua
nt
-iT
 R
N
A
 / 
FA
C
S
 e
nu
m
er
at
io
n
(p
g 
pe
r c
el
l)
LL
SR
 D
ec
on
vo
lut
ion
 
+ 
op
tim
iza
tio
n
1 
/ T
M
M
RMSE (real PBMCs vs reconstructed PBMCs)
Ba
so
ph
ils
 L
D
Ne
ut
ro
ph
ils
 L
D
M
on
oc
yte
s C
M
on
oc
yte
s I
M
on
oc
yte
s N
C
m
DC
s
pD
Cs Tf
h
Tr
eg
s
Th
1
Th
1/
Th
17
Th
17 Th
2
T 
CD
4 
Na
ive NK
T 
CD
4 
EM
RA
T 
γδ
 V
δ2
T 
γδ
 n
on
-V
δ2
M
AI
T
T 
CD
8 
Na
ive
T 
CD
8 
CM
 T
 C
D8
 E
M
T 
CD
8 
EM
RA
Pr
og
en
ito
rs
B 
Na
ive
B 
NS
M
B 
SM B 
Ex
Pl
as
m
ab
las
ts
Cell type
Ba
so
ph
ils
 L
D
Ne
ut
ro
ph
ils
 L
D
M
on
oc
yte
s C
M
on
oc
yte
s I
M
on
oc
yte
s N
C
m
DC
s
pD
Cs Tf
h
Tr
eg
s
Th
1
Th
1/
Th
17
Th
17 Th
2
T 
CD
4 
Na
ive NK
T 
CD
4 
EM
RA
T 
γδ
 V
δ2
T 
γδ
 n
on
-V
δ2
M
AI
T
T 
CD
8 
Na
ive
T 
CD
8 
CM
T 
CD
8 
EM
T 
CD
8 
EM
RA
Pr
og
en
ito
rs
B 
Na
ive
B 
NS
M
B 
SM B 
Ex
Pl
as
m
ab
las
ts
Cell type
Ba
so
ph
ils
 L
D
Ne
ut
ro
ph
ils
 L
D
M
on
oc
yte
s C
M
on
oc
yte
s N
C+
I
m
DC
s
pD
Cs
T 
CD
4 
M
em
or
y
T 
CD
4 
Na
ive NK
M
AI
T
T 
CD
8 
Na
ive
T 
CD
8 
M
em
or
y
B 
Na
ive
B 
M
em
or
y
Pl
as
m
ab
las
ts
T 
γδ
 V
δ2
T 
γδ
 n
on
-V
δ2
Cell type
 129 
total RNA output of LD neutrophils was overall lower than that of most of the 
other immune cells, a finding which is in accordance with a previous work 
(Moulding et al., 2001). This demonstrates the danger of relying on purely 
mathematical methods, i.e. TMM (Robinson and Oshlack, 2010) and DESeq 
(Anders and Huber, 2010) for normalizing the mRNA abundance across very 
diverse samples. 
4.3.6 Absolute deconvolution  
Extracting cell type proportions from RNA mixtures is an approach that has gained 
popularity over recent years. After the pioneering work of Abbas et al. (2009), 
several tools for this aim have been developed (Gong et al., 2011; Newman et al., 
2015), but thus far they have only been tested on few microarray datasets and on 
a relatively small number of immune cell types (Shen-orr and Gaujoux, 2013). 
Here, I used the RNA-Seq data to perform absolute deconvolution and to employ 
it as a novel method to obtain scaling factors for mRNA abundance normalization. 
mRNA normalization through deconvolution 
In contrast to differential expression analysis where it might suffice to compare 
counts normalized only for library size, for deconvolution it is necessary to have 
absolute expression values. For example in the case of LD neutrophils, it is not 
acceptable to push the total gene expression up if the overall mRNA output is 
relatively low compared to the remaining cell types. An optimal way to correctly 
normalize RNA-Seq data for deconvolution approaches is by calculating the TPM 
values first and then multiplying these values with a scaled mRNA yield value. 
Although obtaining TPM values is simple, normalizing for mRNA abundance can 
be a tedious procedure. I already demonstrated the inconvenience of relying on the 
mathematical methods to obtain absolute measurements, e.g. 1/TMM. Moreover, 
it is preferable not to use the total RNA yield value estimated from the RNA 
quantification protocol and FACS enumeration for two reasons: 1) the 
quantification has been made on total RNA and 2) the estimate is only accurate for 
a limited dynamic range. 
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Here, I outline a method to estimate scaling factors to normalize TPM values for 
mRNA abundance based on the simplest deconvolution method, i.e. linear least 
square regression (LLSR), and a basic one dimensional optimization procedure. 
Firstly, I built a signature matrix that fulfils the following requirements: 1) 
inclusion of a set of predictor variables (the cell types) so that their total 
proportions sum up to a full PBMC sample, 2) absence of noisy genes, and 3) 
optimal size to control multicollinearity effects. Secondly, I use LLSR to estimate 
the b coefficients from the transcriptomic data of PBMC, the response variable, 
and immune cell types, the predictor variables. The coefficients, however, also 
incorporate an amount corresponding to immune cell proportions and an amount 
corresponding to the mRNA abundance. Thirdly, to separate the latter amount, I 
use an optimization procedure to find the value that minimizes the error between 
the estimated and real cell type proportions obtained by flow cytometry (see 
Materials and Methods). Because the approach only works if the proportions 
estimated by deconvolution correlate well with the real ones, whenever possible I 
grouped cell types that lead to poor Pearson’s correlations (generally < 0.5) into 
broader categories that give better correlations (see the classification used in Table 
A.2, Figure 4.7a and Figure A.21). The progenitor cells were the only cell type 
where we could not improve the results; for these cells, we used the scaling factor 
estimated from the method based on RNA yield and FACS enumeration.  
The procedure was repeated using signature matrices of increasing size and the 
results are reported in Figure 4.6c and the patterns obtained are closer to the ones 
obtained with RNA quantification and FACS enumeration than the ones obtained 
with inverted TMM (Figure 4.6a,c). To benchmark the accuracy of each 
normalization approach, I compared the real gene expression of PBMCs with an 
assembled gene expression obtained by summing the weighted gene expression of 
each cell type composing the PBMC. The weighting was done by multiplying the 
gene expression of each cell type by its flow cytometry proportion. The RMSE 
obtained from the comparison was the lowest when using a TPM normalized by 
scaled mRNA yield obtained with the deconvolution plus optimization procedure 
(Figure 4.6d).  
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Cell types proportions estimated from RNA-Seq PBMC samples 
Estimating the proportions of cell types constituting a mixed sample with 
deconvolution can only work only if there are specific signals for each cell type. 
The fact that a cell type has a low frequency within a mixed sample would not be 
a limitation itself, given that a sufficiently large sequencing depth is used. 
However, together with the lack of specific signal, the low sequencing depth can 
still be a limiting factor for absolute deconvolution.  
As already stated, whenever possible I grouped together the cell types that yielded 
unsatisfying estimations into broader cell categories that showed better results 
(Figure 4.7a and Table A.2). The only cell type for which I could not improve the 
results is the progenitor cell. A possible explanation could be their overall low 
abundancy which rendered the sequencing depth used unable to catch accurate 
signal of specific genes, such as CD34, within the mixed PBMC samples. Another  
caveat was that the progenitors could not be grouped with any other cell type. The 
performance of five deconvolution methods were compared (Figure 4.7b). Noise 
and multicollinearity were evaluated by the absence of gene filtering and by 
increasing the number of genes for the signature matrix, respectively. I found 
CIBERSORT and RLR to be the least affected by both noise and multicollinearity. 
However, all deconvolution methods apart from QP, performed well with a filtered 
and a well-conditioned signature matrix. Two filtered signature matrices of 
different size are included in Supplement 11, and the smallest one, i.e. the well-
conditioned, has been used to generate Figure 4.7a. 
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Cell types proportions estimated from microarray PBMC samples 
Deconvolution was then performed using microarray data for the same PBMC 
samples used for the RNA-Seq deconvolution (S1Plus cohort). The challenge of 
this analysis lies in deconvoluting the signals from microarray data using a 
signature matrix produced with RNA-Seq, a profoundly different gene expression 
platform. In an assessment made by the SEQC/MAQC III consortium, it was 
 
Figure 4.7 Absolute deconvolution results. (a) Deconvolution performed with LLSR on the most 
optimal cell type classification. For each comparison, concordance correlation coefficient (ccc) 
and the Pearson’s correlation coefficient (r) are reported on the top left. (b) Comparison of 5 
deconvolution algorithms. The total RMSE is calculated by summing the quadratic difference 
of the estimated cell types proportions with the real ones retrieved with flow cytometry. 
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shown to be possible to compare gene expression levels deriving from different 
platforms only after appropriate filtering (Consortium, 2014).  
My strategy consisted of filtering the genes with a Pearson’s correlation >0.70 
between RNA-Seq and microarray data and calculating a scaling factor from them 
only. The scaling factor was retrieved by dividing the upper quartile of the 
microarray subset of genes with the upper quartile of the RNA-Seq subset. The 
microarray samples were then divided by the scaling factor. The upper limit of the 
range in the linear scale obtained for the microarray dataset was 2500; this value 
can be used to normalize other Illumina HT12-v4 microarray datasets when using 
the signature matrix provided (Supplement 11).  
The signature matrix for the microarray deconvolution was also built by filtering 
out noisy genes, i.e. very low, very high and poorly specific expressed genes. A 
well-conditioned matrix and a full matrix are available from Supplement 11. As 
fewer genes were available for the microarray platform, some specific genes 
essential for certain cell types were missing and deconvolution results were less 
accurate. However, deconvolution with a well-conditioned signature matrix still 
generated good Pearson’s correlations with real proportions for several cell types 
(r > 0.8 for naïve B cells, memory B cells, plasmablasts, CD8 T memory cells, NK 
cells, and LD basophils; r > 0.6 for naive CD4 T cells and MAIT cells (Figure 
A.21).  
4.4 Discussion 
This study analysed the gene expression profiles of 29 immune cell types 
comprising the PBMC fraction. I explored the data using different approaches 
giving new insights into their transcriptomic landscape, normalization and 
deconvolution. 
The transcriptomic relationships between the 29 immune cell types were first 
explored with dimensionality reduction and clustering methods using TPM 
normalized values. LD neutrophils, LD basophils, plasmablasts, progenitors and 
pDCs showed very distinct profiles. Other cell types were grouped within broader 
categories with different degrees of variability. CD8 T cells with effector 
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functions, CD8 TEM and CD8 TEMRA, clustered together in accordance to a previous 
work (Willinger et al., 2005). They also cluster close to CD4 TEMRA cells, 
unconventional T cells and NK cells; hence they were all associated with 
degranulation activity. A separate group of T cells consisted of CD4 memory T 
cells and CD8 TCM cells. They all have strong cytokine production activity (Pennock 
et al., 2013) and they show large variability within the formed cluster. A distinct 
cluster of T cells was formed by cells with a naive phenotype, independently from 
their commitment into being CD4 or CD8 T cells already. As expected, memory 
T cells with no effector function clustered between cells with a naive and an 
effector phenotype (Willinger et al., 2005).  
The landscape of the gene expression data was further explored by retrieving the 
differentially expressed genes and the co-expressed genes. From an enrichment 
analysis on the module of genes extracted from the two subsets of genes, I defined 
the set of genes involved in different functions and related to single or multiple 
cell type categories. From these modules, it is possible to identify novel candidate 
genes that can be used as either therapeutic target of as discriminatory marker 
(Figure 4.3, Figure 4.4, and Supplement 9).  
The gene expression composition of the 29 immune cell types resulted to be 
particularly different in progenitors, LD neutrophils and plasmablasts. As 
expected, progenitors have the least number of specific genes, as many diverse 
mRNA molecules are produced by its transcriptional machinery. By contrast, LD 
neutrophils and plasmablasts have very few specific genes that contribute greatly 
to the total mRNA composition (Figure 4.5). Although plasmablasts and LD 
neutrophils seem to have a similar composition in terms of gene expression 
proportions, it is known that these two cell types have profound morphological and 
functional differences. This phenomenon lead me to explore another fundamental 
aspect of mRNA composition: mRNA abundance (Figure 4.6). 
The total mRNA output of a cell type is mainly driven by to two main factors: the 
cell size and the metabolic activity. Although for some analyses, such as co-
expression or differential expression analysis, it might not be necessary to 
normalize for mRNA abundance, there are other cases, such as deconvolution, 
where it is essential. However, only few works until now have described the 
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importance of normalizing for mRNA yield (Lovén et al., 2012; Aanes et al., 
2014). There are mathematical methods that can normalize for mRNA abundance 
without information on cell size and metabolic activity, such as TMM and DESeq. 
Although these methods may work well for most cases, they can produce 
erroneous estimations when comparing cell types with substantial differences. 
Since these mathematical methods assume that the majority of genes have similar 
expression levels, they cannot correctly identify cases where the overall 
transcriptional machinery is downregulated or upregulated. This is a disadvantage 
of almost all mathematical methods that could generally be overcome by 
experimentally cataloguing the mRNA yield of all the cell types constituting the 
most commonly studied organisms. Moreover, by also describing the 
morphological and functional properties it might be possible to establish the 
contribution of the different determining factors.  
A reassuring note for mathematical approaches is that biological questions 
generally revolve around searching for genes that are upregulated or 
downregulated relative to a “standard” pattern of expression. Therefore, using 
mathematically based approaches such as TMM and DESeq as normalization 
methods can generate more meaningful biological results than a comparison of 
absolute gene expression values. For example, if the total RNA output of cell type 
A is 100 and of cell type B is 1,000, it might be meaningless to perform a 
differential expression analysis on absolute expression values as all the genes in 
the cell type A would be probably considered downregulated.  
Given the above concern, I used a two-step normalization approach, TPM and 
TMM (TPMTMM), to provide an additional set of resources, enrichment analysis of 
the Reactome pathways and a list of HK genes (Supplement 10). The enrichment 
analysis showed expected findings, such as plasmablasts under active mitotic 
division, but also some novel ones, such as the low non-coding RNA activity of 
LD neutrophils. Regarding the analysis of HK genes, I selected the genes 
expressed in all samples and with a low standard deviation (mean > 4 and sd < 0.5) 
based on log2 TPMTMM values (Supplement 10). I obtained a large overlap, more 
than half, with the HK genes listed recently by Eisenberg and Levanon (2013), but 
there is also a large set of previously undocumented genes that can be used 
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specifically for immunological studies. Moreover, the commonly used HK genes 
GAPDH and ACTB (Quiroz et al., 2010), although expressed in all cells, were 
under-expressed in lymphoid cells compared to myeloid cells, and thus they may 
not be the best HK genes for certain studies. 
As discussed, deconvolution analyses require an absolute normalization of gene 
expression data that might not always be obtained using mathematical approaches 
such as TMM. Hence, I explored the effect of other two approaches. One approach 
consisted by scaling the TPM values with a factor derived from dividing the total 
RNA yield value obtained with the RNA quantification protocol by the total 
number of cells enumerated by FACS (TPMåçé|). Even though this approach is 
conceptually valid, the protocol used has the best accuracy for a limited dynamic 
range and it only provided results on total RNA and not mRNA. The other 
approach that I developed consisted of scaling the TPM values of a factor that 
minimizes the error between flow cytometry and deconvoluted proportions 
(TPM{{|). The most basic deconvolution method, LLSR, was used to estimate the 
proportions to avoid the introduction of extra noise from more complex 
deconvolution methods that are subjected to constraints (Materials and 
Methods).  
The different normalization methods were benchmarked by calculating the error 
value obtained by subtracting real and reconstructed PBMC expression values. 
This analysis confirmed my approach to be the best among all (Figure 4.6d). 
However, I also noticed that normalizing each sample to its specific mRNA yield 
(jSGèêëí) generated better results than using a median cell-type value 
(jSGèêëí). This finding suggests that there is substantial variability in the mRNA 
yield between individuals and although my method produces a single optimized 
value, further studies are required to explore the mRNA yield variability among 
samples belonging to the same cell type. 
The estimation of the mRNA scaling factor trough LLSR and optimization is only 
accurate if the deconvolution algorithm successively picks up cell type specific 
signals within a mixed sample. To obtain optimal results, I grouped B and T cells 
memory subsets and monocytes with non-classical and intermediate phenotypes, 
obtaining a total of 18 cell categories. Progenitor cells were the only cell type for 
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which deconvolution performed poorly and that could not be grouped with other 
cell types. The deconvolution results after normalization for mRNA abundance are 
reported in Figure 4.7a and a well-conditioned signature matrix is available in 
Supplement 11. The results obtained were robust also for cell types with a very 
low frequency in PBMCs, such as pDCs, mDCs, low-density neutrophils and low-
density basophils. 
The optimization procedure was repeated using microarray data for the PBMC 
samples and 16 cell categories were chosen as optimal classification (Figure 
A.21). Overall, the results were less accurate compared to using PBMC RNA-Seq 
data as mixed samples. There are two main disadvantages of the microarray 
platform compared to RNA-Seq: 1) a restricted upper limit due to probe saturation 
(Gong et al., 2011) and 2) the fewer annotated genes for which expression level is 
obtainable. An example of the latter is the lack of the TRDV2 gene expression 
which is essential to deconvolute the signal of Vδ2 yδ T cells. A limitation of both 
microarray and RNA-Seq technology is the background noise for low gene 
expression signals and this is the most plausible explanation why deconvolution 
performed poorly for progenitor cells. This limitation, however, can be overcome 
in RNA-Seq by increasing the sequencing depth and future studies are needed to 
further enhance deconvolution performance. 
This study used only the basic LLSR for all the deconvolution analyses but several 
other deconvolution algorithms that have been made available over recent years 
(Abbas et al., 2009; Gong et al., 2011; Shen-orr and Gaujoux, 2013; Newman et 
al., 2015). I assessed the performance of five deconvolution methods (Figure 
4.7b) and I found RLR and CIBERSORT (Newman et al., 2015) to be the least 
affected by noise and multicollinearity. All methods, however, reached optimal 
performance with a filtered and well-conditioned signature matrix. Nevertheless, 
I believe that in exploratory phases it is always useful to use the basic LLSR 
method as it reveals the sources of noise in the data. Other deconvolution methods 
apply constraints such as non-negativity and total sum to 1 and although this might 
substantially ameliorate the results in some cases, it would also tend to mask causes 
of low-performance.  
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4.5 Conclusions 
In this work, I used RNA-Seq data from PBMCs and 29 immune cell types to 
explore their transcriptional landscape, and give technical insight on normalization 
and absolute deconvolution. 
Regarding the transcriptional landscape, I found that T and B cells cluster more 
closely according to maturation stage than functionality. Hence, if specific 
transcriptomic signal is needed for memory cells, a better classification should be 
developed. T cell memory cells and monocytes show also a high inter-individual 
variability in terms of both gene expression proportions and abundance. Among 
all cell types, plasmablasts and LD neutrophils are characterized by a few set of 
very specific genes that contribute to the total gene expression, the opposite is seen 
in progenitor cells. Regarding mRNA abundance, instead, plasmablasts have the 
highest yield while LD neutrophils have the lowest. Moreover, the mRNA yield 
can vary greatly not only among cell types but also among individuals; hence the 
various implications should be explored in future works.  
Popular normalization methods, such as TMM and DESeq, are valid strategies for 
analyses like differential expression. With the TMM method I found plasmablasts 
to be under mitotic division while LD neutrophils have poor non-coding RNA 
activities compared to other cells. Moreover, as it is unfeasible to discuss all the 
results produced, lists of DEG, functional enrichments, and HK genes have been 
made available for researchers with specific biological questions (Supplements 8-
10). 
Regarding deconvolution, a correct normalization for mRNA abundance is 
necessary to obtain high-quality results. Hence, I developed a new approach based 
on LLSR and optimization to estimate mRNA yield scaling factors for RNA-Seq. 
Absolute deconvolution was then performed optimally on 18 and 16 cell categories 
on RNA-Seq and microarray mixed samples, respectively. The RNA-Seq signature 
matrices are made available for future deconvolution analyses on both RNA-Seq 
and microarray data of PBMCs (Supplement 11). 
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4.6 Supporting data 
The RNA-Seq data of the 29 immune cell types of the S1 cohort and PBMCs of 
the S1 cohort are available from the GEO repository GSE107011. The microarray 
data of the PBMCs of the S1 cohort are available from GSE106898. Both 
mentioned GEO repositories are accessible from the SuperSeries GSE107019. 
Supplement 7 Custom computer scripts used to perform the analyses. 
Supplement 8 Sheet 1: Information on all the cell categories used for differential 
expression analysis. Sheets 2-5: Fold change and FDR values of the DEG found 
using TPM and TPMTMM values. 
Supplement 9 Genes and functional enrichments analysis of the modules of the 
heatmaps built from differentially and co-expressed genes. 
Supplement 10 Sheet 1: functional enrichment analysis of the DEGs using the 
Reactome database. Sheet 2: list of immune cell HK genes. 
Supplement 11 Full and well-conditioned signature matrices for RNA-Seq and 
microarray deconvolution. 
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Chapter 5 General discussion 
My thesis contains a series of novel computational approaches to process and 
analyse high-throughput data in order to answer immunology-based research 
questions. Hence, my work falls in a field known as computational immunology 
or immunoinformatics, that I have introduced in the first chapter. For the result 
chapters, I analysed and interpreted large scale data from microarray, RNA-Seq 
and flow cytometry platforms. In this section I discuss the findings obtained from 
addressing research questions of both biological and technical interest related to 
the immune system and its data processing. I start with the discussion of the results 
from chapter 2 and chapter 4 that put more emphasis on the biological findings, 
and in particular about the differences and similarities of human processes with 
the mouse model ones and on the heterogeneity of the human immune cells. Next, 
I shift to the technical aspects of data analysis by discussing the algorithms 
employed and developed to analyse gene expression data in chapter 2 and 4, and 
flow cytometry data in chapter 3 and 4. Lastly, I speculate on future works that 
could derive from this thesis. 
5.1 The mouse as a model for the immune system 
The mouse is an extensively used animal model in bio-medical research because 
of its advantageous handling properties. However, translating research findings for 
applications on humans is not always possible because of evolutionary differences. 
In chapter 2, I presented a work that elucidated the similarities and differences 
between human and mouse using co-expression maps and homology annotations. 
I used online databases with gene sets related to tissues, pathways and diseases to 
make a comprehensive list of conserved and diverged elements. The gene sets 
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related with the immune system were found to be significantly conserved. 
However, few specific pathways were found to be diverged and they required more 
attention.  
There are a set of pathways that show diverged co-expression only when including 
one-to-many and many-to-many orthologs. This indicated that the divergence is 
due to the genes that duplicated after speciation. Genes related by duplication are 
referred to as paralogs and they are known to be the drivers of neo- or sub- 
functionalization (Koonin, 2005). The pathways showing this pattern are related 
with processing and trafficking of endosomal TLR, as well as signalling of 
interferon alpha/beta, growth hormone and prolactin.  
Another divergent force for a pathway is a high proportion of non-homologous 
genes. This, together with an increased number of paralogs, is probably the cause 
of divergence for processes that involve the antimicrobial peptides defensins. 
Other processes that are diverged are the ones related to butyrophilin family 
interaction and ubiquitination and proteasome degradation for antigen 
presentation. 
This is the first work presenting evolutionary differences of gene sets related to 
biological processes of any scale, from entire systems to small signalling 
pathways. Previous works have either focused on single diverged genes (Mestas 
and Hughes, 2004; Shay et al., 2013) or on entire tissues and large processes 
(Waterston et al., 2002; Breschi et al., 2016). A similar findings with these works 
include the large proportion of duplicated genes (Waterston et al., 2002; Shay et 
al., 2013) and the divergence of defensins (Mestas and Hughes, 2004). 
The co-expression maps used in my work were built from gene expression data of 
multiple tissues and conditions (van Dam et al., 2012). Collecting everything that 
was publicly available allowed to be more confident of the results because the 
noise of low quality data is minimized by the large sample size. Nonetheless, I 
believe that the size of publicly data is still not large enough to allow robust meta-
analysis for all single tissues or cell types. Moreover, biological processes 
generally involve the interaction among different system, and a selection of 
specific tissues or conditions would probably hide part of the processes.  
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A consideration that might be relevant is that gene expression profiles can be 
strongly influenced by the environment. We must remember that most of the 
mouse studies are done in pathogen free conditions where the immune system is 
generally either poorly or specifically challenged. This can produce differences 
between human and certain laboratory mouse strains that are not driven by 
evolutionary forces. However, since this is a recent phenomenon and I did not 
compare single genes, it is likely that the consideration stated in this paragraph 
does not have a significant impact on my work. 
5.2 Immune system heterogeneity 
The immune system is a complex dynamic network and the heterogeneity of its 
components has not been fully deciphered yet. In chapter 4 I used gene expression 
data to explore the molecular heterogeneity of 29 immune cell types composing 
the PBMCs. Those include 8 types of CD4 T cell, 4 of CD8 T cell, 3 of 
unconventional T cell, 5 of B cell, 3 of monocytes, 2 of dendritic cell, 2 of low-
density granulocytes, NK cells and progenitor cells.  
As expected, the t-SNE and clustering analyses showed that immune cells 
generally form very tight clusters with cells of the same type that in turn form less 
tight cluster with cell types of the same lineage. However, there are some 
exceptions. T cells cluster more closely according to their maturation stage than to 
their main function, e.g. helper or cytotoxic. Moreover, CD4 TEMRA show a more 
similar expression profile with T CD8 memory than with T CD4 memory 
suggesting a switch of functionality for the CD4 T cells in their last stage of 
maturation that has never been described before. CD8 TCM and CD8 TEMRA cluster 
more closely together compared to CD8 TEM, validating a previous finding 
(Willinger et al., 2005).  
Regarding the gene expression composition in terms of proportions, I found that 
the largest fraction of mRNA of plasmablasts and neutrophils is dominated by the 
expression of fewer genes compared to the remaining cell types. The opposite was 
found for progenitor cells, where a large fraction of mRNA is composed of a more 
heterogeneous number of protein-coding genes.  
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Another aspect of gene expression composition, however, is also the mRNA yield. 
As a matter of fact, when I considered this aspect, I found plasmablasts and 
neutrophils to have an opposite profile. The cell types with largest mRNA output 
were plasmablasts, monocytes and dendritic cells, while the cell types with the 
lowest mRNA output were low-density neutrophils, low-density basophils and TEMRA 
cells. 
Modules of differentially expressed genes and co-expressed genes were also 
retrieved and reported. Because this was the first work using RNA-Seq to compare 
such large numbers of different immune cell types, the resources provided are of 
great interest for immunologists that search for novel marker and target genes.  
A limitation of this work is the relatively low sequencing depth used for RNA-
Seq, as it does not allow to capture the signal for very lowly expressed genes. 
Another limitation is the relatively small sample size for each cell type. I used only 
2 samples for CD4 TEMRA and only 4 samples for the remaining cell types of young 
individuals. It is known, that transcriptomics variability increase with age because 
of inheritable factors (Brodin et al., 2015; Martinez-Jimenez et al., 2017) and some 
of the genes that proved to be specific in my work might reveal higher variability 
when using larger sample sizes or samples from elderly individuals. 
5.3 Gene expression data analysis and its applications 
Microarray and RNA-Seq are the two technologies that made it possible to analyse 
large scale gene expression profiles. Having the information on thousands of genes 
presents the researcher with a paradigm shift in the way the research question is 
formulated. From an approach that asks the question “which kind of data do I have 
to collect to validate my hypothesis?” we can shift to “which hypothesis can I make 
with the data I collected?”. In other words, we pass from a hypothesis-driven to a 
data-driven approach, and it is not only valid for bioinformatics but also for other 
research fields (Jaeger and Halliday, 1998; Kimmelman et al., 2014).  
The works reported in chapter 2 and 4 are examples of data-driven approaches. In 
chapter 2, I used co-expression maps built from thousands of datasets (van Dam et 
al., 2012) to find evolutionary differences between mouse and human on hundreds 
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of gene sets. Although I focused my attention on the immune system, I reported 
the results for an extensive list of tissue, pathway and disease gene sets. This 
allowed me to obtain unexpected results as I was not limited to test only few 
candidate gene sets. In chapter 4, I showed a different application called 
deconvolution that consists of retrieving the proportion of specific components 
from mixed samples. My mixed samples were PBMCs and using the distinct gene 
signatures of specific immune cell types I was able to perform absolute 
deconvolution, a task that was hypothesised to be a potential future endeavour in 
a recent review (Shen-orr and Gaujoux, 2013). My work in this case consisted of 
the optimization of this method, not in the determination of a biological 
conclusion. However, with the results I presented, absolute deconvolution can be 
used to make biological advancements by estimating immune cell types 
proportions from gene expression data of tissues from different conditions.  
Limitations of gene expression analysis are generally related to small sample sizes 
and technological caveats. For example, microarray data can only detect the 
expression of a pre-set number of genes and the dynamic range suffers of 
background noise and probe saturation in the lower and upper limit. However, in 
chapter 4 I show that deconvolution from microarray data of PBMC samples is 
still possible at least for major cell types. 
The RNA-Seq technology overcomes the limitation of microarrays and generates 
better deconvolution results (chapter 4). However, I still encountered some 
obstacles as there is still not a consensus on the optimal RNA-Seq data pre-
processing. The normalization of RNA-Seq data was the main obstacle, as it is 
laborious to reduce the bias introduced by the several steps of library preparation. 
The data were first normalized for sequencing depth and gene length with the TPM 
procedure. Next, the data were normalized for mRNA yield using a deconvolution 
based algorithm that I developed (chapter 4). The importance of normalizing the 
data for mRNA yield has already been stated in previous works (Lovén et al., 2012; 
Aanes et al., 2014). However, for simplicity, purely mathematical methods, such 
as TMM and DESeq, are still more widespread (Li et al., 2015). A second 
limitation of RNA-Seq that I could not overcome as it is imbedded with the 
technology, is the inability to detect the signal for very lowly expressed genes. 
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Nevertheless, contrarily to microarrays, this limitation can be overcome by 
increasing the sequencing depth.  
5.4 Flow cytometry in bioinformatics  
Even though flow cytometry is a relatively old technology, it continues being the 
technology of choice among immunologists. Because of its legacy, the analysis of 
flow cytometry data is still largely carried out with manual and time consuming 
approaches. However, large efforts have been made recently to create 
bioinformatics tools to standardize data analysis (Aghaeepour et al., 2013). 
In this context, I gave my contribution by developing flowAI, a tool to discern 
anomalies from flow cytometry data in an automatic or interactive fashion (chapter 
3). flowAI operates by detecting and removing anomalies from 3 properties of flow 
cytometry: 1) flow rate, 2) signal acquisition and 3) dynamic range. A limitation 
of flowAI is that it requires the manual adjustment of the settings to operate 
optimally for different datasets, however, flowAI still presents several advantages 
compared to previous algorithms. flowQ, for example, verifies the same aspects of 
flow cytometry, but it produces less clear graphics and it does neither detect nor 
removes the anomalies (Gentleman et al., 2006). A more recent software, 
flowClean, removes the anomalies automatically but it provides a poorly intuitive 
report and requires larger computer resources (Fletez-Brant et al., 2016).  
Flow cytometry data was also used in chapter 4 to calculate the proportion of 
immune cell types to validate deconvolution algorithms. The quality control and 
the removal of anomalies was performed with flowAI. The gating analysis was 
performed manually using flowJo, although there are already tools that can be used 
for automatic gating and should be considered for future analyses (Finak et al., 
2014; Malek et al., 2015).  
5.5 Future works 
Due to the heterogeneity of the immune system, my thesis and previous works only 
mark the beginning of a long journey. Therefore, in this section I present some 
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directions for future projects that aim at a more comprehensive understanding of 
the immune system. 
Increasing the sample size 
As for many biological components, gene expression is highly influenced by 
genetic and environmental factors. The variability among individuals can only be 
discovered by increasing the sample size of an experiment. For instance, any work 
I presented in this thesis would likely give further insights by just increasing the 
sample size. In addition, detailed clinical information on each individual would 
allow to associate gene expression with factors such as diseases, age or ethnicity. 
More specifically, increasing the sample size would allow to: 1) discriminate the 
genes, or modules of genes, whose expression remains constant from those whose 
expression increases in variability; 2) make more robust assumptions on the 
differences between human and mouse gene expression; 3) create a more stable 
signature matrix for deconvolution by excluding the genes that show increased 
variability. 
Make full use of new sequencing technologies 
RNA-Seq is rapidly superseding the previous most common high-throughput 
technology, the microarray. RNA-Seq has the advantages that it does not have a 
limited dynamic range and it allows for the identification of novel genes and 
transcripts. The limitations of sequencing technologies, such as costs and 
challenging data analysis, are also rapidly disappearing. 
By fully adopting the RNA-Seq, future works could be done at the transcript level 
instead of the gene level and at an increased sequencing depth. In relation to my 
thesis, this would allow the identification of novel transcripts that: 1) cause 
immune cell heterogeneity; 2) cause differences between mouse and human; 3) 
improve absolute deconvolution. 
Moreover, exome SNPs could be detected assuming a high enough sequencing 
depth. This would expand our knowledge on the general and tissue specific 
regulatory SNPs that contribute to variability within a population.  
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Single cells analysis 
The analysis of the heterogeneity among single cells is also another future research 
task to consider. A recent review discusses the importance of single cell analysis 
for the immune system to understand aspects like heterogeneity, classification and 
differentiation trajectories (Chattopadhyay et al., 2014; Proserpio and Mahata, 
2016).  
Flow cytometry has always been able to analyse single cells whereas single cell 
sample preparation protocols for RNA-Seq have only relatively recently been 
designed. Transcriptomic analyses at the single cell level allow the molecular 
classification of sub-population of cells from groups of cells that are 
morphologically similar. This will increase the “resolution” in all the aspects 
considered in this thesis, such as heterogeneity, evolution, and deconvolution.  
Integration with other “omics” data  
It is not possible to fully understand biological processes by analysing only one or 
two molecular aspects. Transcriptomic data should be integrated with other 
“omics” data, such as genomics, epigenomics, proteomics, and metabolomics. 
By integrating the different kinds of data together, we could improve our 
understanding for immune cell heterogeneity as we can classify cells by a set of 
different connected features. We could define the biological processes that are 
conserved between human and mouse in gene expression but diverged in post-
translational modification and other downstream changes. We could improve 
deconvolution by utilizing methylated spots, expressed proteins or metabolites to 
discern different cell types that have similar gene expression profiles. 
Optimization of automatic pipelines 
The automatization of data analysis is fundamental to reduce the time devoted to 
repetitive tasks. However, it is challenging to obtain pipelines of analysis that are 
robust to any sort of variability in the data. Tools developed for both RNA-Seq 
and flow cytometry analysis are more valuable when they can be integrated in 
robust pipelines (Finak et al., 2014). 
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A follow up work to the development of the flowAI tool would be its integration 
in automatic pipelines for the analysis of flow cytometry data. This would require 
a more extensive exploration of the issues encountered in a variety of different 
situations, such as using different flow cytometry instruments and sample 
preparation methods.  
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Chapter 6 Conclusion 
In this thesis, I presented a series of computational works with the aim of 
understanding the immune system using high-throughput gene expression and 
flow cytometry data. Moreover, with this purpose in mind, I carried out research 
with both biological and technical implications.  
In chapter 2, I reported a comprehensive list of conserved and diverged process 
related to tissue, pathways and diseases with a focus on the immune system using 
co-expression networks and gene homology annotations. Part of the results agreed 
with previous findings, while other results have not been described before. The 
main findings related to the immune system include the divergence of interferon 
alpha/beta, prolactin and growth hormone signalling because of duplicated genes 
and the divergence of defensins, butyrophilins, and ubitiquination and proteasome 
degradation for antigen presentation because of different factors. Moreover, from 
the consultation of the full results it is possible to verify in more details the level 
of divergence and conservation of each process of interest. Researchers will benefit 
from them when planning to translate mouse research to human, in order to predict, 
and potentially avoid, human-mouse inconsistencies. 
Chapter 3 is dedicated to the development of flowAI, a tool for the quality control 
of flow cytometry data. flowAI can remove unwanted events in either an automatic 
or interactive fashion. The cleaning procedure consists in the detection and 
removal of anomalies by checking three properties of flow cytometry: 1) flow rate, 
2) signal acquisition, and 3) dynamic range. flowAI should be used as a first pre-
processing step on flow cytometry data analysis and it can be potentially included 
in automatic pipelines. The flowAI tool is available from Bioconductor as an R 
package and it has been implemented by the ImmPortGalaxy platform and the 
flowJo software for a more user-friendly usage. 
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The work in chapter 4 is based on a series of bioinformatics analyses on RNA-Seq 
data from 29 immune cell types constituting PBMCs and flow cytometry data. The 
transcriptomic relationship among the cell types was explored first using clustering 
and dimensionality reduction methods. The analysis on mRNA proportions 
revealed the number of genes contributing to the largest fraction of mRNA for each 
cell type. The analysis on mRNA yield, instead, revealed the differences between 
the cell types in mRNA output. Because of the large heterogeneity of mRNA 
properties between the 29 immune cell types, I developed an algorithm capable of 
optimizing the normalization for mRNA yield of RNA-Seq data. With the resulting 
normalized gene expression data and the flow cytometry data, I performed 
absolute deconvolution. In short, the work in chapter 4 is designed to improve our 
knowledge on the gene signature specific to different immune cell types that can 
potentially reveal novel cell markers or therapeutic targets. In addition, this work 
provides new technical insights on RNA-Seq normalization and absolute 
deconvolution that can add value to future bioinformatics works.  
In conclusion, in this thesis I showed a series of works that fall under the expanding 
umbrella of computational immunology. The novel findings and approaches 
presented here are of interest to any biologist, and more generally to any 
researcher, involved in disease and ageing studies with an inclination toward an 
immune system perspective. 
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Appendix A Supplementary figures and tables 
 
Figure A.1 Parameters used to define the evolutionary changes that occur in a gene set between 
humans and mice. A Mann Withney U test has been used to compare the i) commonly co-expressed 
genes and ii) differential connectivity values of the homologs of a gene set with the values of the 
remaining homologs. As a measurement to indicate the divergence of the distribution of the values 
of a gene set from the ones of the remaining homologs, in a bar plot I reported the median difference 
of the two distributions for each gene set with an asterisk indicating the significant results with 
FDR < 0.05. A Fisher’s exact test has been used to compare the proportion of iii) one-to-many 
orthologs and iv) homologs of a gene set with the proportion of the remaining homologs and non-
homologs respectively. The forest plots display the odd-ratio from the Fisher’s exact test, plus the 
95% confidence intervals. 
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Figure A.2 Conservation and divergence for Reactome pathways belonging to top hierarchy 
categories A-D. All the gene sets of the first and second hierarchical level were reported. The gene 
sets of the third and following levels were only reported if significant for multiple parameters (q-
value < 0.05 in four cases of six considering one-to-one and entire list of orthologous as separate 
cases) or extremely significant in at least one parameter (q-value < 5e-11). For other details refer 
to Methods, Figure A.1 and Figure 2.6. 
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Figure A.3 Conservation and divergence for Reactome pathways belonging to top hierarchy 
categories E-M. For analysis details refer to Methods, Figure A.1, and Figure A.2. 
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Figure A.4 Conservation and divergence for Reactome pathways belonging to top hierarchy 
categories N-Z. For analysis details refer to Methods, Figure A.1, and Figure A.2. 
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Figure A.5 Quality control results of an FCS file from the SLAS dataset (Panel 2). (a) The flow 
rate contains anomalies in the final region arguably due to clogged cells. (b) and (c) are respectively 
the ECDF and boxplots of the fluorescence intensity values of the low-quality events detected in 
the flow rate and sampling of the high-quality ones of the channel Qdot 655-A. (d) In the signal 
acquisition check a change in the signal is detected in the last part of the analysis that corresponds 
to the anomalies detected in the flow rate. (e-f) percentage of doublets in the file with high quality 
cells (e) and with low quality cells (f).  
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Figure A.6 Quality control results of the 0003.fcs file from the ZZZU dataset. (a) The flow rate 
check detects a small surge at the beginning and a large surge at the end of the experiment. (b) A 
changepoint was detected at the bin ID 709 for the PE-A channel and in surrounding regions for 
other channels. The anomalies in this region correspond to the surge in the last region of the flow 
rate. (c) Plot indicating the number of negative outliers detected over time. The peaks correspond 
to the surges in the flow rate. (d-e) The boxplots show the variation of the raw intensity for the low-
quality data and three samplings of the high-quality data values of the channels APC-A and APC-
Cy7-A. All the boxplots data have a sample size corresponding to the total low quality data. 
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Figure A.7 Quality control results of the 002.fcs file from the ZZ99 dataset. (a) The flow rate check 
detects several surges in the flow rate interspersed through the entire duration of the experiment. 
(b) A changepoint was detected at bin ID 95 for the parameter B515-A. Other changepoints were 
detected at bin ID 35 of the channels G780-A, G710-A, G660-A, G610-A. A technical anomaly is 
visible for the green laser and it warrants a monitoring and eventually a check of the laser 
functionality of the flow cytometry instrument. Note that only a sample of exemplary channels is 
reported. (c) Plot indicating the number of negative outliers detected over time. The peaks 
correspond to the surges in the flow rate. (d-e) The boxplots show the variation of the raw intensity 
values for the low-quality data and three samplings of the high-quality data for the parameters 
G660-A and G610-A. All the boxplots data have a sample size corresponding to the total low 
quality data. 
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Figure A.8 Quality control results of an FCS file from the SLAS dataset (Panel 1 staining). (a) As 
for Fig. S2, several surges interspersed in the flow rate are detected by the automatic method in 
flowAI. (b-c) Percentage of debris before (b) and after performing the quality control of the flow 
rate (c), indicating that surges in the flow rate might be elicited by clusters of debris. (d) ECDF 
curves and (e) boxplot show the variation of the logarithmic values of the low-quality events 
recorded in the FSC-A channel compared to three samplings of high quality events. (f) The signal 
acquisition check shows some outliers corresponding to surges in the flow rate. Moreover, there is 
a slow decrease in the signal acquired over time, a rare circumstance due to different possible 
causes, such as laser instability, laser alignment, efficacy of detection, poor sample preparation, 
quality of the sheath fluid and accumulation of dirt in the flow cell. 
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Figure A.9 Quality control results of an FCS file from the SLAS dataset (Panel 1). (a) In this case, 
at about 500 seconds, a consistent change of the flow rate occurred most likely due to the change 
of the speed setting by the FCM operator during the running of the analysis. The ECDF in (b) 
shows that the shift of the signal intensity distribution occurs uniformly across the entire range of 
values. The boxplots in (c) confirm this variation for the channel PE-A. All the boxplots and ECDF 
data have a sample size corresponding to the low-quality data detected in the flow rate check. In 
(d) we can observe that the shift in the flow rate causes a shift of the median intensity value during 
signal acquisition. 
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Figure A.10 Gating strategies for sorting the immune cell types and retrieving their percentages. 
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Figure A.11 Visualization of hierarchical clustering and PCA analysis on filtered TPM values. 
(a) PCA analysis showing the first two components and the variance explained by the first 20 
components. (b) Hierarchical clustering of the immune cell type. The colored dots at the end of 
each terminal node correspond to different individuals. 
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Figure A.12 Module analysis of the DEGs heatmap of Figure 4.3. (a) Hierarchical clustering of 
the differentially expressed genes generated from Euclidean distance. The modules were 
retrieved by cutting the tree with the hybrid method from the Dynamic Tree Cut algorithm. (b) 
Eigengene adjacency heatmap of the modules reported in (a). 
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Figure A.13 Modules analysis of the co-expression heatmap of Figure 4.4. (a) Hierarchical 
clustering generated from the “unsigned” adjacency matrix created in two steps as described in 
the WGCNA manual. In the first step, I calculated the absolute Spearman’s correlation each 
gene pair raised to the soft thresholding power of 6 to approximate to the scale-free topology. In 
the second step, I calculated the consensus Topological Overlap used for the clustering. The 
modules were retrieved by cutting the tree with the hybrid method from the Dynamic Tree Cut 
algorithm and then merging the closest modules. (b) Eigengene adjacency heatmap of the 
modules reported in (a). (c) Boxplot of the co-expression connectivity of the genes contained in 
each module. 
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Figure A.14 Venn diagrams showing the comparison of specific markers found in this work for 
four major cell types (T cells, B cells, NK cells and DCs) with other two publicly available 
collections based on microarray data. Genes symbols annotated for this work were used as 
reference list and the genes from the other two works that were not present in the reference list 
were excluded from the comparison. 
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Figure A.15 Violin plots of the log2 TPMTMM expression of selected gene sets from the Reactome 
database. 
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Figure A.16 Violin plots of the log2 TPMTMM expression of selected gene sets from the Reactome 
database. 
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Figure A.17 Circos plots of the percentage of TPM expression in genomic windows of 15 Mbp 
for all the RNA-Seq of 12 cell types (Part 1). Each circos plot shows a different immune cell 
type. The genes reported have an expression of at least 0.05 % of total expression in at least one 
sample. Asterisks indicates the genes whose expression is significantly higher for the cell type. 
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Figure A.18 Circos plots of the percentage of TPM expression in genomic windows of 15 Mbp 
for all the RNA-Seq of 12 cell types (Part 2). See Figure A.17 for further details. 
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Figure A.19 Circos plots of the percentage of TPM expression in genomic windows of 15 Mbp 
for all the RNA-Seq of 5 cell types and PBMCs (Part 3). See Figure A.17 for further details. 
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Figure A.20 The raw gene counts plotted against GC content for the PBMCs and the 29 immune 
cell types. PBMCs are reported in each plot and the color-code is equivalent to the one in Figure 
4.2a. 
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Figure A.21 Comparison between real flow cytometry proportions and proportions estimated 
with LLSR using microarray data as mixed samples and normalized RNA-Seq data as signature 
matrix. 
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Table A.1 Staining panels used for immunophenotyping and cell sorting. 
* Pre-incubation at 37° for 10 minutes 
 
 
 
 
1) PANEL FOR CD4 T CELLS 
Surface marker Antibody clone Fluorochrome Company 
CD3 UCHT1 FITC BioLegend 
CD4 RPAT4 APC-Cy7 BioLegend 
CD25 M-A251 PE-Cy7 BioLegend 
CD127 A019D5 APC BioLegend 
CXCR5 J25204 PE-TexasRed BioLegend 
CD45RA H100 BV605 BD 
CCR7 G043H7* PerCP-Cy5.5 BioLegend 
CCR6 11A9 PE BD 
CXCR3 G025H7 BV650 BioLegend 
CCR4 L2A1H4 BV421 BioLegend 
 
Cell type Gating strategy 
T follicular helper  
CD3+ 
CD4+ 
CXCR5+ 
T regulatory cells  CD25+ (high)  CD127+ (low) 
T helper 1  CXCR3+ CCR6- 
T helper 1/T helper 17  CXCR3+ CCR6+ 
T helper 17  CXCR3- CCR6+ 
T helper 2  CCR4+ 
T CD4 EMRA CCR7- D45RA+ 
T CD4 Naive CCR7+ CD45RA+ 
 
2) PANEL FOR CD8, ϒ/δ AND MAIT T CELLS 
Surface marker Antibody clone Fluorochrome Company 
CD3 UCHT1 FITC	 BioLegend	
CD8 SK1 APC-Cy7	 BioLegend	
CD45RA H100 BV605	 BD	
CD161 HP3G10 PE	 BioLegend	
Vα7.2 3C10 PE-Cy7	 BioLegend	
TCR ϒ/δ 11F2 APC	 Miltenyi	
Vd2 B6 BV711	 BioLegend	
CCR7  G043H7* PerCP-Cy5.5	 BioLegend	
CD45RA H100 BV605	 BD	
 
Cell type Gating strategy 
ϒ/δ Vd2+ 
CD3
+ 
TCR ϒ/δ+ Vd2+ ϒ/δ Vd2- Vd2- 
MAIT  Vα7.2+  CD161+ (high) 
T CD8 Naive 
CD8+ 
CCR7+ CD45RA+ 
T CD8 Central Memory  CCR7+ CD45RA- 
T CD8 Effector Memory  CCR7- CD45RA- 
T CD8 EMRA CCR7- CD45RA+ 
 
3) PANEL FOR B CELLS AND PROGENITORS 
Surface marker Antibody clone Fluorochrome Company 
CD19 H1B19	 PeCy7	 BioLegend	
IgD 1A6-2	 PE-TexasRed	 BioLegend	
CD45 H130	 AF700	 BioLegend	
DUMP - CD3 UCHT1	 FITC	 BioLegend	
DUMP - CD56 HCD56	 FITC	 BioLegend	
DUMP - CD16 3G8	 FITC	 Miltenyi	
DUMP - CD14 HCD14	 FITC	 BioLegend	
CD27 0323	 BV421	 BioLegend	
CD38 HIT2	 APC	 BioLegend	
CD34 563	 PE	 BD	
 
Cell type Gating strategy 
Progenitor cells 
DUMP- 
CD45+ 
 CD34+ CD45+ (low) 
Naïve	B	cells	
CD19+ 
CD27- IgD+ 
Non-switched	memory	
B	cells	 CD27+ IgD+ 
Exausted	B	cells	 CD27- IgD- 
Switched	memory	B	
cells	
CD27- IgD+ CD38+ 
(low) 
Plasmablasts	 CD27- IgD+ CD38+ (high) 
 
4) PANEL FOR MONOCYTES, DENDRITIC CELLS, NK CELLS AND LOW-DENSITY GRANULOCYTES 
Surface marker Antibody clone Fluorochrome Company 
DUMP	-	CD3	 UCHT1	 FITC	 BioLegend	
DUMP	-	CD19	 H1B19	 FITC	 BioLegend	
CD45 H130	 AF700	 BioLegend	
CD11c	 B-LY6	 APC	 BD	
CD14	 HCD14	 PE-TexasRed	 BioLegend	
CD16	 3G8	 APC-Cy7	 BioLegend	
CD56	 HCD56	 PerCP-Cy5.5	 BioLegend	
CD33	 WM53	 BV421	 BD	
CD11b	 ICRF44	 PE	 BioLegend	
CD123	 6H6	 BV605	 BioLegend	
HLA-DR	 L243	 Pe-Cy7	 BioLegend	
 
Cell type Gating strategy 
Low-density 
neutrophils 
DUMP- 
CD45+ 
SSC-A+ (high) CD16+ (high) 
NK	cells	 CD16+ CD56+ 
Classical monocytes 
CD11c+  
CD14+ CD16- 
Intermediate 
monocytes CD14+ CD16+ 
Non-classical 
monocytes CD14+ (low) CD16+ 
Myeloid	Dendritic	
Cells		 HLA-DR+ CD11c+ 
Plasmacytoid	Dendritic	
Cells		 HLA-DR+ CD123+ 
Low-density	basophils	 HLA-DR- CD123+ 
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Table A.2 Grouping of the immune cell types for RNA-Seq and microarray deconvolution. 
 
 
 
The	29	immune	cell	types	(full	
name)	
The	29	immune	cell	types	
(abbreviated	name)	
Grouping	for	RNA-
Seq	deconvolution	
Grouping	for	microarray	
deconvolution	
Progenitor	cells	 Progenitors	 Progenitors	 Progenitors	
Naive	B	cells	 B	Naive	 B	Naive	 B	Naive	
Non-switched	memory	B	cells	 B	NSM	
B	Memory	 B	Memory	Exhausted	B	cells	 B	Ex	
Switched	memory	B	cells	 B	SM	
Plasmablasts	 Plasmablasts	 Plasmablasts	 Plasmablasts	
Naive	T	helper	cells	 T	CD4	Naive	 T	CD4	Naive	 T	CD4	Naive	
Follicular	helper	T	cells	 Tfh	
T	CD4	Memory	 T	CD4	Memory	
T	regulatory	cells	 Tregs	
Th1	cells	 Th1	
Th1/Th17	cells	 Th1/Th17	
Th17	cells	 Th17	
Th2	cells	 Th2	
Effector	memory	RA	CD4	T	cells	 T	CD4	EMRA	
Naive	CD8	T	cells	 T	CD8	Naive	 T	CD8	Naive	 T	CD8	Naive	
Central	memory	CD8	T	cell	 T	CD8	CM	
T	CD8	Memory	 T	CD8	Memory	Effector	memory	CD8	T	cells	 T	CD8	EM	
Effector	memory	RA	CD8	T	cells	 T	CD8	EMRA	
Vd2	γδ	T	cells		 T	γδ	Vd2	 T	γδ	Vd2	 T	γδ	Non-Vd2	γδ	T	cells		 T	γδ	non-Vd2	 T	γδ	non-Vd2	
MAIT	cells	 MAIT	 MAIT	 MAIT	
Natural	killer	cells	 NK	 NK	 NK	
Plasmacytoid	dendritic	cells	 pDCs	 pDCs	 pDCs	
Myeloid	dendritic	cells	 mDCs	 mDCs	 mDCs	
Classical	monocytes	 Monocytes	C	 Monocytes	C	
Monocytes	Intermediate	monocytes	 Monocytes	I	 Monocytes	NC+I	Non-classical	monocytes	 Monocytes	NC	
Low	density	neutrophils	 Neutrophils	LD	 Neutrophils	LD	 Neutrophils	LD	
Low	density	basophils	 Basophils	LD	 Basophils	LD	 Basophils	LD	
